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The thymus in mice and humans originates from the third pharyngeal pouch 
endoderm. This process is divided into early Foxn1-independent stages and later 
Foxn1-dependent stages. Foxn1 is indispensible for the differentiation of thymic 
epithelial progenitor cells (TEPCs) as the development of thymus in Foxn1 mutant 
mice is arrested around E12.5. The transcriptional changes associated with the 
developmental of the thymus are poorly understood. In particular, the transcriptional 
regulation of Foxn1 in the developing thymic rudiment has not been definitively 
identified. Recently, Pax1, Pax9, Tbx1, and E2Fs have been implicated in 
transcriptional regulation of Foxn1. However, with the exception of E2Fs, evidence 
regarding their direct involvement in regulating Foxn1 expression is missing. 
Therefore, the aims of this thesis were to study the transcriptional regulation of 
Foxn1 through identification of its regulatory regions and studying the transcriptional 
changes associated with the developing thymus. These aims were addressed through 
the use of chromatin-immunoprecipitation technique combined with next-generation 
sequencing and gene expression analyses of the developing TEPCs. The data 
presented in this thesis identified H3K4me3 and H3K27ac marked Foxn1 promoter 
and five H3K4me1 and H3K27ac marked putative enhancer regions. The 
combination of gene expression analyses and transcription factor binding sites within 
the above regions suggested Ets1, Isl1, Foxc1, Nfia, Nfib, Srf, Foxo1, Nfatc2, Ing4, 
Foxa2, Hes1, E2Fs, and p53 as candidate transcriptional regulators of Foxn1. Nfatc2 
appears also to be a target of Foxn1 that could play an important role in thymus 
development by regulating a large set of genes. Comparison of wild type and Foxn1 
null thymus showed that Foxn1 could act as positive regulator of Pax1 and negative 
regulator of Gata3 and Eya1, genes important for third pharyngeal pouch 
development. The comparison of transcriptome of E10.5 and E11.5 third pharyngeal 
pouch cells and E12.5 TEPCs showed that genes involved in tissue development are 
downregulated while those involved in antigen presentation, a process important for 
thymus function, are upregulated during development. These results also 
demonstrated a decrease in the activity of transcription factor network involving Hox 
genes and an increase in the activity of a network involving Nfkb, Rela, and Irf 
genes. Analysis of signalling pathways suggested that the NFκB signalling pathway 
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could be important for thymus development after E12.5 while TGFβ signalling 
pathway appeared to be detrimental to Foxn1 expression in thymic epithelial cells. 
Together, I identified several transcription factors that could be involved in 
transcriptional regulation of Foxn1 in TEPCs, several genes that could be a target of 
FOXN1, changes in transcription factor network and signalling pathways associated 




The maturation of T-cells depends on an extensive crosstalk between the developing 
thymocytes and a functional thymic stroma, which consists of thymic epithelial cells, 
mesenchymal cells, dendritic cells, and others cell types. Amongst these, the thymic 
epithelial cells play a critical role in positive and negative selection of maturing T-
lymphocytes ensuring generation of a pool of self-restricted and self-tolerant 
functional T-cells. The development of the thymus from third pharyngeal pouch 
depends on the transcription factor, Foxn1. Transcription factors are proteins that can 
regulate the expression of genes (transcription) within a cell. The transcriptional 
regulation of Foxn1 in TECs is currently not well understood. Thus, the aim of this 
thesis was to use high-throughput and genomic approaches to investigate the 
transcriptional regulation of Foxn1 in thymic epithelial progenitor cells, which are 
capable of giving rise to all TEC subpopulations. Using analysis of fetal wild type 
and Foxn1 null thymi, I interrogated the expression pattern of candidate genes for 
those consistent with candidate transcriptional regulators of Foxn1. This led to 
identification of genes whose expression in TEPCs is influenced by presence or 
absence of FOXN1 and also of genes whose expression profile matches that expected 
of a transcriptional regulator of Foxn1. I then identified TEPC-specific putative gene 
regulatory elements using chromatin-immunoprecipitation (ChIP), a technique that 
identifies proteins bound to DNA, combined with next generation sequencing. ChIP 
for histone (proteins around which DNA is wrapped in the cell) marks characteristic 
of active promoter and enhancer regions (genomic regions that regulate gene 
expression). Four putative enhancer regions and a promoter region were identified 
for Foxn1. Bioinformatics analysis of the Foxn1 promoter and enhancers identified 
several transcription factors binding sites within each of these regions. Furthermore, 
the transcriptional changes associated with developmental progression from third 
pharyngeal pouch cells to thymic epithelial progenitor cells were investigated using 
RNA (products of gene expression) sequencing. This allowed identification of genes 
characteristic of each developmental time point, and genes and signaling pathways 
regulated differentially during development. The RNA-seq data also suggested that 
most of the genes with physical binding sites within identified Foxn1 promoter and 
putative enhancers are expressed in the developing thymic rudiment. Collectively, 
the above approaches identified a signaling pathway which, when modulated in-vitro 
or in-vivo, can affect the expression of Foxn1 within thymic epithelial cells, possibly 
by the binding of its effector molecules to the binding sites identified within Foxn1 
promoter and/or putative enhancers. Finally, I also present a list of transcription 
factors that represent good candidates for further testing their involvement in 
regulation of Foxn1 expression. 
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1.1 Regulation of gene transcription in eukaryotes 
Regulation of gene expression is fundamental for every biological process. Genes 
within any cell are constantly being turned on or off depending on numerous cell 
intrinsic and extrinsic factors. Perturbations in regulation of this process results in 
abnormal behavior of cells, leading to disorder and diseases. Reflective of its 
importance to cell survival and function, gene regulatory mechanisms have evolved 
to become exquisitely sophisticated. François Jacob and Jacques Manod pioneered 
the first gene regulatory model in the early 1960s. This model laid the foundation for 
the concept of gene products being involved in regulation of transcription. The 
current model of gene transcription regulation involves integration of cellular history 
and extracellular environment occurring at chromatin level and mediated by 
functionally diversified cis-regulatory elements, such as promoter, enhancers, 
silencers, and insulators. Among these, promoters and enhancers have received great 
interest from the research community owing to their importance in gene transcription 
regulation. Promoters are typically defined as DNA region in the immediate vicinity 
of the transcription start site, which acts as a docking site for pre-initiation complex 
and other proteins. Enhancers, on the other hand, are DNA elements that could 
improve the transcription of target genes over huge genomic distances and 
independently of both orientation and position. Enhancers also govern the spatial and 
temporal regulation of its target gene(s) expression. Given this property of 
enhancers, their identification in the past often relied upon discovery of disease-
associated mutations occurring at a considerable distance from the candidate gene. 
However, recent advances in our understanding of epigenetics and its role in 
regulating gene transcription has allowed identification of combinatorial chromatin 
signatures that allow prediction of enhancers, and also of promoters. Genome-wide 
analysis of histone modifications, facilitated by approaches such as chromatin 
immunoprecipitation combined with microarray or next-generation sequencing, 
showed that combinations of histone modifications can be used to identify promoters 
and enhancers (Heintzman et al. 2007; Creyghton et al. 2010; Rada-Iglesias et al. 
2011). These studies showed that promoters and enhancers can be identified by 
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presence of histone modifications H3K4me3 and H3K4me1, respectively. 
Furthermore, presence of overlapping H3K27ac histone modification in addition to 
the above can distinguish between “active” and “inactive” promoters and enhancers.  
 
The promoters and enhancers influence the transcription of target genes by binding 
of transcription factors (TFs) to specific DNA sequences within these elements. The 
binding of TFs to DNA is influenced by various factors associated with DNA 
sequence, such as CpG island, DNA methylation, presence of histones and higher-
level DNA structures, and histone modifications (reviewed in (Lenhard et al. 2012; 
Calo & Wysocka 2013)). Furthermore, some transcription factors, such as FOX 
family members, have the ability to modify chromatin structures to make the 
underlying DNA sequence more accessible for other factors . The binding of TFs to 
specific DNA sequences is also influenced by the presence of other TFs and co-
factors, providing additional layer of specificity and selectivity (Lelli et al. 2012). 
Given that enhancers can be located at huge distances from their target genes, the 
question of how these elements affect transcription has received a lot of attention in 
the last few years. One such study showed that cohesion complex could play an 
important role in bringing together enhancers and promoters by a threading 
mechanism in which Mediator-bound DNA is bought in close proximity of the TSS 
(Kagey et al. 2010). Recent studies have also suggested coding exons could act as 
enhancers for nearby genes, controlling their tissue-specific expression (Birnbaum et 
al. 2012). Furthermore, there is also evidence of bidirectional transcription from 
some enhancer elements, suggesting that these non-coding RNAs from enhancers 
could provide another level of complexity in regulation of transcription (Creyghton 
et al. 2010; Rada-Iglesias et al. 2011). Finally, the relative contribution of enhancers 
and promoters in regulation of transcription can be different for different gene 
classes. Developmental genes are typically regulated at both the enhancer and 
promoter level, tissue-specific genes predominantly depend on cis-regulatory 
modules, and housekeeping genes have a preference for promoter based regulation 
(Ernst et al. 2011). Thus, gene transcription results from cumulative effect of various 
inputs of varying degrees of complexity. This thesis addresses the transcriptional 
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regulation of a key cell type in the thymus, one of the central organs of the immune 
system. 
	
1.2 Introduction to the thymus 
The thymus, a primary lymphoid organ central to immune system function, is a 
multi-lobed organ located within the mediastinum of the thoracic cavity, in front of 
the heart and behind the sternum (Figure 1.1A). The thymus is the main site of T-
lymphocyte development, the commitment, differentiation, and repertoire selection 
of T-lymphocytes happens within the thymus. The classical mouse model nude, 
caused by a recessive mutation in the key transcription factor Foxn1, results in the 
absence of a functional thymus (athymia) leading to a lack of mature, functional T-
cells in the periphery and thus severe immunodeficiency (Nehls et al. 1994). 
 
1.2.1 Thymus structure and morphology 
The thymus is a multi-lobular organ. Each lobe consists of a central medulla, an 
outer cortex, and a cortico-medullary junction (CMJ) (Figure 1.1B). The thymic 
lobes are surrounded by a layer of connective tissue, known as the outer capsule, and 
an inner sub-capsular layer composed of simple epithelium (Boyd et al. 1993). In 
adults, the developing T-lymphocytes account for most of thymic cellularity (~95%) 
with the rest being composed of the thymic stroma (Blackburn & Manley 2004). The 
thymic stroma is a highly complex microenvironment consisting of a number of 
different cell types, including thymic epithelial cells (TECs), dendritic cells, 
fibroblasts, macrophages, natural killer cells, and B-cells. The TECs, which form the 
major component of the thymic stroma, can be further sub-divided based on their 
location within the thymus and the presence of various surface markers. The 
epithelial cells of the cortex, also known as cortical thymic epithelial cells (cTECs), 
are identified by the presence of Ly51 or CD205. On the other hand, the medullary 
epithelial cells (mTECs) are identified by the presence of UEA1. A small proportion 
of the UEA1+ mTECs also express AIRE, and are thought to be post-mitotic. Mature 
cTECs and mTECs are thought to be distinguished from their immature counterparts  
A B
C
Figure 1.1: Thymus location, structure and the process of T-cell development.
(A) The murine thymus is located within the midline (mediastinum) of the thoracic cavity, in front of the 
heart and behind the sternum. (B) H&E stain of the murine thymus depicting the darker cortex and lighter 
medulla. The cortex stains darker due to higher density of thymocytes relative to the medulla. The thymic 
storma consists of thymic epithelial cells, dendritic cells, macrophages, and fibroblasts. Also shown is the 
surrounding capsule indicated with an arrow. C: cortex, M: medulla. (A) and (B) adapted from Kelly M, 
PhD thesis. (C) Schematic of major events in thymocyte development. The early thymic progenitors 
entering the thymus at the cortico-medullary junction are multipotent. When ETPs lose multipotency, they 
become double negative (DN) cells, and begin T cell receptor rearrangements. Upon TCRβ gene 
selection, the DN cells generate double positive (DP) cells, which express a properly rearranged TCR β-
chain and both CD4 and CD8 co-receptors. This is followed by TCR α-chain rearrangement and 
expression of αβTCR. At this stage, a failure to contact MHC molecules presented by cTECs and 
dendritic cells results in death by neglect. TCRs that bind to MHC Class I molecules lose CD4 
expression, wherease those that bind to MHC Class II lose CD8 expression, generating single positive 
(SP) cells. This process is termed positive selection. If the avidity of binding to MHC-peptide ligands 
exceeds a certain threshold, the cells are deleted by negative selection in the medulla. Mature SP cells 
finally migrate out to the periphery via bloodstream. A small percentage of CD4+ thymocytes with an 
avidity for MHC Class II molecules just below the threshold for negative selection become regulatory T 
(Treg) cells through upregulation of Foxp3 expression. Adapted from Miller 2011.
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by the presence of MHC Class II on the mature cells. A small proportion of the 
epithelial cells in an adult thymic lobe express PLET1, a surface marker used to 
identify the common thymic epithelial progenitor cells in the developing mouse 
thymus. Recent studies in our lab show that the adult PLET1+ cells contain stem cells 
capable of contributing to TEC networks in a transplantation assay.  
 
1.2.2 The function of the thymus in adaptive immune system 
The process of T cell repertoire generation occurs in the thymus, as a series of highly 
regulated steps. Haematopoietic progenitor cells from the bone marrow enter the 
thymus via the bloodstream, a process mediated by chemokine signals (Bleul & 
Boehm 2000; Lind et al. 2001; Liu et al. 2005) (Figure 1.1C). In the adult, these cells 
are lin-CD44+CD25-Sca-1+c-kit+, and are termed early thymic progenitors (ETPs) 
(Godfrey et al. 1992; Godfrey et al. 1993; Matsuzaki et al. 1993; Allman et al. 2003). 
The incoming progenitor population is thought to be heterogenous but recent studies 
have defined the canonical T cell progenitor cell as the Flt3+ fraction of ETPs, which 
is highly similar to the LMPP (lymphoid-primed multipotent progenitor) based on 
transcriptome and potency analysis (Luc et al. 2012). The studies have demonstrated 
the potential of single ETPs to generate T-cells, B-cells, bone marrow derived natural 
killer cells, dendritic cells and macrophages (Balciunaite et al. 2005; Porritt et al. 
2004; Luc et al. 2012; De Obaldia et al. 2013). The commitment of these progenitor 
cells to the T-lineage pathway and their subsequent development is a complex 
process, which depends on their interaction with TECs. The ETPs entering the 
thymus have a triple negative (TN) phenotype characterized by the absence of the T-
cell co-receptors CD4 and CD8, and the CD3 chain of the T-cell receptor (TCR) 
(Godfrey et al. 1992) (Figure 1.1C). Upon entry at the CMJ, these cells migrate 
outwards through the cortex towards the subcapsule (Lind et al. 2001). The 
intrathymic migration of developing thymocytes is directed by chemokines 
expressed by the thymic stroma (Takahama 2006). During their outward migration 
through the cortex, these cells are provided necessary signals for their differentiation 
and proliferation (such as DLL4, IL7), and for the beta and positive selection steps 
(Lind et al. 2001). The development of these outward migrating TN cells can be sub-
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divided into four progressive maturation stages based on the expression of CD44 and 
CD25. The ETPs entering the thymus is a heterogeneous population capable of 
generating T-cells, B-cells, macrophages, dendritic cells, and natural killer cells 
(Allman et al. 2003; Luc et al. 2012). The commitment of ETPs to T-cell fate 
depends on activation of Notch signalling in these cells through interaction with 
DLL4, produced mainly by cTECs in the thymus (Koch et al. 2008). The TN cells 
entering the thymus are CD44+CD25- (TN1) and progress to a CD44+CD25+ (TN2) 
stage during which they undergo proliferative expansion (Godfrey et al. 1993). The 
transition from TN2 stage to TN3 stage (CD44-CD25+) is accompanied by 
commitment to T-cell fate and T-cell receptor (TCR) gene rearrangement, which 
generates T-cells of either αβ+ or γδ+ lineage (Godfrey et al. 1993). Upon successful 
TCRβ rearrangement, the DN3 population migrate to the subcapsular region where 
they develop into DN4 (CD44-CD25-), complete TCR gene rearrangement, undergo 
further proliferation and subsequently become CD4+CD8+ double positive (DP) 
(Godfrey et al. 1993). The DP cells then migrate back towards the CMJ and undergo 
‘positive selection’, a process mediated by the interaction of DP cells with cTECs. 
During this selection process, the DP cells are screened for their ability to recognize 
peptide in the context of self-MHC. A large proportion of the DP cells express 
αβTCRs that are incapable of peptide:self-MHC recognition and therefore do not 
receive survival signals from cTECs. Such DP thymocytes undergo apoptosis due to 
‘death by neglect’. The remaining DP thymocytes, which receive cytokine mediated 
survival signals, undergo further maturation and ultimately become either CD4 or 
CD8 single positive (SP) cells depending on the strength and duration of MHC-
induced T-cell receptor signalling (Liu & Bosselut 2004). During their migration 
through the cortex, the maturing thymocytes undergo several rounds of proliferation 
resulting in a substantial increase in the number of thymocytes within this region. 
The SP cells then enter the medulla under influence of the cytokines such as CCL21 
and CCL19. Within the medulla, the self-reactive thymocytes that express a TCR 
that bind self peptide in the context of MHC with high affinity are deleted from the 
repertoire by negative selection, while self-restricted, self-tolerant thymocytes 
receive further maturation signals. The self-antigen presenting Aire+ mTECs and 
dendritic cells within the thymic medullary compartment play an important role in 
 7	
this negative selection process. It has been shown that mice carrying mutations in the 
Aire gene suffer from the autoimmune disorder, APECED (autoimmune 
polyendocrinopathy-candidiasis-ectodermal dystrophy). Finally, the mature T-
lymphocytes exit the thymus and enter the bloodstream. The pool of naïve T-cells 
leaving the thymus constitutes a diverse TCR repertoire, enabling these cells to bind 
peptides from a very broad range of pathogens. The negative selection process 
ensures that the T-cells entering the peripheral blood are largely tolerant against 
normal components of the body, which is essential for preventing autoimmune 
attacks.  
 
1.2.3 Thymus organogenesis 
1.2.3.1 Thymic epithelial progenitor cells (TEPCs) in thymus 
organogenesis 
The thymus is a specialized lymphoid organ, which evolved in the vertebrates, 
except the jawless fish, to support the development of T-cells. The evolution of the 
thymus coincides with the appearance of VDJ recombination (Boehm & Bleul 2007).  
The development of the thymus can be viewed as  a  process  of organogenesis  and  
thus  can  be  divided  into  different  stages:  positioning,  initiation, outgrowth and 
patterning, and differentiation and migration. Positioning  determines the  precise  
location  of  organ  rudiment  in  the  developing  embryo;  initiation  is  the visible  
development  of  the  organ  rudiment;  outgrowth  and  patterning  involves  the 
generation  of  regional  differences  in  the  growing  rudiment  and  detachment  of  
the organ  from  its  surrounding  tissue;  and  differentiation  and  migration  
involves generation  of  distinct  cell  types  and  migration  of  the  organ  towards  
its postnatal position (Manley 2000; Blackburn & Manley 2004). Thymus 
organogenesis depends on interactions between cells of all three embryonic germ 
layer origins: endoderm-derived epithelium, neuroectoderm-derived neural crest 
mesenchyme, and mesoderm-derived hematopoietic cells and endothelial cells of 
blood vessels.  
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In mice, the thymus and parathyroid organs develop from a bilateral organ primordia 
arising from the third pharyngeal pouch endoderm (Blackburn & Manley 2004). 
These organs develop as an outgrowth (visible from E10.5) from the third 
pharyngeal pouch resulting from epithelial-mesenchymal interaction between the 
third pharyngeal pouch endoderm and neural crest derived mesenchyme from the 
third and the forth pharyngeal arches. Gordon and colleagues (Gordon et al. 2004) 
showed that the specification of the third pharyngeal pouch endoderm to thymus fate 
occurs as early as E9.0. The cells of 3PP start to proliferate from E10.0 to form the 
organ outgrowth, characterised by expansion of both epithelial and mesenchymal 
compartments. The common thymus/parathyroid primordium begins to separate from 
the pharynx by E11.5, with the organs subsequently migrating towards their final 
location in postnatal mice. The thymus and parathyroid domains within this common 
primordium can be identified by the presence of intra-cellular markers Foxn1 and 
Gcm2 respectively. The expression of Gcm2 within the third pouch endoderm can be 
detected from as early as E9.5; whereas, the expression of Foxn1 is detectable from 
E11.25 (Gordon et al. 2001). At E11.5, Gcm2 and Foxn1 are expressed in a 
complementary fashion marking the parathyroid- and thymus-specific regions 
(Gordon et al. 2001). The first ETPs begin to colonize the thymus around E11.5 
(Owen & Ritter 1969), under the influence of cytokines secreted from differentiating 
thymic epithelial cells and mesenchyme (Bleul & Boehm 2000; Wurbel et al. 2001; 
Liu et al. 2005; Liu et al. 2006).  
 
The embryonic origin of the various sub-populations of the TECs had been a topic of 
much debate for a number of years. An elegant study in 2004 brought this debate to 
an end (Gordon et al. 2004). This study, using the classical lineage tracing techniques 
and grafting of E9.0-E9.5 pharyngeal endoderm under the kidney capsule, proved the 
endodermal origin of both cTECs and mTECs. The third pharyngeal pouch 
endoderm gives rise to a common thymus/parathyroid primordium, which separates 
from the pharynx by E11.5. This process of separation from the pharynx involves 
apoptotic death of the cells at the junction between the primordium and pharynx 
(Gordon et al. 2004). By E12.5, the common primordium begins to separate into 
respective thymus and parathyroid domains, which continue their migration towards 
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their locations in the adult mouse. At this stage, the thymic rudiment is composed 
mainly of thymic epithelial progenitor cells (TEPCs), capable of giving rise to all 
thymic epithelial lineage cells. The existence of a TEPC population was first 
postulated by Blackburn and colleagues (Blackburn et al. 1996). This study showed 
that the nu (Foxn1) gene is required cell-autonomously for the generation of a 
functional thymic stroma. Moreover, this study also identified that the cells of the 
nude thymic rudiment had a MTS20+MTS24+MTS33+ phenotype, which in normal 
adult thymus identifies a small population of TECs. Furthermore, this population 
persisted in nude-wild type chimeric mice and was found to be negative for the 
expression of markers associated with mature TECs, such as major 
histocompatibility complex (MHC) class-II (Blackburn et al. 1996). The above 
discoveries, together, lead to generation of the hypothesis that the developing thymus 
contained MTS20+MTS24+MTS33+ thymic epithelial progenitor cells, which 
undergo developmental arrest in the absence of Foxn1. This hypothesis was later 
proven when the capability of this MTS20+24+ population to form a fully functional 
thymus upon ectopic transplantation was demonstrated (Bennett et al. 2002; Gill et 
al. 2002). The antigen bound by mAbs MTS20 and MTS24 was later shown to be 
PLET1 (placenta-expressed transcript-1), an orphan protein of unknown function 
(Depreter et al. 2007). Although proving the existence of TEPCs, these studies did 
not answer the question regarding the presence of a single bipotent progenitor cell 
population capable of giving rise to both cTECs and mTECs. An alternate possibility 
to the presence of such a bipotent progenitor is the existence of lineage specific 
progenitors. Recent studies have demonstrated evidence favouring the existence of a 
bipotent progenitor (Rossi et al. 2006; Bleul et al. 2006), and more restricted lineage 
specific progenitors (Bleul et al. 2006). One of these studies transplanted single 
GFP+ EpCAM+ cells from E12.5 thymic rudiment, which contain the PLET1+ 
population, into intact, isolated E12.5 thymic rudiments from WT mice and 
subsequently grafter under the kidney capsule (Rossi et al. 2006). Four out of 
thirteen grafts exhibited the presence of GFP+ mTECs and cTECs four weeks post 
transplantation, concluding the existence of common bi-potent progenitors. The 
second study showed that functional thymic tissue containing both cortical and 
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medullary regions can be generated upon reactivation of a conditional null Foxn1 
allele in single epithelial cells postnatally (Bleul et al. 2006).  
 
Upon separation of the common primordium from the pharynx, it resolves into 
discrete thymus and parathyroid organs, which continue to develop and migrate 
toward their final location in the adult body. The first cTECs and mTECs begin to 
appear in the developing thymic rudiment soon after this and the development of 
these two compartments proceeds until E15.5 in a lymphocyte independent manner 
(Bennett et al. 2002; Klug et al. 2002; Shakib et al. 2009). After E15.5, the 
development of thymic epithelium into an organised 3D structure depends on its 
interaction with the developing thymocytes, as shown by analysis of Ikaros-/- mice, 
which exhibit absence of thymocytes and a thymic rudiment which is similar in 
appearance to that at E13.5-E15.5 (Klug et al. 2002). The thymi in these mice is 
devoid of organised medullary areas defined by K8-K5+ TECs, and instead is 
dominated by more immature K8+K5+ TEC clusters. A wild type thymus continues 
to develop beyond this point with the developmental process being completed around 
4 weeks postnatally.  
 
1.2.3.2 Role of neural crest cells (NCC) derived mesenchyme in 
thymus development 
The development of the third pharyngeal pouch and the organs derived from it 
depends on the interaction between the pouch endoderm and the surrounding 
mesenchyme. Jiang et al. showed that the mesenchyme that migrates towards and 
surrounds the third pharyngeal pouch endoderm are of neural crest (NC) origin 
(Jiang et al. 2000). NC-derived mesenchyme have been implicated in patterning of 
3PP endoderm based on the observation that the E12.0-E12.5 Splotch mutants, which 
lack a functional Pax3 gene and thus functional mesenchyme, have larger thymus 
domain and a smaller parathyroid domain, as determined by the expression of Gcm2 
and Foxn1, compared to WT embryos (Griffith et al. 2009). The thymic lobes in 
E12.5 Splotch mutants were found to have developed normally, with no defect 
observed in thymocyte migration into thymic rudiment or TEC proliferation or 
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differentiation, but were ectopically located above the laryngeo-tracheal groove 
(Griffith et al. 2009). The ectopic location of the thymus in these mutants was likely 
a result of severe deficiency of NC-derived mesenchymal capsule surrounding the 
developing 3PP and subsequent thymic rudiment (Griffith et al. 2009), suggesting 
that the NC-derived mesenchyme are required for separation of the common thymus-
parathyroid primordium from the pharynx and/or subsequent migration. The role of 
NC-derived mesenchyme in migration of thymic rudiment was recently confirmed 
through the observation that the adult thymus in NC-specific ephirn-B2-/- mutant 
mice but was located ectopically, however no defects were observed in the 
development of thymus from 3PP, migration of NC-derived mesenchyme, or 
separation from pharynx (Foster et al. 2010). The NC-derived mesenchyme are 
found in the outer capsule, inner connective tissue and trabeculae, intrathymic 
fibroblasts and pericytes, and smooth muscle cells that surround blood vessels, and 
persist in the adult thymus (Foster et al. 2008; Müller et al. 2008). The normal 
development of the thymus after E12.5 in vitro was arrested in fetal thymus organ 
cultures stripped of mesenchymal cells (Jenkinson et al. 2003), suggesting an 
important role for these cells in thymus development. The NC-derived mesenchyme 
produce FGF7 and FGF10 growth factors that activate the fibroblast growth factor 
receptor, FgfR2IIIb, which is important for normal proliferation of TECs (Erickson 
et al. 2002; Jenkinson et al. 2003; Revest et al. 2001). In the absence of functionally 
competent mesenchyme, as in the case of Patched (ph/ph) mutants, which lack 
functional PDGFRα, there is a marked reduction in the expression of Kitl, and Dll4 
by the thymic epithelium (Itoi, Tsukamoto, Yoshida, et al. 2007). However, the 
inference of results from these mutants is complicated as the Patched deletion also 
results in loss of other relevant genes including c-kit (Nagle et al. 1994).  
 
More recently, Neves and colleagues showed that culturing quail E2.5 third and 
fourth pharyngeal pouch endoderm (prior to expression of Foxn1) with chick 
somatopleural mesenchyme (shown to be permissive for development of quail 
endoderm into thymus and parathyroid) allows initiation of Foxn1 expression in the 
endoderm in absence of Noggin but not in its presence (Neves et al. 2012). Although 
Noggin can inhibit initiation of Foxn1 expression in the above conditions, there 
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seems to be no effect of Noggin on Foxn1 expression from a later stage, E3.0 (~12 
hours before detectable Foxn1 expression in quail embryo), quail endoderm (Neves 
et al. 2012). Thus, mesenchyme to be necessary for the induction of Foxn1 in these 
in-vitro culture system. The importance of BMP4 signaling for thymus development 
in mice has also been a subject of interest for several years. Recently, Gordon et al. 
used three different Cre-recombinase systems to study the role of Bmp4 in mice. The 
deletion of Bmp4 from pharyngeal pouch endoderm and NC- derived mesenchyme 
using Foxg1-Cre (Gordon et al. 2010) does not result in an absence of Foxn1 
expression; however the Foxg1-Cre does not give uniform deletion of Bmp4 in the 
mesenchyme and thus the absence of any phenotype can be due to presence of BMP4 
produced by mesenchymal cells failing to undergo recombination. On the other hand, 
deletion of Alk3/Bmpr1a (a Bmp4 receptor) from TECs resulted in mild thymic 
hypoplasia suggesting that Bmp signalling may contribute to organ size.  
 
1.2.3.3 Role of vascularisation in thymus development 
The first immigration of ETPs into thymic rudiment occurs in the absence of thymic 
vascularisation, however vascularisation is important for subsequent colonisation 
events. Thymic vascularisation begins at E13.5 with the migration of endothelial 
progenitor cells from surrounding blood vessels in to the thymus under the influence 
of angiogenic stimuli, such as Vegf (Leung et al. 1989; Bryson et al. 2013), expressed 
by TECs and mesenchymal cells (Müller et al. 2005). Subsequently, perivascular 
cells, such as pericytes and smooth muscle cells, are recruited at E14.5 to the vessel 
walls via PDGFR-β signalling, and provide structural support to the growing vessel 
network (Lindahl et al. 1997; Bryson et al. 2013). The NC-derived mesenchyme, 
surrounding the blood vessels within the thymus (Le Douarin & Jotereau 1975), act 
as a source of both pericytes and smooth muscle cells (Foster et al. 2008; Müller et 
al. 2008). Analysis of spatial arrangement of blood vessels, studied using light and 
electron microscopy, showed that a large artery present at the CMJ branches into 
arterioles as it penetrates the thymic parenchyma from within the connective tissue 
trabeculae (Kato 1997). These arterioles in turn connect to a network of capillaries 
that extend out into the cortex and loop back at the periphery towards the CMJ where 
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they drain into post capillary venules (Kato 1997). More recently, it has been shown 
that only small blood vessels are present within the cortex, while large blood vessels 
are present at the CMJ and within the medulla of an adult thymus (Mori et al. 2007). 
The large blood vessels at CMJ and within medulla are surrounded by perivascular 
space, which plays a role in selective transport of haematopoietic precursors and 
mature thymocytes between thymic parenchyma and blood stream (Mori et al. 2007).  
 
1.3 Molecular regulation of thymus organogenesis 
As described above, thymus organogenesis requires interactions between various 
different cell types and the entire process can be divided into distinct stages, from 
3PP formation to generation of functional thymus. Each of these distinct stages is 
thought to be governed by sets of distinct but overlapping transcription factors which 
act in a network to support the various organogenetic and morphological changes. 
Our current understanding of the transcription factors involved at various stages 
stems mainly from analysis of naturally occurring mutations, gene inactivation 
studies and in-situ hybridisation experiments. These studies have identified several 
transcription factors, such as Hoxa3, Pax1, Pax9, Tbx1, Eya1, Six1, Foxg1 and 
others, which are important for normal development of 3PP and/or thymus. These 
factors are discussed in detail below. Wei and Condie recently studied the expression 
of several transcription factors by performing series of in-situ hybridization at 
various stages of the developing thymic rudiment (Wei & Condie 2011). Their 
results suggested important roles for Foxg1 and Isl1 in thymus development beyond 
E11.5 and possibly in initiation of Foxn1 expression. Furthermore, they also showed 
that the expression of Gata3, Nkx2.5, and Nkx2.6 was restricted to thymus domain of 
the common primordium at E11.25 but was absent at E11.5, suggesting that these 
genes are important for development of the thymus prior to E11.5 but are not 
required (or detrimental) for subsequent development. Several signalling pathways 
have also been implicated in thymus development, including the BMP and FGF 
signalling pathways. Table 1.1, adapted from Michelle Kelly’s thesis, summarizes 
these factors and our knowledge of their importance in thymus, and this is further 
discussed in detail below. 
Table 1.1: Key genes important for thymus development.
Shown is a summary of the expression pattern, null phenotype, and potential role of key genes during 
thymus development. CMJ: corticomedullary junction, TEC: thymic epithelial cells, 3PP: third 
pharyngeal pouch, NC: neural crest. Table adapted from Kelly M., PhD thesis.
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1.3.1 Tbx1 (T-box 1) 
Tbx1 gene encodes a member of the T-box family of transcription factors and is the 
key gene deleted in the DiGeorge syndrome in humans, which causes defects in 
development of the craniofacial and pharyngeal regions (Lindsay et al. 1999; 
Lindsay 2001). During murine pharyngeal development, Tbx1 is first expressed in 
mesoderm at E7.5. Its expression in pharyngeal endoderm, ectoderm, and core 
mesoderm can be detected between E8.5 and E11.5 (Chapman et al. 1996). The 
expression of Tbx1 in pharyngeal region appears to be regulated by the sonic 
hedgehog (Shh) and Wnt signalling pathways (Garg et al. 2001; Huh & Ornitz 2010). 
In mice, the absence of Tbx1 expression during development results in abnormal 
patterning of the first pharyngeal arch, hypoplasia of the second pharyngeal arch and 
absence of the third, fourth, and sixth pharyngeal arches and pouches (Jerome & 
Papaioannou 2001). These defects may be partly due to the absence of Fgf8 and 
Fgf10 expression in Tbx1 null embryos as these fibroblast growth factors play a role 
in induction or maintenance of proliferation. This is supported by the observation 
that pharyngeal endoderm has reduced levels of proliferation in the absence of TBX1 
at E8.5 (Xu et al. 2005). This study analysed the temporal requirement of Tbx1 
expression in developing murine pharyngeal regions by using a tamoxifen-inducible 
Cre recombinase to delete exon-5, encoding part of the T-box domain, from a 
conditional Tbx1 allele (Xu et al. 2005) and showed that deletion of Tbx1 at E7.5 or 
E8.5 resulted in defects in formation of the third pharyngeal pouch and subsequent 
absence of thymus at E18.5. However, deletion of Tbx1 at E9.5 or E10.5 resulted in a 
hypoplastic thymus; whereas its deletion at E11.5 did not have any effect on the 
thymus. This study, therefore, predicts a critical time window for Tbx1 expression in 
thymus development of between E8.5-E9.5, which coincides with 3PP formation. In 
addition, the contribution of TBX1 expressing cells to the thymus was demonstrated 
using fate mapping experiments, where tamoxifen-inducible Cre was knocked into 
the Tbx1 locus and used to activate β-galactosidase expression, which demonstrated 
that cell expressing Tbx1 at E8.5 contributed to the thymus primordium, whereas 
those expressing Tbx1 at E9.5/10.5 showed only a small contribution to the thymus 
(Xu et al. 2005). This suggests that Tbx1 is crucial for 3PP formation. Furthermore, it 
also suggests that cells of E9.5/10.5 third pharyngeal pouch endoderm are 
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heterogeneous for the expression of Tbx1 possibly because of down-regulation of 
Tbx1 expression. This is supported by the observation that Tbx1 expression is 
restricted to the parathyroid domain by E10.5 (Vitelli et al. 2002; Dooley et al. 
2007). Further evidence for importance of temporal regulation of Tbx1 expression 
comes from a study showing that ectopic expression of Tbx1 in thymus fated cells 
within 3PP results in down-regulation of Foxn1 expression and reduced proliferation 
of these cells leading to reduction in thymus size (Reeh et al. 2014). A consequence 
of defects in pharyngeal pouch development upon deletion of Tbx1 at E7.5/8.5 is the 
absence of Pax1 expression at E10.5. However, whether this loss of Pax1 expression 
is a direct effect of the absence of Tbx1 expression or an indirect effect resulting 
from failure of normal pouch development is not clear.  
 
Recently, Ripply3 was shown to represses the transcriptional activity of Tbx1 in in-
vitro Luciferase assays (Okubo et al. 2011). The expression domain of Pax9 (and 
also possibly Pax1) was increased in the pharyngeal region of E9.5-E10.5 Ripply3-/- 
mice (Okubo et al. 2011). Furthermore, a 3.7kb promoter region of Pax9 was shown 
to be TBX1 responsive in Luciferase assay. The results from the above two studies 
together suggest that the expression of Tbx1 may be required for the initiation of 
Pax9 expression. Furthermore, temporal regulation of Tbx1 expression is necessary 
as Ripply3-/- embryos have an ectopic and hypoplastic thymus, located in the 
oropharynx, a phenotype similar to Pax9 null thymus (Okubo et al. 2011). 
 
1.3.2 Fgf8 (Fibroblast growth factor 8) 
Secreted molecules of the Fibroblast growth factor (Fgf) family of proteins signal via 
cell surface tyrosine kinase receptors that have both mitogenic and differentiative 
effects. In the developing pharyngeal regions, Fgf8 is expressed from E8.0 in foregut 
endoderm and NC-derived mesenchyme, and later also in pharyngeal pouches (Abu-
Issa et al. 2002). A recent study characterized expression domains for various genes 
involved in Fgf signalling using in-situ hybridization (Gardiner et al. 2012). This 
revealed that various Fgf genes and downstream targets of FGF signalling are 
expressed in a highly localized fashion in the E10.5 3PP with Fgf3, 8, and 15 being 
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expressed in posterior pouch and Fgf10 being expressed by NC-derived mesenchyme 
surrounding the pouch (Revest et al. 2001; Gardiner et al. 2012). Homozygous null 
mutation of Fgf8 phenocopies the 22q11 deletion syndrome (DiGeorge Syndrome) 
with respect to defects associated with development of pharyngeal arches and 
pharyngeal pouches (Frank et al. 2002), however, null mutant embryos die at E8.5 
preventing their use in studying the role of FGF8 in thymus development. On the 
other hand, Fgf8 hypomorphic embryos show a failure in formation of third and 
fourth pharyngeal pouches, suggesting a role for FGF8 in 3PP formation (Abu-Issa et 
al. 2002). The observed defects in pharyngeal pouch formation are consistent with a 
role for FGF8 as a downstream signalling effector of Tbx1 (Vitelli et al. 2002; Huh & 
Ornitz 2010; Guo et al. 2011). Conditional deletion of Fgf8 in Hoxa3-expressing 
cells, using Fgf8loxpP/loxP;Hoxa3IRESCre, which deletes Fgf8 from 3PP at E9.5, 
resulted in hypoplasia and ectopia of the thymus and increased apoptosis of NCCs 
(Macatee et al. 2003). Thus, Fgf8 expression in both NC-derive mesenchyme and 
endodermal cells of 3PP is required for normal pouch formation.  
 
Other Fgf genes important for epithelial-mesenchymal interactions during thymus 
development include Fgf10. Fgf7 and Fgf10 are both expressed by stromal 
mesenchyme and its receptor FgfR2IIIb is expressed by TECs, suggesting these Fgfs 
could play an important role in interaction between these two cell types. Indeed, 
deletion of either Fgf10 or its receptor results in severe thymic hypoplasia and 
developing thymic epithelium is developmentally arrested at E12.5 (Revest et al. 
2001). A role for Fgf7 in regulating TEC function was supported by a study 
demonstrating that administration of FGF7 to thymocyte depleted E16.0 thymic 
lobes in culture resulted in expansion of mTECs and restored normal mTEC 
associated chemokine expression (Erickson et al. 2002).  These studies suggest that 
Fgf7 and Fgf10 may have important roles during later stages of thymus development, 
possibly promoting proliferation of TECs. However, the role of FGF signalling 
between E8.5 and E12.5 remained unknown until a recent study studied the effect of 
FGF signalling using Spry1 and Spry2, two FGF feedback antagonists mutants 
(Gardiner et al. 2012). This study showed that Sprouty genes are expressed at low 
levels throughout most of the E10.5 3PP and a loss of this expression in Spry1-/-
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Spry2-/- results in increased expression of FGF signalling target genes Etv4, Etv5, and 
Dusp6 across the E10.5 3PP, suggesting increased FGF signalling, and reduced 
expression of Gcm2 in the parathyroid domain (Gardiner et al. 2012). Spry1-/-Spry2-/- 
mutants also show defects in apoptosis of endodermal cells at the junction between 
the common primordium and the pharynx at E11.75 leading to the failure of the 
common primordium to completely separate from the pharynx (Gardiner et al. 2012). 
The loss of Spry1 and Spry2 in these mutants results in reduced Bmp4 expression at 
E10.5, resulting in a delay in initiation of Foxn1 expression. However Sprouty 
mutant embryos also show reduced expression of Fgf10 by mesenchyme surrounding 
the developing thymus, resulting in a hypoplastic thymus (Gardiner et al. 2012). 
Thus, dynamic regulation of FGF signalling is required for normal thymus and 
parathyroid development. 
 
1.3.3 Hoxa3 (Homeobox protein A3) 
Hoxa3 is a member of the homeobox family of transcription factors that are involved 
in specification of lineage identity (Krumlauf 1994). It is expressed in 3PP endoderm 
and NC-derived mesenchyme from E9.5. Hoxa3 is not required for the formation of 
3PP (Manley & Capecchi 1995; Manley & Capecchi 1998), however, the expression 
of Bmp4 is severely reduced in 3PP endodermal cells of the Hoxa3-/- thymi, while the 
expression domain of Fgf8 is expanded compared to WT thymi (Chojnowski et al. 
2014). Analysis of Hoxa3-/- embryos showed that expression of Pax1 is initiated 
normally but is not maintained at E11.0, suggesting that Hoxa3 is not required for 
initiation of Pax1 expression but is required for its subsequent maintenance (Manley 
& Capecchi 1995). The organ specific domains undergo initial pattering in absence 
of HOXA3 as evident from the presence of Foxn1 and Gcm2 expression within the 
cells of the common primordium, however, the initiation of Foxn1 expression is 
delayed whereas Gcm2 expression is not maintained after E10.5 in Hoxa3-/- embryos 
(Chojnowski et al. 2014). This led to failure of parathyroid cell to undergo 
differentiation and loss of thymus through apoptosis, resulting in an absence of both 
parathyroid and thymus in Hoxa3-/- mice (Chojnowski et al. 2014). In mice, Hoxa3, 
together with Hoxb3 and Hoxd3, has also been shown to be involved in normal 
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migration of the common thymus-parathyroid primordium (Manley & Capecchi 
1998).  
 
1.3.4 Pax1 (Paired box protein 1) 
Pax1 is a member of the paired box family of transcription factors, whose expression 
in 3PP endoderm can be detected from E10.5 (Wallin et al. 1996). Pax1, and also 
Pax9, are atypical members of the paired box family in vertebrates as they lack the 
homeodomain (DNA binding domain independent of paired box domain), which is 
found in all other Pax genes. At E12.5, most (if not all) TEPCs express Pax1. 
However, the expression of Pax1 is restricted to a small subset of cTECs and cells of 
the subcapsule in adult thymus (Wallin et al. 1996). This was demonstrated through 
whole mount in-situ hybridization and immunohistochemical analysis of embryonic 
and adult (6-weeks old) thymi. Interestingly, the cTECs that express Pax1 appear to 
be immature TECs as determined from an absence of the mature TEC markers MHC 
Class-II or ER-TR4 (Wallin et al. 1996), suggesting that Pax1 might be maintained 
in undifferentiated progenitor cells population. The thymu in Pax1-/- mice is mildly 
hypoplastic with a 2.5-fold reduction in thymocyte numbers. This defect mainly 
affects the CD4+8+ double positive and CD4+ single positive thymocytes (Wallin et 
al. 1996). The Pax1-/- mouse thymus showed a reduction in both the total number of 
MHC Class-II+ TECs and also the level of expression of this differentiation marker 
(Su & Manley 2000), which could explain the defects observed in maturing 
thymocytes. This suggests a role for Pax1 in the TEC development. Analysis of 
Hoxa3+/-, Pax1+/-, Pax1-/-, and Hoxa3+/-Pax1-/- mice has shown that the Hoxa3+/-Pax1-
/- have a markedly more severe thymus phenotype, including delayed separation of 
the common primordium from the pharynx, increased thymic hypoplasia due to 
reduced proliferation and increased apoptosis (Su & Manley 2000). This phenotype 
in Hoxa3+/-Pax1-/- mice is more severe than the Pax1-/- phenotype, indicating that 




1.3.5 Pax9 (Paired box protein 9) 
Pax9 is the most closely related member of the paired box family of proteins to 
Pax1. It is expressed in 3PP from E9.5 (Neubüser et al. 1995; Peters et al. 1998). 
Compared to Pax1-/-, the Pax9-/- mice exhibit a more severe phenotype with a 
transient thymic rudiment located ectopically within the larynx, and a complete 
absence of ultimobranchial bodies. Interestingly, the thymic primordium in Pax9 null 
mice develops as an ectopic polyp-like structure in the larynx (Hetzer-Egger et al. 
2002). This ectopic thymus is extremely hypoplastic and fails to migrate to upper 
mediastinum. The expression of Foxn1 is detectable at E14.5 in Pax9-/- mice and the 
thymic rudiment appears to be colonized by heamatopoetic progenitors. However, 
the thymic rudiment appears highly disorganised at E16.5, is severely reduced in size 
and contains large number of apoptotic cells (Hetzer-Egger et al. 2002). Thus, Pax9 
is required for correct positioning of the thymus, and may play a role in survival and 
development of TECs.  
 
Given that Pax1 and Pax9 genes are related by duplication, it is expected that there 
exists some redundancy between their functions in the thymus. Functional 
redundancies between these two genes has been demonstrated during vertebral 
column development in a gene dosage-dependant manner (Peters et al. 1999). In this 
system, Pax1 can fully compensate for the absence of Pax9, while Pax9 can partially 
rescue defects in Pax1 deficient mice. Recently, studies in our lab have shown that 
there indeed are functional redundancies between Pax1 and Pax9 in thymus 
(Michelle Kelly, unpublished). 
 
1.3.6 Eya1 (Eyes Absent 1) and Six1 (Sine oculis homeobox 1) 
Eya1 and Six1 belong to the Eyes Absent and homeobox Six families of proteins 
respectively. Eya1 encodes a transcriptional co-activator that is often co-expressed 
with the SIX1 transcription factor (Xu et al. 1997). Eya1 is expressed in the second, 
third, and fourth pharyngeal pouch endoderm, pharyngeal arches (one to four), and 
the surface ectoderm at E9.5-E10.5 (Kalatzis et al. 1998). Six1 is expressed in the 
 21	
pharyngeal endoderm, mesenchyme, and surface ectoderm from E9.5. The 
expression of Six1 in E9.5 third pharyngeal pouch endoderm and the surface 
ectoderm of third clefts is markedly reduced in Eya1-/- embryos showing that the 
expression of Six1 in these regions is Eya1-dependent (Xu et al. 2002).  
 
The common thymus/parathyroid primordium is absent in E12.5 Eya1-/- embryos (Xu 
et al. 2002). Similarly, no common primordium is detectable in E12.5 Six1-/- embryos 
(Zou et al. 2006). However, the common thymus/parathyroid primordium is present 
at E11.5 in both Six1-/- and Six1-/-Six4-/- embryos. The common primordium is 
smaller in these embryos and consists of more apoptotic cells than their wild-type 
counterparts, with these defects being more severe in Six1-/-Six4-/- than Six1-/- mutants 
(Zou et al. 2006). Thus, it would appear that the patterning of third pharyngeal pouch 
endoderm into common thymus/parathyroid primordium is initiated in Six1-/- and 
Six1-/-Six4-/- embryos but undergoes apoptosis by E12.5. Furthermore, the expression 
of Gcm2 (at E10.5) and Foxn1 (at E11.5) was reduced in Six1-/- thymi and their 
expression was absent in Six1-/-Six4-/- embryos suggesting defects in maintenance and 
differentiation of the cells within the common primordium. Studies on Hoxa3, 
Pax1/9, Eya1, and Six1/4 mutant mice indicate a transcriptional network involving 
these genes. Hoxa3 expression in third pouch endoderm or NC-derived mesenchyme 
was unaffected in Pax1-/-Pax9-/- and Eya1-/-Six1-/- embryos; placing Hoxa3 at the top 
of this regulatory network. Eya1 expression was maintained at E10.0 in Six1-/-Six4-/- 
embryos. Also, the expression of both Eya1 and Six1 was found to be normal in 
Pax9-/- and Pax1-/-Pax9-/- mutants. Thus, Eya1 and Six1 expression do not require 
Pax1/9 and so appear to be above Pax1/9, with Eya1 being above even Six1 in the 
transcriptional network. Although Pax1 expression was present in Eya1-/-, Six1+/- and 
Six1-/- (lower than that in Six1+/- genotype) embryos at E9.5/10.5, its expression is 
absent in Eya1-/-Six1-/- embryos. Similarly, Pax9 expression was reduced at E10.5 in 
Eya1-/-Six1-/- embryos, further confirming that Pax1/9 are downstream of Eya1 and 
Six1 in this transcriptional network (Zou et al. 2006). However, further work is 
required to elucidate how these transcriptional factors interact and co-operate in the 
development of the third pharyngeal pouch endoderm and its subsequent organs, the 
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thymus and parathyroid. The interactions between these transcription factors are 
summarized in the network diagram below: 
 
 
1.3.7 BMP (Bone Morphogenic Proteins) 
As described above, a short pulse of BMP has been shown to be required for 
initiation of Foxn1 expression (Neves et al. 2012), suggesting that BMPs play an 
important role in development of the thymus. BMPs belong to the TGFβ superfamily 
of proteins that play important roles during development of various organs. During 
thymus development, Bmp4 (and also Bmp7) is first expressed at by a small number 
of NC-derived mesenchymal cells in third pharyngeal arch at E9.5 and is 
subsequently expressed in endodermal cells in the ventral and medial part of 3PP and 
surrounding mesenchyme by E10.75. Bmp4 expression becomes restricted to lateral 
part of thymic anlage by E11.5 and strong expression is maintained at E12.5 (Bleul 
& Boehm 2005; Patel et al. 2006). Thus, Bmp4 may be involved in specification of 
thymus identity in the ventral part of 3PP. Bmp4-/- mice die between E6.5 and E9.5 
(Winnier et al. 1995), preventing their use for analysis of its role in thymus 
development. However, expression of the BMP antagonist noggin in TECs via the 
Foxn1 promoter resulted in a dysplastic thymus that was drastically reduced in size 
and exhibited an ectopic location (Bleul & Boehm 2005). This suggests that BMP 
signaling is required for normal growth, migration, and differentiation of the thymus. 
Furthermore, the importance of Bmp4 in epithelial-mesenchymal interaction was 
demonstrated by conditional deletion of Bmp4 in pharyngeal endoderm and NC-
derived mesenchyme using Foxg1-Cre;Bmp4lacZ (Gordon et al. 2010). This study 
showed that deletion of Bmp4 in this system results in normal patterning of 3PP to 
thymus but a partial absence of thymic capsule and failure of the thymic primordium 
to migrate, suggesting that Bmp4 is not required in specification process.  
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1.3.8 TGFβ (Transforming Growth Factor – beta) 
The TGFβ signalling pathway plays important roles during development, 
morphogenesis, cell proliferation, differentiation, tissue homeostasis, regeneration, 
and various diseases (Massagué 2012). In mammals, there are three known isoforms 
of TGFβ: TGFβ1, TGFβ2, and TGFβ3. These isoforms function through the same 
receptor signalling pathways upon binding to TGFβ receptors. The TGFβ ligands 
bind to TGFβRII, which subsequently binds to TGFβRI to form an active complex. 
This complex phosphorylates receptor-associated SMADs (SMAD2 and SMAD3), 
which form a hetero- or homo-dimer and subsequently bind to SMAD4 (co-SMAD) 
forming an active SMAD complex. The active SMAD complex is then nuclearized 
where is regulates the expression of target genes. The genes targeted by SMAD3 
(and possibly other SMADs) are determined by cell-type specific transcription 
factors that direct the occupancy of SMAD3 to the genome (Mullen et al. 2011). 
Figure 1.2, adapted from Kubiczkova 2012, shows a schematic representation of the 
TGFβ pathway 
 
In the developing pharyngeal regions, TGFβ is important for the non-neuronal 
commitment and survival of migrating NCCs (Wurdak et al. 2005; Wang et al. 
2006). The NCC in Wnt1-Cre;Tgfbr2loxP/loxP  and Wnt1-Cre;Tgfbr1loxP/loxP mice 
migrate normally but fail to contribute to the normal development of pharyngeal 
regions due to defects in differentiation and increased apoptosis, resulting in 
formation of hypoplastic thymus that is ectopically located in the neck regions 
(Wurdak et al. 2005; Wang et al. 2006). The expression of TGFβ signalling ligands 
by the stromal cells of the thymic cortex, particularly the subcapsule and cTECs, is 
important for maturation of CD4-CD8- DN thymocytes to DP state (Takahama et al. 
1994). In the adult thymus, TGFβ signalling in thymocytes plays an important role in 
generation and survival of thymic T-regulatory cells (Ouyang et al. 2010; Hauri-Hohl 
et al. 2014). Furthermore, TGFβ signalling has been implicated in thymus involution, 
because Tgfb2 expression in thymus increases with age (Sempowski et al. 2000; 
Hauri-Hohl et al. 2008). Consistent with this idea, enforced reduction of TGFβ  
Figure 1.2: Canonical TGFβ signalling pathway.
The binding of TGFβ ligand to its receptor TGFβRII leads it being dimerized with TGFβRI. This receptor 
dimer complex subsequently phosphorylates intracellular SMAD protiens (SMAD2 or SMAD3), which 
then form a complex with SMAD4. The SMAD complex is subsequently transported into the nucleus 
where it binds with specific transcription factors (TF) to regulate the expression of TGFβ target genes. 
Figure adapted from Kubiczkova et al. 2012
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signalling in TECs, HSCs or other non-haemtopoetic cells results in mitigation of 
thymic involution (Kumar et al. 2006; Hauri-Hohl et al. 2008). Two important 
studies have shed light on the importance of this pathway in TEC biology. One of 
these showed that deletion of Tgfbr2 in Hoxa3-expressing cells does not have any 
adverse effect on thymus development or function, suggesting that TGFβ signalling 
in 3PP endoderm and NC-derived mesenchyme is dispensable from E10.5 for normal 
thymus development (Hauri-Hohl et al. 2008). In fact, deletion of TGFβ signalling in 
TECs in Foxn1-Cre;Tgfbr2loxP/loxP mice resulted in an increase in the number and 
proportion of mTECs due to increased proliferation of these cells (Hauri-Hohl et al. 
2014). This increase in mTEC numbers and proportions has a direct functional effect 
characterised by increased proportion and number of naïve CD4+ and CD8+ SP cells 
in medulla (Hauri-Hohl et al. 2014).  
 
The TGFβ signalling pathway interacts with various other signalling pathways such 
as Notch (Andersson et al. 2011), Wnt, Fgf (Paek et al. 2011), and NFκB (Criswell & 
Arteaga 2007). In primary TEC cultures, deletion of androgen receptor results in 
decreased Tgfb1 expression (Lai et al. 2013). TGFβ also negatively affects mTEC 
differentiation by inhibiting NFκB activation in these cells (Hauri-Hohl et al. 2014). 
Thus, TGFβ signalling is important for several aspects of thymus biology. However, 
molecular insights into its functions remain unexplored. In both the classical TGFβ 
and BMP signalling pathways, signals are transduced via SMAD proteins, which act 
as transcriptional regulators. Two studies have explored the importance of SMAD 
proteins in TECs. SMAD4, the SMAD protein common between TGFβ and BMP 
signalling was studied using Smad4co/co;Foxn1-Cre mice in which exon-9 of Smad4 
is flanked by LoxP sites (Jeker et al. 2008). Deletion of Smad4 in these mice resulted 
in thymic hypoplasia, characterized by a reduction in TEC number and in the number 
of ETPs within the thymus. While the TEC numbers appeared to recover in mutant 
mice by 8 weeks old, and no difference is observed in T-cell development, thymus 
architecture and the ability of thymic stroma to attract ETPs remained compromised 
throughout life (Jeker et al. 2008). The Smad4co/co;Foxn1-Cre thymus shows a 
blurred distinction between cortex and medulla with TECs expressing both K5 and 
K18, clusters of ERTR7+ fibroblasts, and presence of cysts, a phenotype similar to 
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that of an involuting thymus (Jeker et al. 2008). This suggests that TGFβ and BMP 
signalling through SMAD4 play an important role in development and homeostasis 
of the thymus. Furthermore, the MHC Class-IIhi cells in mutant thymus show slightly 
elevated levels of Foxn1 mRNA but significantly decreased expression of both Ccl21 
and Ccl25, suggesting that there might be some interaction between SMAD4 and 
FOXN1 proteins as the expression of these cytokine genes is Foxn1-dependant 
(Jeker et al. 2008). The other SMAD protein studied in the context of thymus 
development is SMAD7, which acts as a negative regulator of TGFβ and BMP 
signalling pathways. Over-expression of Smad7 using a transgene driven by the 
bovine K5 promoter led to severe thymic atrophy and increased thymocyte apoptosis 
(He et al. 2002). The K5.Smad7 thymi were significantly smaller than controls, and 
showed extensive thymocyte apoptosis in the cortex, such that the number of 
CD4+CD8+ thymocytes was ~50-fold lower in mutant thymi (He et al. 2002). These 
studies show that mis-regulation of TGFβ and/or BMP signalling in TECs leads to 
several defects and thus the functions of these pathways in TECs warrants further 
investigation. The figure below summarizes the defects in the thymi of the above-




1.4 FOXN1 – the master transcription factor in TECs 
Foxn1 belongs to the Forkhead family of genes, which encode transcription factors 
that are essential for normal development, homeostasis, function, and aging of 
various cell types, organs, and tissues. The evolution and function of Forkhead genes 
and the importance of Foxn1 in the thymus are described below. 
 
1.4.1 Evolution of Forkhead genes 
The Forkhead gene family is an evolutionarily ancient gene family that derives its 
name from D. melanogaster gene fork head (fkh). The fkh gene was named after the 
observed phenotype of spiked head appearance in mutant adult flies (Weigel et al. 
1989). At the time of its discovery, fkh gene was described as encoding a putative 
transcriptional regulator with a homeotic activity, due to its role in development of 
terminal segments in fruit fly. The fkh gene product showed little homology with any 
other known class of proteins at the time. Subsequently, the discovery of the rat gene 
HNF3 (hepatocyte nuclear factor 3) in 1990, which showed no similarity to any 
known DNA-binding factors, enabled identification of a highly homologous region 
between the products of these two genes. This region, consisting of approximately 
100 amino acids, was suggested to the DNA binding domain (DBD) of these 
transcription factors (Carlsson & Mahlapuu 2002). Thus, a new superfamily of 
transcription factors containing the ‘winged helix’ or ‘forkhead’ DBDs (Structural 
Classification of Proteins (SCOP) classification n°46785), whose members are found 
in Eubacteria, Archaea, and Eukaryota, was discovered. The term ‘winged helix’ was 
coined to reflect the butterfly-like winged structure adopted by DNA-bound Fox 
proteins. Interestingly, similar wing structures are also observed for DNA 
interactions with linker histones such as H1 and H5 (Clark et al. 1993). The 
canonical ‘forkhead’ domain consists of three N-terminal α-helices (H1, H2, H3), 
three β-sheets (S1, S2, S3) and two C-terminal ‘wing’ regions/loops (W1, W2), 
arranged in the order H1-S1-H2-H3-S2-W1-S3-W2 (Gajiwala & Burley 2000). An 
additional α-helix is sometimes found in some Forkheads. The DNA binding 
specificity of the ‘forkhead’ domain depends on the variable region at the junction of 
α-helices and wing loops, which interact with bases in minor groove of DNA (Obsil 
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& Obsilova 2008). To date, over 2000 members of Forkhead superfamily have been 
identified in 108 species of animals and fungi. The number of Fox genes differs 
between species presumably due to evolutionary pressures. Among metazoans, 16 
Fox genes are found in C. elegans, 18 in D. melanogaster, 49 in zebrafish, 46 in 
mouse, and 50 in humans. The nomenclature for these genes was revised in 2000 
when a new classification system based on phylogenetic analysis of 172 Fox proteins 
in 14 species was proposed, in order to unify gene names (Kaestner et al. 2000). The 
‘forkhead’ DBD is highly conserved among the different members of this 
superfamily and represents the only part of the peptide sequence that can be 
confidently aligned across all Fox proteins. Earlier phylogenetic trees divided the 
Fox proteins into 15 classes from FoxA to FoxO based on similarities in FKH 
domain. These trees were extended over time to include four more classes – from 
FoxP to FoxS, of which FoxQ, FoxR, and FoxS are vertebrate specific. Figure 1.3 
shows the evolutionary tree for Forkhead genes, as adapted from (Hannenhalli & 
Kaestner 2009). As seen in this tree, the FoxN genes are clustered separately from 
other classes and the gene most closely associated to Foxn1 is Foxn4, a paralog of 
Foxn1.  
 
Figure 1.4, adapted from Bajoghli et al., shows the evolutionary history of Foxn1-
like genes (Bajoghli et al. 2009). As seen in this figure, Foxn4 first appears in 
cephalochordates (amphioxus), which also contain a more ancient paralog, Foxn4b. 
This ancient paralog, Foxn4b, appears to be absent from the genomes of 
urochordates and all vertebrates. Jawless fish possess a gene very similar to Foxn4, 
termed Foxn4-like (Foxn4L). Foxn1 has been proposed to be an ortholog of Foxn4L 
based on protein sequence and short-range synteny relationships. The expression 
patterns of these genes further support this genealogy. Foxn4 (i.e. Foxn4a) is 
expressed in the pharyngeal endoderm, among other sites, in amphioxus; Foxn4L is 
expressed in epithelia lining the gill basket in lamprey; and Foxn1 is expressed in the 
thymus in cartilaginous fishes and all other jawed vertebrates. However, Foxn1 has a 
unique role in the thymus in jawed vertebrate, which cannot be substituted by Foxn4 
(Swann et al. 2014).  
Figure 1.3: Evolutionary tree of mouse forkhead box (Fox) genes.
Shown is a neighbour-joining tree based on multiple alignment of protein sequences of the forkhead 
domain. Figure adapted from Hannenhalli and Kaestner 2009.
Figure 1.4: Evolutionary history of Foxn1-like genes.
The gene Foxn4b represents an ancient eumetazoan gene that duplicated in cephalochordata to give rise to 
Foxn4a, which is orthologous to Foxn4 in urochordates and all vertebrates. Foxn4L is a paralog of Foxn4 
in jawless fishes, while Foxn1 is a paralog of Foxn4 in jawed vertebrates. Figure adapted from Bajoghli et 
al. 2009.
 31	
1.4.2 Functions of Forkhead genes 
While the Forkhead proteins share the highly conserved ‘forkhead’ DBD, the 
function of these proteins are thought to be determined by the transactivation or 
repression domains, which show almost no sequence homology between members of 
this superfamily. Functional diversity is also achieved through differences in 
interaction partners and in spatio-temporal expression patterns. Thus, while the 
Forkhead superfamily members have largely distinct functions, some overlap in 
function can be observed between members of the same sub-group. Mutation of 
Forkhead genes leads to a range of phenotypes, such as craniopharyngeal defects in 
Foxe1 mutants, speech defects in Foxp2 mutants, a hearing defect in Foxi1 mutants 
and others. Several Forkhead genes play an important role in immune system, for 
example Foxp3 (development and function of Treg cells), Foxn1 (TEC 
differentiation), Foxj1 (suppression of T-cell activation), and Foxo3 (regulation of 
lymphocyte proliferation and apoptosis) (Coffer & Burgering 2004). The FoxO 
factors are crucial regulators of longevity in D. melanogaster and C. elegans and 
strong associations are observed between single nucleotide polymorphisms in the 
Foxo1 and Foxo3a genes and human longevity (Benayoun et al. 2011).  
 
The Forkhead factors were among the first transcription factors identified as having 
‘pioneer’ function. A transcription factor is considered to be a pioneer factor if it can 
access its target sequence on nucleosomes and certain forms of compacted 
chromatin, can bind nucleosome stably and before the binding of other transcription 
factors or initiation of the target gene expression, and possess chromatin-opening 
capabilities (Zaret & Carroll 2011). The first forkhead factors identified as having 
pioneer activity were HNF-3 (FOXA). FoxA factors are required for hepatic 
specification in mouse; embryos that are deficient for both Foxa1 and Foxa2 lack 
liver bud (Lee et al. 2005). FoxA factors have been shown to be the first TFs to bind 
the Albumin enhancer in gut endodermal cells (Gualdi et al. 1996; Bossard & Zaret 
1998). Furthermore, FoxA factors stably bind their target sequences on in vitro 
assembled nucleosome and can open the local nucleosomal domain through the 
activity of their C-terminal domain (Cirillo et al. 1998; Cirillo et al. 2002). These 
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elegant studies on the ability of FoxA factors to bind and open nucleosome to 
regulate target gene expression showed that these TFs could act as pioneer factors. 
The similarities between the ‘winged-helix’ structure of the forkhead domain and 
structures of linker histones is likely why these TFs can displace linker histones from 
compacted chromatin, even in the absence of SWI-SNF chromatin remodeling 
complex, and facilitate binding of other transcription factors. Forkhead factors 
mostly bind to DNA as monomers (Clark et al. 1993), however cases of homodimers 
(Tsai et al. 2006) and heterodimers (Seoane et al. 2004) have also been documented. 
Forkhead proteins also interact with non-transcription factor proteins such as co-
activators, co-repressors, enzymes and other proteins. Furthermore, some Forkhead 
proteins are also subject to many posttranslational modifications such as 
phosphorylation, acetylation, methylation, and ubiquitination (Benayoun et al. 2011). 
These post-translational modifications affect binding affinity and specificity of their 
target Forkhead proteins, their nuclear localization and even stability of some of 
these transcription factors. Finally, Forkhead proteins act as effector molecules for 
several signaling pathways, converting extra-cellular signals to changes in gene 
expression (Benayoun et al. 2011).  
 
1.4.3 Foxn1 in skin 
Besides thymus, the only other tissue where the role of Foxn1 has been studied in 
any detail is the skin. Foxn1 expression has been detected in the matrix and the hair 
shaft of anagen hair follicles (Meier et al. 1999). The skin of nude mice show 
presence of largely normal hair follicles but produce hair shafts that bend and coil, 
due to abnormal keratinization, and fail to penetrate the epidermis (Mecklenburg et 
al. 2001). This results in an absence of fur coat in these mice. More recently, Foxn1 
and Msx2 were shown to be required for Notch1 expression in the hair follicle 




1.4.4 Foxn1 in thymus development 
Foxn1 is one of the earliest markers of cells fated towards the TEC lineage within the 
common thymus/parathyroid primordium. Foxn1 is expressed at high levels in the 
ventral aspect of the third pharyngeal pouch endoderm from E11.25, although 
transcripts can be detected as early as E9.5 by RT-PCR (Nehls et al. 1994; Gordon et 
al. 2001). Its expression subsequently expands dorsally to cover the entire thymic 
region of the common primordium. As mentioned above, Foxn1 was identified as the 
gene mutated in the classic mouse mutant nude, which is characterized by congenital 
athymia, leading to immune-deficiency, and hairlessness (Flanagan 1966; Pantelouris 
1968; Nehls et al. 1994; Nehls et al. 1996). In nu/nu mice, a small, cystic, alymphoid 
thymic rudiment is present in adult mice, and does not support T cell development at 
any stage in ontogeny. Subsequent to the localization of nude locus to chromosome 
11 in mice, Foxn1 (a.k.a. Whn) was cloned by position, and it was demonstrated that 
Foxn1 transcript in nu/nu mutant mice carried a single base pair deletion in the third 
exon of the gene (which codes for DBD), resulting in the absence of Foxn1 mRNA 
presumably due to nonsense-mediated decay. These data suggested that Foxn1 was 
the nude gene (Nehls et al. 1994). To test this hypothesis, Nehls and colleagues 
generated a targeted null allele, termed whn-, by inserting a lacZ-neo cassette in the 
third exon of Foxn1, close to the site of the spontaneous mutation in nude (Nehls et 
al. 1996). Whn-/- homozygous mice generated using this allele exhibited a phenotype 
of hairlessness and a thymia, phenocopying the nude phenotype, confirming Foxn1 
as the nude gene (Nehls et al. 1996). Thus, Foxn1 became the first member of the 
forkhead superfamily of genes to be implicated in a specific developmental defect in 
vertebrates. The targeted disruption study mentioned above also showed that Foxn1 
was not required for formation of 3PP or thymic primordium (Cordier & Heremans 
1975; Cordier & Haumont 1980) but was essential for subsequent differentiation of 
the cells of thymic primoridum into subcapsular, cortical, and medullary epithelial 
cells (Blackburn et al. 1996). Further insight into the function of Foxn1 during 
thymus development came from studies on nude mice showing that the absence of 
functional FOXN1 leads to maturational arrest in TEC at around E12.5 (Blackburn et 
al. 1996). Furthermore, using nude – WT chimeras, this study showed that the nude-
derived cells persisted in adult thymus but failed to contribute to cTECs or mTECs 
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and continued to express the antigens bound by MTS-20 and MTS-24 antibodies 
(later identified as PLET1), leading to the hypothesis that FOXN1 was required for 
differentiation of TEPCs. Similarly, the skin of chimeric mouse showed contribution 
from both nude and WT cells as determined by presence of patches of skin without 
hair. Thus, this study showed that Foxn1 was required cell-autonomously in both 
skin and thymus.  
 
The common thymus-parathyroid primordium forms normally in nude mice and 
thymus organogenesis is initiated and proceeds normally until E11.5-E12.0 but the 
thymic primordium fails to differentiate or be colonized by T-cell precursors, which 
remain in surrounding perithymic mesenchyme (Cordier & Haumont 1980; Itoi et al. 
2001). The presence of a thymic rudiment in nude and Whn-/- mice suggests that the 
cells within the ventral aspect of the 3PP are specified to a thymus fate well before 
the onset of high-levels of Foxn1 expression. Thus, although indispensible for 
differentiation of TEPCs, Foxn1 is not required for thymus fate specification of 3PP 
cells. This is consistent with the observation that transplantation of E9.0 3PP under 
kidney capsule generates an intact thymus containing both cortical and medullary 
thymic epithelial compartments (Gordon et al. 2004). Vascularization of 
developmentally arrested thymic rudiment fails in nude mice and these defects result 
in presence of small, cystic, alympoid thymic rudiment in adult mice (Itoi et al. 
2001). It was recently shown that during normal development, endothelial progenitor 
cells enter the thymus at E13.5, with the supporting mesenchymal cells following at 
E14.5, and that the timing and extent of migration of these cells is dependent on 
levels of Foxn1 expression (Bryson et al. 2013). Interestingly, the expression of 
Vegf-a and Pdgf-b, expressed in TECs, vasculature-associated mesenchyme and 
endothelium in the thymus, is severely reduced under conditions of low Foxn1 
expression, suggesting that the expression of Foxn1 in TECs is important for normal 
vascularization of the organ (Bryson et al. 2013). A thymic rudiment with reduced 
Foxn1 expression shows fewer capillaries, leaky blood vessels, disrupted 
endothelium-perivascular cell interactions, endothelial cell vacuolization, and an 
overall failure of vascular organization at later stages of development. The process of 
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thymus development can, therefore, be divided into early Foxn1-independent (from 
E9.0 to E12.5) and later Foxn1-dependent (after E12.5) processes.  
 
Nowell and colleagues recently studied the requirement of Foxn1 for various stages 
of TEC differentiation using a tamoxifen-inducible Cre recombinase to revert a 
severely hypomorphic Foxn1 allele back to WT levels (Nowell et al. 2011). The 
levels of normal Foxn1 transcript from the hypomorphic Foxn1R allele are around 
15% of that from WT allele, allowing generation of an allelic series to study the 
dose-dependent effects of Foxn1. This study showed that increasing levels of Foxn1 
expression are required for TEPCs to progress through multiple intermediate stages 
of thymic epithelium lineage development in the fetal and adult thymus (Nowell et 
al. 2011). Reverting the Foxn1R allele at various fetal and adult stages revealed that 
the Foxn1 deficient TEPCs can persist in the thymic rudiment until at least 6 months 
of age in mice and upon reversion are able to generate functional thymic organ with 
both cTECs and mTECs, showing that these cells are stably locked in a 
developmentally undifferentiated state under conditions of low Foxn1 expression 
(Nowell et al. 2011; Jin et al. 2014). Similar results demonstrating the survival of 
TEPCs in adult Foxn1 null mice have been reported using a different revertible 
Foxn1 allele termed Foxn1SA2 (Bleul et al. 2006). Using a Cre-ERT2 system that 
exhibits low level activity even in the absence of tamoxifen induction, this study 
showed that reactivation of Foxn1 in a single cell in the thymic rudiment of Foxn1 
null mice results in generation of small, well defined, functional medullary areas 
which are surrounded by cortical spheres (Bleul et al. 2006). This study also 
demonstrated, using hK14::Cre-ERT2;Rosa26R-eYFP reporter mice, the presence of 
a bipotent progenitor in post-natal thymus, which is capable of giving rise to both 
cortical and medullary TECs (Bleul et al. 2006). Another hypomorphic allele termed 
Foxn1Δ, whose transcript lacks an N-terminal domain of FOXN1, is able to support 
the development of T-lymphocytes but with specific defects at both DN and DP 
stages characterized by a significant decrease in their proportions and functionality 
(Su et al. 2003). The Foxn1Δ/Δ thymus is severely hypoplastic and cystic and does not 
contain distinct cortical and medullary regions. This suggests that TEPC 
differentiation was initiated in Foxn1Δ/Δ mice, however cells do not progress through 
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the entire differentiation process and the developing thymus thus lack functionally 
differentiated TECs. Indeed, the differentiation of TECs in Foxn1Δ/Δ appeared to be 
delayed and arrested as determined by K5, K8, and MTS10 staining (Su et al. 2003). 
It has recently been shown that TEC differentiation consists of a series of progressive 
states along the differentiation process, each identified through the expression of cell 
surface markers (Nowell et al. 2011). The earliest stages of commitment to mTEC 
cell fate appear to be Foxn1-independent, as demonstrated by presence of 
K5hiCldn4hi and K5-Cldn4lo/- regions in Foxn1-/- thymi (Nowell et al. 2011). 
Furthermore, mice expressing very low levels of Foxn1 expression (~15% of WT) 
showed presence of CD205+ cells, suggesting that this level of Foxn1 expression was 
sufficient to promoter early stages of cTEC development (Nowell et al. 2011). 
However stable entry into either differentiation programme and subsequent 
progression through the differentiation stages depended on increasing dosage of 
Foxn1 expression (Nowell et al. 2011). Thus, Foxn1 appears to be dispensable for 
earliest fate-choice decisions of TEPCs but is required for subsequent establishment 
of the differentiation programme. 
 
While the molecular functions of Foxn1 have not yet been determined in full, it has 
been shown to be required for expression in TECs of proteins with essential roles in 
promoting thymocyte development, such as Dll4, Ccl25, Cxcl12, and Scf (a.k.a. Kitl) 
(Nowell et al. 2011; Calderón & Boehm 2012). Ccl25 and Cxcl12 are chemokines, 
which are required for attracting ETPs into developing thymic rudiment. Dll4 is a 
Notch ligand, which signals to developing thymocyte within the thymus to commit 
them to T-cell fate and Scf is required for thymocytes survival and proliferation. 
While induced expression of these genes together in Foxn1-/- thymic rudiment is able 
to support, at least to an extent, the generation of CD4+ and CD8+ SP T-cells, TECs 
in this transgenic thymic rudiment remain in an undifferentiated state with an 
absence of medullary regions and very few MHC Class II+ cells (Calderón & Boehm 
2012). The absence of functional TECs suggest that the SP T-cells observed in this 
transgenic mice model are likely to have untested functional defects. This indicates 
that Foxn1 regulates additional genes that are required for TEC differentiation and 
function. Indeed, the expression of genes such as Trp63, Pax1, Fgfr2IIIb, Aire, 
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CD40, CD80, CyclinD1, which have known roles in TEC differentiation or function, 
and that of several genes involved in Wnt signaling is responsive to levels of FOXN1 
in TECs (Nowell et al. 2011; Bredenkamp, Nowell, et al. 2014). Furthermore, 
FOXN1 may also regulate as yet unknown genes important for thymus development.  
 
A recent study showed that Foxn1 in mammals has evolved unique functions in 
TECs that are compensated to some extent by its closest forkhead gene, Foxn4 
(Swann et al. 2014). This study showed that induced expression of Foxn4, which is 
normally only expressed by very few cells in the mouse thymus, in Foxn1 deficient 
TECs leads to the development of CD4+ and CD8+ SP thymocytes in the transgenic 
thymus. However, there is a reduction in the number of DN and SP thymocytes and a 
proportionate reduction of CD8+ SP thymocytes and a proportionate increase of DN 
thymocytes (Swann et al. 2014). These transgenic thymi are substantially smaller 
compared to WT and show restoration of thymic architecture characterized by the 
presence of cortex and medulla, while also containing several cystic regions (Swann 
et al. 2014). Both K5 and K8 are widely expressed throughout the adult transgenic 
thymi, however the expression of Ly51 and UEA1 was restricted to cTECs and 
mTECs respectively (Swann et al. 2014). The cTEC/mTEC ratio in transgenic thymi 
is much higher compared to WT resulting from both an increase in the total number 
of cTECs and a decrease in total number of mTECs. On the other hand, induced 
Foxn4 expression was sufficient to rescue the keratinocyte differentiation defect in 
the skin of Foxn1-/- mice (Swann et al. 2014). Contrary to mammalian thymus, the 
fish thymus expresses similar levels of Foxn1 and Foxn4 in TECs. Similar 
compensation was also observed by the endogenously expressed foxn4 in foxn1-/- 
medaka thymus (Swann et al. 2014). Interestingly, the induced expression of Foxn4 
in Foxn1-/-, or a combined induced expression of both Foxn1 and Foxn4 in Foxn1-/- 
mouse thymus results in dramatic increase in the number of B cells within the 
thymus compared to WT thymus (~100 fold in the later transgenic model). B cells 
are readily detectable in the medaka thymus, which expresses both foxn1 and foxn4. 
Thus, the specialized function of mammalian thymus to support T-cell development 
over B-cell development stems from a loss of Foxn4 expression combined with the 
maintenance of Foxn1 expression in TECs. 
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1.4.5 Foxn1 in thymus homeostasis and involution 
TECs in the adult thymus continue to express Foxn1 (Nehls et al. 1996), with cTECs 
expressing higher levels of the gene than mTECs and MHC Class-IIhi cells 
expressing higher levels than MHC Class-IIlo TEC in each compartment (Nowell et 
al. 2011; Ki et al. 2014). Although Foxn1 continues to be expressed in postnatal 
TEC, it is not yet clear whether its expression is maintained in all postnatal TECs. 
The presence of postnatal TECs not expressing Foxn1 has been suggested from 
immunohistochemistry analysis of FOXN1, showing an absence of the protein in a 
proportion of TECs (Itoi, Tsukamoto & Amagai 2007). While the expression of 
Foxn1 by all postnatal TECs is still disputed, several studies have demonstrated its 
importance in maintenance of a functional adult thymus. Interestingly, down-
regulation of Foxn1 expression in the thymic stroma is one of the earliest events in 
the age-associated degeneration of the thymus (Ortman 2002). This observation 
suggested that Foxn1 could play an important role in postnatal thymus homeostasis 
and function and subsequent thymic involution. This hypothesis was recently tested 
using a Foxn1 allele termed Foxn1lacZ, which has a IRES-lacZ cassette knocked into 
the 3` untranslated region of Foxn1, that results in normal Foxn1 expression during 
fetal and newborn stages but a decline in Foxn1 expression beginning at about 1 
week after birth (Chen et al. 2009). This study showed that, in the postnatal thymus, 
a reduction in Foxn1 expression below 50% of WT levels resulted in degeneration of 
the thymus, characterized by reduced thymus size, deterioration of the cortico-
medullary junction, loss of TEC subsets, reduced proliferation of MHC Class-IIlo 
TECs, and defects in thymocyte maturation, in a highly dosage-dependent manner 
(Chen et al. 2009). The lacZ/lacZ thymi demonstrate these adverse effects by as early 
as 2 weeks of age. The TEC subset most affected by the reduced Foxn1 expression 
were the ones with the highest levels of Foxn1 expression, suggesting that these cells 
might require high levels of expression of this gene and are sensitive to changes in 
the level of its expression (Chen et al. 2009). These changes are similar to that 
observed during age-dependent thymic degeneration, suggesting that reduced Foxn1 
expression in postnatal thymus can accelerate this process. Consistent with this, 
another study showed that a ubiquitous deletion of Foxn1 in postnatal mice results in 
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rapid (within 5 days) thymic atrophy, further supporting the role of Foxn1 in thymus 
homeostasis (Cheng et al. 2010). In zebrafish, mcm2 and cdca7, which are down-
regulated in presence of foxn1 morpholinos, appear to be able to partially rescue the 
T-cell development defect as demonstrated by the expression of rag1 and ikaros in 
these cells at 4dpf (Ma et al. 2012).  
 
The importance of Foxn1 in thymus maintenance, as demonstrated by above-
mentioned postnatal reduction in Foxn1 expression studies, is further supported by a 
study demonstrating the effects of over-expression of Foxn1 in postnatal thymus. 
Zook et al. generated a novel Foxn1 allele, termed Foxn1Tg, where a 2.1 kb of 
mouse Foxn1 cDNA fragment is expressed under control of the human K14 
promoter, resulting in over-expression of Foxn1 in thymic stroma due to the presence 
of multiple copies of the transgene (Zook et al. 2011). Transgenic Foxn1Tg mice 
show around 20-fold higher expression of Foxn1 in TECs than WT mice and the 
level of expression does not change with age (Zook et al. 2011). Interestingly, 
expression of the transgene in these mice results in a 7.2-fold higher expression of 
the endogenous Foxn1 in 2-months old Foxn1Tg mice compared to WT, suggesting 
a possible auto-regulation of Foxn1 in TECs (Zook et al. 2011). Trangenic thymi 
from old mice are considerably bigger in size and show little adipose tissue 
deposition and a well defined architecture with proper cortical-medullary 
demarcation (Zook et al. 2011). The thymi from 3-months old Foxn1Tg mice showed 
a 2.5 fold increase in the number of EpCAM+ MHC Class-II+ Ly51- TECs and a 
further 5-fold increase in MHC Class-IIhi subpopulation within these TECs, partly 
resulting from increased proliferation of TECs in transgenic mice (Zook et al. 2011). 
Thus, overexpression of Foxn1 is able to prevent the age-related decrease in TEC 
numbers and organization. This alleviated involution phenotype also resulted in 
increased thymic output, as demonstrated by higher number of total thymocytes and 
higher naïve T-cell output from transgenic thymi as compared to that from WT 
(Zook et al. 2011). The authors of this study also observed an increase in the number 
of ETPs in Foxn1Tg thymi (Zook et al. 2011), which has been suggested to be a 
result of increased expression of Foxn1 in novel population of Linneg/low CD45+ 
EpCAM+ Sca1+ CD117- CD138- MHCII- bone marrow cells which in turn is thought 
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to affect the number of hematopoetic stem cells and multipotent progenitors (Zook et 
al. 2013). This later study suggests that Foxn1 affects thymus homeostasis and 
involution not only through its function in TECs but also through its role in bone 
marrow.  
 
1.4.6 Foxn1 as master transcriptional regulator of TECs 
The above-mentioned studies showed that Foxn1 plays an important role in 
maintenance of transcriptional programme prevalent in TECs, and that decreasing 
levels of Foxn1 expression are directly related to age-related changes in this 
programme. On the other hand, as described in detail below, studies in our lab have 
shown that Foxn1 is also able to restore in aged TECs a transcriptional programme 
similar to that in a young TECs and that Foxn1 is furthermore able to establish this 
transcriptional programme in an unrelated cell type resulting in its reprogramming. 
Bredenkamp and colleagues recently addressed the possibility of regeneration of an 
aged thymus through overexpression of Foxn1 by using a novel transgene 
R26Foxn1ERT2 encoding a tamoxifen-inducible form of FOXN1 expressed under the 
control of CAG promoter, from the Rosa26 locus, upon excision of a stop cassette 
(Bredenkamp, Nowell, et al. 2014). The expression of this transgene was restricted to 
TECs in the thymus by using a Cre-recombinase, which is expressed from 
endogenous Foxn1 locus. The presence of IRES-Gfp following Foxn1ERT2 in the 
transgene showed that most TECs in fetal and aged transgenic mice were GFP+, 
suggesting that most TECs in adult thymus express Foxn1 (Bredenkamp, Nowell, et 
al. 2014). Using this transgenic mice model, Bredenkamp et al. showed that 
tamoxifen treatment of 12- and 24- month old mice for 1 month resulted in in-vivo 
regeneration of thymus, characterized by an increase in thymus size and TEC 
numbers, total thymocyte numbers (including ETPs), restoration of thymic 
architecture to that similar in young mice, increased mTEC:cTEC ratio, and 
increased naïve T-cell output (Bredenkamp, Nowell, et al. 2014). Induced expression 
of Foxn1 in this mouse model lead to increased expression of various genes 
important for TEC biology and function, including Dll4, Ccl25, Kitl, Pax1, Trp63, 
Fgfr2IIIb, and Aire, to levels observed in young thymus (Bredenkamp, Nowell, et al. 
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2014). This indicates that Foxn1 is able to drive and restore the transcriptional 
network prevalent in young TECs. A unique advantage of this approach for thymus 
regeneration is restoration of architecture and function of old thymus to that observed 
in young thymus, which has not been observed with other approaches for provoking 
thymus regeneration such as sex-steroid ablation (Bredenkamp, Nowell, et al. 2014). 
Furthermore, consistent with previous reports, this study also showed increased 
proliferation in various TEC subsets as a result of induced Foxn1 expression, 
supporting the role of Foxn1 in TEC proliferation (possibly by regulating Trp63, 
Fgfr2IIIb, Ccnd1 – all of which are involved in cell proliferation) as well as 
differentiation (Bredenkamp, Nowell, et al. 2014). Despite the role of Foxn1 in 
TEPC differentiation, the Foxn1Tg and R26Foxn1ERT2 thymi do not show 
uncontrolled differentiation of TEC progenitor/stem cells suggesting that other 
factors regulate the balance between proliferation and differentiation. However, the 
identity of such factors remains unknown. 
 
In an approach similar to that mentioned above, a full-length Foxn1 cDNA under the 
control of CAG promoter was expressed from Rosa26 locus upon excision of a 
STOP cassette and the CRE-recombinase is provided by CreERT2 knocked into the 
second Rosa26 locus, allowing excision of the cassette in MEFs (Bredenkamp, 
Ulyanchenko, et al. 2014). Using this system, Bredenkamp and colleagues showed 
that by 10 days after initiation of Foxn1 expression in MEFs, the cells had undergone 
changes in morphology, adopting a broad polygonal shape characteristic of epithelial 
cells, suggesting that these cells were being reprogrammed (Bredenkamp, 
Ulyanchenko, et al. 2014). These FOXN1-induced MEFs were shown to express 
genes important in TECs and provide a permissive environment for maturation of 
ETPs to DP and SP thymoctyes in-vitro, with similar kinetics to that observed for the 
well established OP9-DL1 stromal cell line (Bredenkamp, Ulyanchenko, et al. 2014), 
leading to the conclusion that enforced expression of FOXN1 resulted in induction of 
TEC identity in MEFs, generating induced or iTEC. The authors further showed that 
these FOXN1 reprogrammed iTECs were able to generate a fully functional thymus 
organ, with characteristic thymus architecture, upon transplantation under the kidney 
capsule together with supporting stromal cells and immature thymocytes 
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(Bredenkamp, Ulyanchenko, et al. 2014). The reprogrammed iTECs showed 
induction of endogenous Foxn1 expression, consistent with the autoregulation of 
Foxn1 observation in Foxn1Tg mice (Bredenkamp, Ulyanchenko, et al. 2014). While 
reprogramming of cell fate using a single transcription factor has been demonstrated 
for other systems, the above study is the first example of generation of a functional 
organ using such reprogrammed cells. Together, the above two studies suggest that 
FOXN1 is a master regulator of TEC differentiation, capable of establishing and 
maintaining a transcription factor network characteristic of young thymus.  
 
1.4.7 Regulation of Foxn1 expression in TECs 
Given the importance of Foxn1 in the thymus, it is no surprise that several studies 
have analyzed the regulation of its expression in this organ. As mentioned above, 
evidence exists for autoregulation of Foxn1 in TECs, however whether this is a direct 
or indirect effect of induced Foxn1 expression remains to be determined. Recently, 
E2Fs have been shown to be able to bind to their consensus binding site in Foxn1 
promoter in-vitro and increased activity of E2F3 in vivo was shown to correlate with 
increased expression of Foxn1 in TECs (Garfin et al. 2013). Furthermore, genetic 
analysis has shown that reduction in Foxn1 expression is sufficient to reverse the 
phenotype of enlarged thymus associated with Rb mutants, further supporting the 
idea of regulation of Foxn1 expression by E2Fs (Garfin et al. 2013). Another gene 
suggested to be involved in regulating the expression of Foxn1 in the thymus is Tbx1 
(Reeh et al. 2014). Induced expression of Tbx1 in Foxn1 expressing cells of E11.5 
3PP results in down-regulation of Foxn1 expression in these cells, suggesting that 
Tbx1 could act as a repressor of Foxn1 transcription in TECs (Reeh et al. 2014). As 
expected, the reduced Foxn1 expression in Foxn1Cre;R26iTbx1/+ thymi leads to 
dedifferentiation of TECs (loss of Cldn4 expression at E14.5) resulting in an 
accumulation of PLET1+ cells in the fetal thymus (Reeh et al. 2014). Finally, Hoxc13 
has been suggested to be a transcriptional regulator of Foxn1 in the hair follicle and 
skin (Potter et al. 2011).  
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The regulatory regions governing the expression of Foxn1 in TEPCs or TECs still 
remain to be identified. Several studies have investigated the size of the minimal 
genomic region surrounding the Foxn1 gene on chromosome-11 that can reproduce 
the wild-type Foxn1 expression pattern in skin and thymus. The largest region tested 
was a 110 kilobase pairs (kb) region containing the entire Foxn1 locus plus 74kb of 
5`-flanking sequence and 12kb of 3`-flanking sequence; this region rescued the nude 
phenotype in vivo, suggesting that it contains all regulatory elements required for 
normal expression of Foxn1 (Cunliffe et al. 2002). Another study used a cosmid-
derived transgene containing 26kb of genomic DNA encompassing the coding exons 
of Foxn1 plus 8.5kb of 5`-flanking sequence and 3kb of 3`-flanking sequence 
(Kurooka et al. 1996). However, this 26kb transgene resulted in rescue of only the 
hairless phenotype but could not rescue the athymic phenotype of nude mice, 
showing that it lacked at least some of the regulatory regions required for Foxn1 
expression in TECs (Kurooka et al. 1996). As mentioned above, several studies 
expressing various genes under the control of Foxn1 promoter element have been 
published. These studies employ as the Foxn1 promoter a 30 kb fragment containing 
the entire upstream sequence between the first coding exon of Foxn1 (exon-2) and 
the upstream gene Slc13a2 (Schlake 2005). This 30kb promoter fragment has been 
shown to be able to recapitulate Foxn1 expression pattern in the developing thymus, 
however it does not reproduce the normal Foxn1 expression pattern in postnatal and 
adult thymus (NR Manley, personal communication). Thus, it appears that the 
regulatory regions governing the transcription of Foxn1 in fetal TEPCs and TECs are 
present within the 30 kb region identified by Schlake, while the postnatal expression 
of Foxn1 requires additional regions present in the 110 kb region used by Cunliffe. 
However, the promoter and enhancers governing the expression of Foxn1 in TEPCs 
and TECs remain to be definitely identified and similarly the identity of the tissue-
restricted transcription factors important for its expression remains elusive.  
 
Studies focusing on improving our understanding of thymus development have so far 
identified several genes important for this process, however information on 
molecular insight of this process remains scarce. Particularly, the regulation of 
Foxn1 expression in the developing thymus still remains unknown. Analysis of mice 
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carrying mutations in genes considered to be potential upstream regulators have 
provided some clues as to potential regulators of Foxn1, but with the exception of 
E2F, evidence of direct binding to Foxn1 regulatory elements is lacking: 
i) Ectopic Tbx1 expression in Foxn1 expressing TECs results in 
downregulation of Foxn1 expression. However, whether this is a direct or 
indirect effect remains to be determined (Reeh et al. 2014). 
ii) Hoxa3-/- and Eya1-/- embryos demonstrate a block in primordium 
formation prior to onset of Foxn1 expression, hindering analysis of their 
potential role in regulation of Foxn1 expression (Manley & Capecchi 
1998; Zou et al. 2006). It is now clear that Foxn1 expression is delayed 
but initiated in Hoxa3-/- thymi (Chojnowski et al. 2014). 
iii) Pax1-/-Pax9-/- thymic rudiment does not express Foxn1 (Blackburn lab, 
unpublished). However, direct interaction of the PAX proteins with the 
Foxn1 locus has not been demonstrated. 
iv) Mice mutant for Rb family genes show increased Foxn1 expression in 
thymus at 3-months of age and E2Fs can bind to their consensus binding 
sites in Foxn1 promoter in-vitro (Garfin et al. 2013). However, the fetal 
Rb mutant thymi are indistinguishable from controls, suggesting that 
Foxn1 may not be regulated by E2Fs during fetal thymus development. 
 
1.5 Aim 
The aims of this thesis were therefor to identify candidate transcriptional regulators 
of Foxn1 in fetal thymic epithelial progenitor cells, through analysis of the regulatory 
regions governing Foxn1 expression in fetal thymic epithelial progenitor cells, in 




2. Materials and Methods 
2.1 Mice 
All animals were housed in Animal Facility at either the Roger Land Building or the 
Scottish Centre for Regenerative Medicine Building at the University of Edinburgh 
and treated in accordance with the Animal (Scientific Procedures) Act 1986.  Mice 
were housed in a stabilised environment with a 12-hour light/dark cycle with food 
and water provided as required. 
 
2.1.1 Mice Mating Set-up and Embryo Collection 
The mice embryos used in this study were of C57BL/6 X CBA genotype. Briefly, 
C57BL/6 females were mated with CBA males by caging together overnight. The 
females were examined for the presence of a vaginal plug the following morning, 
which was taken as embryonic day 0.5 (E0.5). Pregnant females were sacrificed at 
the desired stage and the uterus isolated in an ice-cold tube. The uterus was 
subsequently dissected into ice-cold phosphate buffered saline (PBS) to release the 
embryos. All extra-embryonic tissue was discarded at this stage. The embryos were 
sacrificed by removal of heads. 
The Foxn1 null embryos (termed nude) were obtained by intercrossing Foxn1 
heterozygous mice, Foxn1lacZ/+. The resulting embryos, a combination of wild type 
(WT) and transgenic, were collected as described above. 
 
2.1.2 Embryo Developmental Stage Identification 
In most cases, the developmental stage of embryos was determined by counting the 
number of days post vaginal plug examination. More precise classification of the 
developmental stage, was carried by counting the number of somites in accordance 
with the guidelines in Karl Theiler’s “The House Mouse: atlas of embryonic 




The genotypes of embryos resulting from Foxn1lacZ/+ X Foxn1lacZ/+ cross were 
determined by collecting yolk sacs and tail clips for each embryo and adding to a 
tube containing 50µl tissue and cell lysis buffer. Samples were incubated at 55°C 
overnight in a shaking waterbath. These samples were then incubated at 95°C for 10 
minutes to inactivate Proteinase K and then placed on ice for 5 minutes. Samples 
were then centrifuged at 13,000rpm for 10 minutes at room temperature and the 
supernatant, containing genomic DNA (gDNA), was transferred to a clean 
microcentrifuge tube. The isolated gDNA was used for PCR analysis with allele 
specific primer pairs.  
 
2.1.3.1 Tissue and Cell Lysis Buffer 
10mM Tris-HCL, ph 8.3 (Roche) 
50mM Potassium Chloride (KCl) 




To 50ml in distilled water (Autoclave without NP40 and Tween20) 
50µg/ml Proteinase K (Promega) added as required 
 
2.1.3.2 Genotyping PCR Reaction Mix 
2µl yolk sac or tail clip gDNA 
3µl 10X PCR Reaction Buffer (Qiagen) (containing 1.5mM MgCl2) 
0.5µl 100µM dNTPs (Invitrogen) 
1µl of 10µM each primer  
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2.5U Taq DNA polymerase (Qiagen) 
To 50µl with sterile water 
 
The following PCR conditions were used: denaturation at 94°C for 5 minutes 
followed by 30-35 cycles of amplification, 94°C for 30 seconds, 55°C (59°C for 
exon-3 PCR) for 30 seconds, and 72°C for 30 seconds. Following the completion of 
amplification cycles, the PCR products were incubated at 72°C for 10 minutes to 
ensure complete elongation of all PCR products. Finally, the samples were cooled 
and held at 4°C until analysis by gel electrophoresis.  
	
2.1.3.3 Agarose gel electrophoresis 
For gel electrophoresis, 1% agarose gel was prepared by dissolving 1 gram of 
agarose in 100ml of TBE buffer and 0.5µg/ml ethidium bromide was added to 
facilitate visualization of DNA. PCR products were mixed with 1X Orange G 
loading buffer (NEB) before loading in the gel. The agarose gel containing PCR 
products was typically run at 100-120V in TBE buffer. 0.5µg of 1kb ladder 
(Invitrogen) or 100bp ladder (NEB) was used as molecular weight marker. The gel 
was analyzed under a UV transilluminator at 312nm (Gene Flash, Syngene, UK) and 
photographed either digitally or printed.  
 
2.1.4 Third Pharyngeal Pouch (3PP) and Embryonic Thymus 
Dissociation 
3PP from mice embryos ranging from E9.5 to E10.5 and the thymic primordium 
from embryos ranging from E11.0 to E12.5 were microdissected under a dissection 
microscope. Dissected tissue was pooled (where appropriate) in a clean 
microcentrifuge tube containing ice-cold 1ml of PBS with 5% fetal calf serum 
(FCS), together termed FACS wash. Collected tissue was then washed twice with 
PBS containing magnesium (Mg) and calcium (Ca) (Sigma) to remove any traces of 
FCS, which can inhibit subsequent dissociation steps. Washed tissue was then re-
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suspended in 1ml of PBS (+Mg+Ca) containing 0.05mg/ml DNaseI (Roche), 
0.7mg/ml collagenase D (Roche), and 1.4mg/ml hyaluronidase (Sigma) enzymes. 
The samples were then incubated at 37°C for ~15 minutes and mixed by pipetting 
every 3-4 minutes to aid dissociation of tissue to a single cell suspension. At the end 
of this incubation time, ~900µl of the suspension was transferred to a clean 
polypropylene tube (BD Falcon) used for fluorescent activated cell sorting (FACS). 
The remaining 100µl of the above suspension, which contains smaller, un-
dissociated pieces of tissue, was then mixed with 500µl 250µg/ml trypsin containing 
0.05mg/ml DNaseI and further incubated at 37°C for 5 minutes, with repeated 
mixing every minute by pipetting. The resulting single cell suspension was pooled 
together with that in the FACS tube. The presence of DNaseI in this dissociation 
protocol ensures that the DNA released from any dying cell is rapidly digested 
without adversely affecting the dissociation process. The resulting single cells were 
subsequently washed twice with FACS wash before staining for cell surface markers. 
All centrifugation steps were carried out at 213 rcf in a refrigerated centrifuge at 4°C.  
 
2.2 Flow Cytometry 
 
2.2.1 Sample Preparation for FACS 
A single cell suspension was prepared from tissue samples as described in section-
2.1.4 for sorting cell types of interest. All the steps mentioned below were carried out 
on ice and using ice-cold reagents. All centrifugation steps were carried out at 213 
rcf in a refrigerated centrifuge at 4°C. After washing the dissociation enzyme free 
single cell suspension twice with FACS wash, ~10% of the sample was transferred to 
a clean FACS tube and used as unstained control for adjusting voltages for lasers 
being used. For experiments where cells needed to be stained for PLET1, a marker of 
thymic epithelial progenitor cells (TEPCs) (Depreter et al. 2007), the cell suspension 
was centrifuged after removal of unstained samples. The supernatant was then 
discarded and the cell pellet was re-suspended in 200µl of either unconjugated 
MTS20 or 1D4 antibody, which was generated in the lab, and incubated for 15 
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minutes on ice. The sample was then diluted with 800µl of FACS wash, centrifuged 
and the supernatant, containing unbound antibodies, was discarded without 
disturbing the cell pellets. All subsequent incubations were carried out in dark. The 
cell pellet was then re-suspended in 200µl of FACS wash containing appropriate 
concentration of secondary antibody and incubated for 15 minutes on ice. Following 
this, sample was washed with FACS wash as described above to remove unbound 
secondary antibodies. Given that the secondary antibodies used were usually always 
generated against rat (e.g. goat α-rat), the cell pellet obtained after discarding the 
supernatant from the last step was re-suspended in 200µl of FACS wash containing 
5% rat serum to prevent cross-reactivity with any of the antibodies used in 
subsequent steps. The sample was incubated for 5 minutes on ice and then washed 
with FACS wash. The resulting cell pellet was then stained for Epithelial Cell 
Adhesion Molecule (EpCAM; a marker of epithelial cells), CD45 (a marker of 
haematopoietic cells, including thymocytes), CD31 (a marker of vascular endothelial 
cells), and Ter119 (a red blood cells marker) in a single step. To this end, the cell 
pellet was re-suspended in FACS wash containing appropriate concentrations of each 
of these antibodies and incubated for 15 minutes on ice. Following this, the sample 
was washed twice with FACS wash and the cell pellet was finally re-suspended in 
200-300µl of FACS wash containing appropriate concentration of DAPI (dead cell 
marker). The cells were kept on ice in dark until sorting.  
 
Single stain controls were used for each fluorochrome for adjusting the 
compensation between different excitation-emission spectrums. UltraComp beads 
(BD Falcon) or in-house produced beads were used for single stain controls. A 
separate bead sample was prepared for each fluorophore used in the experiment. 
Briefly, one drop of bead was mixed with 1µl of appropriate antibody and incubated 
on ice for 15 minutes. The bead sample was then washed with FACS wash and then 
re-suspended in 200µl of FACS wash and kept on ice until analysis. Unconjugated 
beads were added to stained bead sample as appropriate. FMO controls (full minus 
one; lacking one colour from the staining panel) were prepared by using 10% of cell 
suspension transferred into a fresh FACS tube before beginning the staining 
procedure. The FMO control was subsequently stained for all colours except one, 
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usually the colour used for identification of PLET1, and used for setting sorting 
gates. 
 
2.2.2 Cell Sorting 
Cell sorting was kindly performed by the FACS facility staff, Simon Monard, Olivia 
Rodrigues, Claire Cryer, and Fiona Rossi, on FACS Aria-II (BD) using 100µm 
nozzle. Depending on experimental needs, the cells were either sorted into sterile, 
DNase and RNase free 1.5µl eppendorf tubes or into 200µl PCR tubes.  
 
For subsequent analysis using CellsDirect One-Step qRT-PCR kit (Invitrogen), 200 
cells were sorted into a 200µl PCR tube containing 10µl of reaction mix (see Section 
2.3.3). The tubes were immediately centrifuged after sorting and placed on dry ice, to 
prevent any RNA degradation, to be subsequently transferred to -20°C freezer.  
 
2.2.3 Antibodies 
Primary antibodies used for FACS are described in Table 2.2, along with their clone, 
source, isotype and dilution factor. Secondary antibodies used were raised in goat 
and conjugated to either alexa fluor-647 or alexa fluor-568, as described in Table 2.3. 
 
2.3 Molecular Techniques: Real Time PCR 
 
2.3.1 RNA Isolation 
Before RNA isolation, the bench surface and pipettes were wiped clean with 70% 
ethanol and RNase OUT (Ambion) to remove any traces of RNase. RNA isolation 
was carried out using sterile, DNase and RNase-free filtered pipette tips (Alpha 
Laboratories) and 1.5ml Biosphere SafeSeal Tubes (Sarstedt). RNA from samples 
that were not limited in cell number (i.e. when not using CellsDirect One-Step qRT-
PCR kit) was isolated using RNeasy Mini Kit (Qiagen) according to the 
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manufacturer’s instructions. Isolated RNA was kept on ice for immediate use or 
transferred to -80°C for long-term storage.  
 
2.3.2 Reverse Transcription and cDNA synthesis 
Full-length cDNA was synthesized from total RNA using Superscript-II First-Strand 
Synthesis kit (Invitrogen), according to the manufacturer’s guidelines. First strand 
synthesis was carried out using oligo(dT) as primers. The reverse transcriptase 
enzyme was substituted with water to obtain –RT (negative) controls, for each 
sample, for subsequent PCR reactions.  
 
2.3.3 Protocol For Samples with Low-Cell Numbers 
Samples were designated as being low-cell number if it was predicted that sufficient 
numbers of cells could not be sorted to be able to isolate sufficient quantity of good 
quality RNA with above-mentioned protocol. Such samples included single embryo 
sorting for transgenic crosses, cells sorted after cell-culture experiments, and others. 
Furthermore, samples were treated as low-cell number samples if the sorted cells 
were to be analyzed using the Fluidigm system. CellsDirect One-Step qRT-PCR kit 
(Invitrogen) was used to carry out one-step reverse transcription and cDNA synthesis 
for cells sorted from such samples to avoid material wastage and increase the number 
of genes whose expression could be tested from a single sample.  
 
Up to 200 cells from low-cell number sample were sorted into a 200µl PCR tube 
containing 10µl of reaction mix (see below). Care was taken to ensure that cells were 
sorted in to the center of the tube to maximize the chance of sorting them into the 
reaction mix, rather than onto the side of the tube. Upon sorting, the PCR tube was 
immediately centrifuged briefly, to collect all the material (cell droplets and reaction 
mix) to the bottom of the tube, and then transferred to dry ice for quick freezing of 




2.3.3.1 CellsDirect Reaction Mix for Cell Sorting  
For 200µl PCR tube contains the following: 
10µl CellsDirect 2X Reaction Mix (from CellsDirect One-Step qRT-PCR kit, 
Invitrogen) 
0.2µl SUPERase-In (Applied Biosystems) 
Up to 200 cells were be sorted in to this reaction mix. 
 
2.3.3.2 Pre-amplification of low-cell number samples for 
subsequent qPCR analysis 
The CellsDirect One-Step qRT-PCR kit has been optimized for gene expression 
analysis using very few cells, including single cells. The protocol used here is a 
modification of the protocol for pre-amplification of single cell for use with the 
Fluidigm platform, based on BioMark User Bulletin 5 (Fluidigm PN 68000107 Rev. 
A). The protocol was modified for analysis of up to 200 cells, as per 
recommendations from the Quake lab at Stanford University, USA. PCR tubes 
containing cells in reaction mix were thawed on ice before use. Following this, 10µl 
of 4X Assay Mix was added to each tube and pre-amplification was carried out using 
a PCR machine in accordance with the guidelines in BioMark protocol. Pre-
amplified samples were either used immediately or stored at -20°C for later use.  
 
Pre-amplification reaction mix: 
To each sample, add the following 
5µl 4X Assay Mix 
1µl SuperScript III RT/Platinum Taq mix (CellsDirect kit) 
4µl TE buffer 
 
 53	
-RT (negative) control samples were prepared by substituting the SuperScript III 
RT/Platinum Taq mix in the above pre-amplification reaction mix with Taq 
polymerase.  
 
2.3.3.3 100X Assay Mix 
100X Assay Mix was made for each gene using forward and reverse primer pairs. 
100X Assay Mix can be stored at -20°C for later use. 
 
Each 100µl 100X Assay Mix contains: 
20µl 100µM Forward primer 
20µl 100µM Reverse primer 
60µl sterile water 
 
2.3.3.4 4X Assay Mix 
4X Assay Mix was made using 100X Assay Mix for each gene whose expression 
was to be analyzed for a given sample. The 4X Assay Mix contains equimolar 
concentrations of primer pairs for all the genes to be analyzed. Of note, the samples 
could only be pre-amplified once, thus the expression of only the genes included in 
the 4X Assay Mix could subsequently be analyzed by qPCR. The number of genes 
that were included in 4X Assay Mix depended on the type of platform used for 
downstream qPCR analysis. For analysis using LightCycler 480 (Roche), a 
maximum of 16 genes was analyzed from a pre-amplified sample, due to volumetric 
constraints. On the other hand, up to 48 or 96 genes could be included in 4X Assay 
Mix if subsequent qPCR analysis was to be carried out using 48.48 or 96.96 
Dynamic Array from Fluidigm, respectively. The 4X Assay Mix could be stored at 
4°C for a limited amount of time.  
 
4X Assay Mix contains: 
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1µl of each 100X Assay Mix 
to 100µl using sterile water 
 
2.3.3.5 Pre-amplification Thermal Cycling Conditions 






RT enzyme inactivation; Platinum Taq activation 













2.3.4 Quantitative PCR using Univeral Probe Library (UPL) on 
LightCycler 480-II (Roche) 
The following protocol was used for gene expression analysis of both non pre-
amplified and pre-amplified samples on LightCycler 480-II instrument. 8µl of 
reaction mix was mixed with 2µl of diluted cDNA in one well of a multiwell qPCR 
plate. The reaction mix was kept on ice and shielded form light to prevent probe 
degradation. PCR was performed as per manufacturer’s guidelines.  
 
Reaction Mix: 
5.0µl 2X Master Mix (Roche) 
0.1µl UPL probe (Roche) 
0.5µl 10µM Forward primer 
0.5µl 10µM Reverse primer 
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to 8µl with PCR grade water (Roche) 
 
2.3.4.1 Cycling Conditions on LightCycler 480-II 
Temperature Time (min) Function 
95°C 05:00 Denaturation and Hot-start 









4°C Continuous Cool down 
 
2.3.5 Quantitative PCR using Univeral Probe Library (UPL) on 
Fluidigm (BioMark) 
The following protocol was used for gene expression analysis of pre-amplified 
samples on Fluidigm instrument. 10X Assay mix, containing 2µM of each primer 
and 1µM of the probe, was prepared as described below for each assay. 5µl of each 
10X Assay mix was dispensed into individual assay inlets on a primed 48.48 
Dynamic Array Chip. 5µl of sample mixes (prepared as described below) were 
dispensed into individual sample inlets on the same Dynamic Array. The Dynamic 
Array was loaded into the BioMark instrument and PCR performed as per 
manufacturer’s recommendations. 
 
10X Assay Mix: 
2.5µl DA Assay Loading Reagent 
0.5µl 100X Primer Pair Mix 





3.64µl TaqMan® Universal PCR Master Mix 
0.36µl GE Sample Loading Reagent 
2.5µl pre-amplified sample 
 
2.3.5.1 Cycling Conditions on Fluidigm BioMark 
Temperature Time (min) 
50°C 02:00 
95°C 10:00 










2.4 Molecular Techniques: Chromatin Immunoprecipitation 
combined with next generation sequencing (ChIP-seq) 
 
2.4.1 Sample fixation 
Low cell number ChIP-seq was performed using 125,000 cells per ChIP reaction. 
The number of cells used per ChIP was chosen based on the low-cell ChIP-seq 
protocol kindly provided by Wysocka Lab at Stanford University, USA.  
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125,000 cells were sorted into clean, DNase and RNase-free DNA-low Bind 1.5ml 
Eppendorf tube containing 200µl of FACS wash. After sorting, cells were washed 
twice with PBS to remove traces of FCS. The cells were then re-suspended in 1ml of 
sterile PBS (Sigma) and fixed by adding formaldehyde to a final concentration of 1% 
and incubating at room temperature (RT) for 10 minutes. Excess formaldehyde was 
then quenched by adding glycine to a final concentration of 0.125M and incubating 
at RT for 5 minutes. The cells were then washed with ice-cold 1ml of HBSS media 
containing 1X protease inhibitor cocktail (Roche). The supernatant was discarded 
and the cell pellet stored at -80°C until further use. All centrifugation steps were 
carried out at 239 rcf for 5 minutes at 4°C.  
 
2.4.2 Cell lysis and Sonication 
All the steps were carried out using sterile filtered pipette tips and on ice unless 
stated otherwise. Formaldehyde fixed, frozen cell pellets were thawed on ice for 30 
minutes. Following this, a three-step gentle lysis protocol was followed to isolate 
nuclei for sonication. Briefly, the cell pellet was first re-suspended in 500µl of ice-
cold LB1 containing 1X protease inhibitor cocktail and incubated at 4°C for 10 
minutes on a vertical spinning wheel. The lysis reaction was then centrifuged for 5 
minutes at 1350g at 4°C and the supernatant discarded. The pellet was then re-
suspended in 500µl of ice-cold LB2 containing 1X protease inhibitor cocktail and 
incubated at RT for 10 minutes on a vertical spinning wheel. The sample was then 
centrifuged at 1350g at 4°C for 5 minutes and the supernatant discarded. The pellet 
containing nuclei was finally re-suspended in 100µl of ice-cold LB3 containing 1X 
protease inhibitor cocktail and used immediately for sonication.  
 
Sonication was carried out using chilled (ice-cold) BioRuptor Sonicator from 
Diagenode. Four rounds of sonication was carried out for each sample. The 
BioRuptor setting for each sonication round was: 10 cycles of sonication at high 
power, “on” interval = 30 seconds, “off” interval = 30 seconds. The ice-cold water in 
sonication bath was changed after every sonication round to keep the apparatus 
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chilled and to avoid heat mediated degradation of sonicated chromatin. The sonicated 
chromatin was used immediately for ChIP. 
 
2.4.2.1 Lysis Buffer-1 (LB1) 
Final concentration 
2.5ml  1M Hepes-KOH pH7.5  50mM Hepes 
1.4ml  5M NaCl    140mM NaCl 
100µl  0.5M EDTA    1mM EDTA 
10ml  50% glycerol    10% glycerol 
2.5ml  10% NP-40 (or substitute)  0.5% NP-40 
1.25ml  10% Triton X-100   0.25% Triton X-100 
32.25ml dH2O 
store at room temperature 
 
2.4.2.2 Lysis Buffer-2 (LB2) 
Final concentration 
0.5ml  1M Tris-HCl pH8.0   10mM Tris 
2.0ml  5M NaCl    200mM NaCl 
100µl  0.5M EDTA    1mM EDTA 
50µl  0.5M EGTA    0.5mM EGTA 
47.35ml dH2O 
store at room temperature 
 
2.4.2.3 Lysis Buffer-3 (LB3) 
Final concentration 
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0.5ml  1M Tris-HCl pH8.0   10mM Tris 
1.0ml  5M NaCl    100mM NaCl 
100µl  0.5M EDTA    1mM EDTA 
50µl  0.5M EGTA    0.5mM EGTA 
0.5ml  100% Na-Deoxycholate  0.1% Na-Deoxycholate 
1.25ml  20% N-lauroylsarcosine  0.5% N-lauroylsarcosine 
46.60ml dH2O 
store at RT 
 
2.4.3 Chromatin Immunoprecipitation (ChIP) 
Following sonication, samples were centrifuged at 16,000g for 25 minutes at 4°C to 
pellet any cellular debris. The supernatant (~100µl), containing sonicated chromatin, 
was then transferred in to a clean DNA-low Bind tube, followed by addition of 10µl 
of 10% Triton X-100 (1% final concentration) to facilitate antibody stability by 
sequestering anionic detergent. 2.5µg of appropriate ChIP-seq grade antibody was 
then added and the samples incubated at 4°C for 12-16 hours (overnight), on a 
vertical spinning wheel, to bind antibody to chromatin.  
 
Following overnight incubation, the antibody-bound chromatin was transferred to a 
clean DNA-low bind tube containing bovine serum albumin (BSA)-blocked 40µl 
Protein A Dynabeads (Invitrogen). This Dynabead-antibody-chromatin mixture was 
then incubated at 4°C for 3 hours on vertical spinning wheel to bind the Dynabeads 
to antibody. The Dyanbead-antibody-chromatin mixture was then washed 5 times 
with 1ml ice-cold RIPA wash buffer to remove any unbound antibody, chromatin, 
and other cellular debris and to reverse any non-specific binding between antibody 
and chromatin. Following the final wash, the beads are finally washed with 1ml ice-
cold TE buffer containing 50mM NaCl. The resulting cleaned Dynabead-antibody-
chromatin complex, containing antibody enriched chromatin, was re-suspended in 
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210µl of Elution Buffer and incubated at 65°C for 15 minutes, with continuous 
shaking at 850rpm, to release the antibody-chromatin complex from Dynabeads. The 
sample in Elution Buffer was then cleared off of Dynabeads and transferred to a 
clean DNA-low Bind tube and incubated at 65°C overnight to reverse formaldehyde 
mediated cross-linking of DNA with histone proteins.  
 
The de-crosslinked DNA-protein mixture was then treated with Proteinase K 
(Invitrogen) to a final concentration of 0.2mg/ml and incubated at 55°C for 2 hours 
to digest histone proteins. Enriched DNA was subsequently purified using Zymo 
Research’s ChIP DNA Clean and Concentrator kit as per the manufacturer’s 
instructions.  Samples were eluted in 6µl for use in qPCR or 10µl for sequencing 
library preparation.  
 
2.4.3.1 Block Solution 
0.5% BSA (w/v) in sterile PBS, stored at 4°C.  
 
2.4.3.2 RIPA Wash Buffer 
Final Concentration 
12.5ml  1M Hepes-KOH pH7.5  50mM Hepes 
25.0ml  5M LiCl    500mM LiCl 
0.5ml  0.5M EDTA    1mM EDTA 
25.0ml  10% NP-40 (or substitute)  1% NP-40 
17.5ml  10% Na-Deoxycholate  0.7% Na-Deoxycholate 
169.5ml dH2O 
store at room temperature 
 
 61	
2.4.3.3 Elution Buffer 
Final Concentration 
2.5ml  1M Tris-HCl pH8.0   50mM Tris 
1.0ml  0.5M EDTA    10mM EDTA 
5.0ml  10% SDS    1% SDS 
41.5ml  dH2O 
store at room temperature 
 
2.4.4 Real Time PCR using SYBR-Green dye 
Enrichment for positive and negative control loci in ChIP samples was tested by 
qPCR using SYBR Green chemistry (Roche). 7.5µl of SYBR Green reaction mix 
was mixed with 2.5µl of diluted DNA in a well of a multiwell qPCR plate and PCR 
carried out as per manufacturer’s instructions. 
 
Each SYBR Green reaction mix contained: 
5µl 2X SYBR Green Master Mix (Roche) 
0.5µl 10µM Forward primer 
0.5µl 10µM Reverse primer 
1.5µl water 
 
2.4.5 Sequencing Library Preparation 
Sequencing libraries were prepared from ChIP-ed DNA using Diagenode’s 
MicroPlex Library Preparation kit, as per the manufacturer’s instructions. Step C.5 in 
the library preparation protocol was performed using the LightCycler with 1µl of 
PicoGreen dye (Life Technologies) to visualize amplification curves. Sequencing 
libraries were store at -20°C.  
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2.4.6 Sequencing Library Quantification 
Sequencing libraries, before and after purification, were quantified using Quant-iT 
PicoGreen dsDNA Kit (Life Technologies) as per the manufacturer’s instructions. 
Briefly, 1µl of library was diluted to 100µl using sterile TE buffer (pH8.0 was used 
instead of pH7.5 as recommended by the manufacturer) and mixed with equal 
volume of 1:200 diluted PicoGreen dye in a well of 48-well flat-bottom Corning 
plate. The resulting 200µl mixture was incubated at room temperature for 5 minutes 
and subsequently quantified using FLUOstar Omega (BMG Labtech). DNA 
standards were prepared in similar way using the Lambda DNA provided in Quant-
iT PicoGreen dsDNA Kit. 
 
2.4.7 Sequencing ChIP libraries on HiSeq 2000 
The ChIP libraries were sent to Source Bioscience, a commercial next generation 
sequencing service, for sequencing on a HiSeq 2000. Libraries were multiplexed in 
one lane, generating a total of 120M 50-bp single end reads.  
 
2.4.8 ChIP-seq data analysis 
The sequencing data generated for ChIP libraries was analyzed using GeneProf 
(Halbritter et al. 2011), an analysis software produced by Tomlinson Lab, University 
of Edinburgh. The raw sequenced reads were aligned to NCBIM37/mm9 mouse 
reference genome using Bowtie algorithm (Langmead et al. 2009), using default 
GeneProf parameters: mean quality score ≥10, max mismatch = 2. Peaks were called 
from the aligned reads using MACS algorithm (Zhang et al. 2008; Feng et al. 2012), 
using default GeneProf parameters: bandwith = 100, PET inset size = 200, p-value ≤ 
10-5, fold enrichment over background (for model) = 10-30, local lamda = 1000-
10000, FDR < 0.1. Identified peaks were then used for downstream analysis. 
 
2.5 Tissue Culture 
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2.5.1 Thawing of Frozen Embryonic Stem (ES) Cells 
ES cells were routinely stored in liquid nitrogen for long-term storage. To thaw ES 
cells, a T25 tissue culture flask (Corning) was coated with pre-warmed 0.1% gelatin 
for 15 minutes. Cells were retrieved from liquid nitrogen and quickly thawed in a 
37°C water bath. Thawed cells were transferred to a universal tube containing 9.5ml 
of pre-warmed ES cells media, to dilute DMSO (see section 2.5.3), and centrifuged 
at 1000rpm for 5 minutes in a bench top centrifuge. The supernatant was carefully 
aspirated and the cell pellet gently re-suspended in 1ml of pre-warmed ES cell 
media. The excess gelatin in the T25 flask was removed and replaced with 6-7ml of 
pre-warmed ES cell media. Thawed ES cells were transferred to media-containing 
flask and placed in a 37°C incubator with 7.5% CO2. Media was change either at the 
end of the day, if cells were thawed first thing in the morning, or in the morning of 
the next day.  
 
2.5.2 Passaging Cells 
To passage the cultured cells, the media was aspirated and the cells washed twice 
with sterile pre-warmed PBS. Cells were then treated with appropriate volume of 
trypsin (0.025% trypsin in PBS) or trypsin-EDTA (1.3mM EDTA) and placed in 
37°C incubator for between 0.5-3 minutes (some primary cells require longer 
incubation) to detach cells. Pre-warmed media was then added, 4 times the volume 
of trypsin used, to neutralize trypsin and pipetted gently to dissociate colonies in to 
single cell suspension. The cell suspension was then transferred to a sterile universal 
tube and centrifuged at 1200rpm for 3 minutes in a bench top centrifuge. The 
supernatant was discarded and cell pellet re-suspended in 1ml of media. Cells were 
diluted as required and transferred to a fresh pre-coated flask or plate and returned to 
cell culture incubator.  
 
2.5.3 Freezing ES Cells 
To freeze ES cells, cells were harvested as for regular cell passaging. The cell pellet 
after dissociation was re-suspended in ES cell media containing 10% DMSO 
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(freezing solution) and then centrifuged at 1000rpm for 5 minutes. The supernatant 
was discarded and cell pellet re-suspended in appropriate volume of freezing 
solution. 0.5ml of this cell suspension was added to each 1ml cryotube vial. The 
number of cryotube vials produced depended on the size of the flask used for 
growing ES cells. Typically, 4-5 vials were produced from a near confluent T75 
flask and 2-3 vials produced from a T25. Cryotubes were stored in -80°C freezer 
overnight after which they were transferred to liquid nitrogen cell bank.  
 
2.5.4 Culturing Embryonic Thymic Tissue 
Thymic tissue was routinely cultured in 48-well tissue culture plates using N2B27 
media supplemented with 1:100 Pen/Strep antibiotics. Cytokines were added to 
media as required and media was changed everyday to prevent major changes in 
cytokine concentration throughout culture duration. Briefly, dissociated embryonic 
thymic tissue was obtained as described in previous sections. The tissue was washed 
twice with N2B27 containing antibiotics and transferred to tissue culture hood. The 
cell pellet was re-suspended in required volume of media and added to tissue culture 
plate pre-coated with Matrigel. Cells were transferred to 37°C incubator with 5% 
CO2.  
 
2.5.4.1 Coating Tissue Culture Plates with Matrigel 
The tissue culture plates used to culture embryonic thymic tissue were coated with 
Matrigel (Corning). Matrigel was thawed and kept on ice through the procedure. 
Tissue culture plates and pipette tips were cooled to 4°C before use. Adding matrigel 
to each well and placing the plate at room temperature for 15-20 seconds to allow 
polymerization of matrigel created a thin layer of matrigel. The remaining matrigel 
was aspirated and the cell suspension added to the well. 
 
2.5.5 ES cell media 
1X Glasgow Minimum Essential Medium (Invitrogen) 
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10% foetal calf serum 
1X non-essential amino acids 
4mM glutamine 
2mM sodium pyruvate 
0.1mM 2-mercaptoethanol 
1X leukaemia inhibitory factor (LIF) 
 
2.5.6 N2B27 media 
1X DMEM/F12-N2 with 1X Neurobasal/B27 medium in 1:1 ratio (SCS) 
0.1mM β-mercaptoethanol (Sigma) 
1µM PD (Stem Cell Sciences) 
10ng/ml LIF  
0.005µg/ml Recombinant Human BMP4 (R&D systems) 
 
2.6 Molecular Techniques: Cloning 
 
2.6.1 TOPO TA Cloning 
Full-length cDNA was amplified for desired gene using either Phusion High-Fidelity 
DNA Polymerase (Thermo Scientific) or PrimeSTAR HS DNA Polymerase 
(Clontech) as per the manufacturers’ instructions. The PCR product was checked by 
gel electrophoresis using 1.5% agarose gel. The band representing amplified PCR 
product was cut out of the gel and cleaned up using QIAquick Gel Extraction Kit 
(Qiagen). The purified full-length PCR product was then incubated at 72°C for 30 
minutes with 10X PCR buffer, dATPs, and Taq polymerase to add dATPs to the 3` 
of the product, which allows the product to be ligated to TOPO vectors. The resulting 
PCR product was purified using QIAquick PCR Purification kit (Qiagen) and 50ng 
of the purified product was then mixed with 10ng of pCR 2.1-TOPO vector (1µl), 
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1µl salt solution, and water to a total volume of 6µl. The cloning reaction was 
incubated at room temperature for 30 minutes. 2µl of the cloning reaction was 
subsequently used for transformation of either TOP10 competent cells (Invitrogen) 
or DH10B competent cells (NEB) according to manufacturers’ instructions for 
chemical transformation.  
 
2.6.2 Restriction Enzyme Digestion 
Restriction digests were carried out according to the manufacturer’s guidelines. 
Typically, digests were carried out in a 50µl total reaction volume with 1U of 
enzyme per 1µg of DNA in 1X NEB buffer. Reactions were supplemented with 
100µg/ml BSA if required. Reactions were typically incubated at 37°C for 2-3 hours, 
following which the enzyme was inactivated and the digestion products separated by 
gel electrophoresis. 
 
2.6.3 Agarose Gel Electrophoresis 
Gel electrophoresis was carried out as described above.  
 
2.6.4 Gel Extraction 
PCR products and restriction digests products were separated by agarose gel 
electrophorosis to allow isolation of single bands. The bands representing the desired 
products were excised using a sterile scalpel (Swann-Morton) under a UV 
transilluminator (Herolab, GmbH Laborgerate) that emits at a wavelength of 254nm. 
To reduce damage to DNA from excess UV exposure, a Perspex plate was placed 
between the transilluminator and the gel. Cut gel slices were transferred to a 1.5ml 
microcentrifuge tube. Extraction of DNA from gel slices was carried out using the 
QIAquick Gel Extraction Kit (Qiagen) according to the manufacturer’s guidelines. 
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2.6.5 Ligation reaction 
Isolated DNA fragments were ligated into vectors using T4 DNA Ligase enzyme 
(NEB) as per the manufacturer’s guidelines. Briefly, digested vector and insert 
(DNA fragment) were mixed in 1:5 molar ratio in presence of 1µl of T4 DNA Ligase 
Buffer, 1µl T4 DNA Ligase enzyme, and water to a final volume of 20µl. A vector 
only control was set up to determine vector background. The ligation reaction was 
incubated at room temperature for 12-16 hours, following which 2µl was used to 
transform competent bacteria. 
 
2.6.6 Plasmid DNA isolation 
Transformed bacteria were plated on agar plates containing suitable antibiotics for 
selection of bacterial clones containing plasmid. Typically, 100µg/ml ampicillin was 
used. A single bacterial colony containing transformed plasmid was used to set up 
each starter culture by transferring to a 15ml round bottom polystyrene tubes 
containing 5ml Luria-Bertani (LB) culture medium with antibiotics and followed by 
incubation at 37°C for 8 hours with vigorous shaking (~250rpm) to allow bacterial 
growth. The starter cultures were then diluted 1/500 into 100ml fresh selective LB 
medium and grown overnight. Plasmid purification was carried out from these 
cultures using the Plasmid Maxi Kit (Qiagen) according to the manufacturer’s 
protocol. Plasmid DNA was re-suspended in the Elution Buffer provided with the kit. 
DNA concentration and purity were measured using the NanoDrop ND-1000 
Spectormeter (Labtech) and samples stored at -20°C until required.  
 
2.6.7 Luria-Bertani (LB) Broth 
10g Bacto-tryptone (BD Biosciences) 
5g Bacto-yeast extract (BD Biosciences) 
10g Sodium Chloride (NaCl) 
Make up to 1L with deionized water and adjust pH to 7.5 with sodium hydroxide 
(NaOH) and autoclave. 
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2.6.8 Transfection of ES cells with Lipofectamin 
Lipofectamin 2000 (Invitrogen) was used to transfect ES cells with plasmids. All 
steps were carried out in a sterile environment inside a tissue culture hood. 
Transfection was typically carried out in 6-well plates. ES cells were harvested as 
described above and 106 cells were plated in one well of a pre-coated 6-well plate 
containing ES cells media. Transfection reagents were prepared according to the 
manufacturer’s instructions. 3µg of plasmid DNA was mixed with 250µl of ES cells 
media without FCS. Similarly, 3µl of Lipofectamine 2000 was mixed with 250µl of 
serum free ES cells media in a separate microcentrifuge tube. Both plasmid and 
lipofectamine were incubated at room temperature for 5 minutes, following which 
media containing plasmid was mixed with that containing lipofectamine, mixed by 
gentle pipetting, and incubated at room temperature for 20 minutes. This enables the 
plasmid DNA to be encapsulated by lipofectamine reagent. This lipofectamine-
plasmid mixture was then added to the well containing freshly plated ES cells. The 
transfected ES cells were cultured as described above. The media was replaced with 
fresh ES cells media on the morning after the transfection. ES cells were cultured for 
48 hours after transfection before use.  
 
2.7 Molecular Techniques: RNA-seq 
The protocol for RNA-seq was obtained from Prof. Sten-Erik Jacobsen’s lab at the 
University of Oxford. RNA-seq was performed using SMART-seq2 protocol (Picelli 
et al. 2014). Only sample collection was performed in our lab. The samples were 
then sent to Jacobsen lab for processing.  
 
2.7.1 RNA-seq sample collection 
Before sample collection for RNA-seq, all the equipments - pipettes, pipette tips, 
DNase and RNase-free 1.5ml microcentrifuge and 0.2ml PCR tubes, marker pens, 
and clean hood - were treated with disinfectant, DNA-OFF (Takara Bio), and 
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RNaseZap (Ambion) and treated with UV light for at least 30 minutes. Reagents 
were treated with disinfectant, DNA-OFF, and RNaseZap every time before placing 
in to the clean hood. Reagent preparation was carried out away from the regular lab 
space to avoid contamination. The personal protective equipment (PPE) used for 
RNA-seq reagent preparation and sample collection were kept separate from the PPE 
routinely used in the lab. PPEs included disposable lab coat, apron, sleeves, and 
gloves, which were discarded after every use.  
 
The flow cytometric cell sorter, Aria-II (BD Bioscience), was cleaned and sterilized 
before use. Cells were sorted as per the normal protocol. 100 cells were sorted into 
clean, sterile 0.2ml PCR tubes containing 5µl of reaction mix. Sample were 
centrifuged briefly and placed on dry ice immediately. Samples were then transferred 
to -80°C until required.  
 
2.7.1.1 Cell Lysis Buffer for RNA-seq 
19µl 0.2% Triton X-100 (Sigma) 
1µl Recombinant RNase inhibitor (Clontech) 
 
2.7.1.2 Reaction Mix for Sample Collection 
Each 0.2ml PCR tube contains: 
2µl Cell Lysis Buffer 
1µl 10µM oligo-dT primer (custom made, see (Picelli et al. 2014)) 
1µl dNTP mix (10mM each) 
 
2.8 CRISPR-Cas9 for genome editing 
The CRISPR-Cas9 system was used to delete genomic regions containing binding 
sites for transcription factor of interest.  
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2.8.1 guide-RNA (gRNA) Design 
gRNAs were designed using E-CRISP (http://www.e-crisp.org/E-CRISP/) online 
software (Heigwer et al. 2014). The sequence for genomic region containing the 
binding site(s) for transcription factor(s) was obtained from ENSEMBL and used for 
designing gRNAs. Default parameters were used to design gRNAs, except for 
parameters in “Off-Target analysis”.   
 
Additional base pairs were added to the 5` and 3` of gRNAs and their 
complementary sequences to allow for direct cloning in to BbsI digested plasmid. 
 
2.8.2 Annealing gRNA and its Complementary Sequence 
gRNAs and their complementary sequences were obtained from Sigma. The 
complementary sequences were annealed together to obtain double-stranded DNA, 
which could be directly ligated to BbsI digested expression vector. Annealing 
reaction mix was heated to 98°C to denature oligos and then gradually cooled to 
20°C over 2 hours and 39 minutes to allow for annealing of complementary oligos. 
Annealed oligos were diluted 1:500 (~100nM) using TE buffer and 4µl of diluted 
oligos was ligated to the expression vector.  
 
Annealing reaction mix: 
9µl 100µM sense oligo 
9µl 100µM antisense oligo 
2µl 10X T4 DNA ligase buffer 
 
2.8.3 Ligation of Annealed Oligos and Vector 
Annealed oligos were ligated to BbsI digested vector to obtain vector containing 
Cas9 and gRNA sequences. Ligation reaction mix was incubated at room 
 71	
temperature for 2 hours. Ligated vector was used for transforming DH10B competent 
cells as described above.  
 
Ligation reaction mix: 
4µl 100nM annealed oligos 
1µl BbsI cut vector 
1µl 10X T4 DNA ligase buffer 





2.9.1 Statistical test for qPCR data 
Statistical significance for qPCR data was calculated using Student’s T-test. First, the 
expression value of a gene in each sample was converted to logarithmic scale to 
enable statistical testing for genes with low expression levels. Biological replicates 
were treated as separate sample within a group. Student’s T-test was run using one-




2.10.1 Genotyping primers 
Primer Sequence 
β-gal F TAATGGGATAGGTTACGT 
β-gal R ACAACGTCGTGACTGGGAAAA 
Foxn1 exon-3 F CTCCAGAGAGGACACCCTCA 
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Foxn1 exon-3 R CTCTGCTGGGAAGCTAGGC 
 
2.10.2 Primary antibodies for FACS 
Antibody Clone Isotype Conjugate Company Concentration 
EpCAM G8.8 Rat 
IgG2a 
PE Biolegend 0.25µg/ml 




BD/eBioscience  1µg/ml 










Ly51 6C3 Rat 
IgG2a 





PE BD 1µg/ml 
CD11b M1/70 Rat 
IgG2b 
FITC BD 2.5µg/ml 





Plet1 MTS24 Rat 
IgG2a 




UEA1  Rat 
IgG2a 
-   
 
2.10.3 Secondary antibodies for FACS 
Flurochrome Isotype Company Concentration 
Alexa568 IgGa/b Invitrogen 4µg/ml 
Alexa647 IgGa/b Life Technologies 4µg/ml 
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Alexa488 IgG2a/b Molecular Probes 4µg/ml 
 
2.10.4 ChIP-seq antibodies 
Antibody Source-Isotype Company 
H3K4me3 Rabbit IgG Diagenode (pAb-003-050) 
H3K27ac Rabbit IgG Abcam (ab4729) 
H3K4me Rabbit IgG Abcam (ab8895) 
panH3 Rabbit IgG Abcam (ab1791) 
IgG Rabbit IgG Diagenode (kch-504-250) 
 
2.10.5 Cytokines for TEPC culture 
Mouse TGFβ1 Recombinant Protein (eBioscience; Catalogue number: 14-8342)	
 
2.10.6 ChIP-qPCR primers 
Primer Sequence 
Esrrb 3` F ACTCCTCCCCTTACCCCTGT 
Esrrb 3` R GGCTGTGGTCACTGCATCTA 
Esrrb E6 F CCCATTTTGTACCAGTCCTTGA 
Esrrb E6 R TAGCCAGGTAGCCATCCAAA 
Nanog enh-2 F GATCTTGTCTCCTGCGTGCT 
Nanog enh-2 R TTGGCACAGTACTCGCTTTG 
Gapdh pro F Diagenode (pp-1045-050) 
Gapdh pro R Diagenode (pp-1045-500) 
FN1.1 F ACCATGCTTCAGCCAGACTC 
FN1.1 R GGACAGGTGGGTTGTATGGG 
FN1.4 F AGTGTGGGATCTGTGTGTGG 
FN1.4 R CCAGTGAGTGAGCCATGGAA 
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FN1.7 F ATTGCCTCCCAACTCAAGGT 
FN1.7 R GCCCAGGCCTTCTGACTTT 
FN1.10 F CCTCGCAGGGATTTGTCTGT 
FN1.10 R AATGACACCGTAGCGTGGAG 
FN1.13 F ACATCCTATGGCGCTGAACC 
FN1.13 R GCCTGCAGACAGATGGAAGT 
 
2.10.7 Quantitative real-time PCR primers 
Name Sequence UPL Probe # 
Pax1 F CTCCGCACATTCAGTCAGC 105 
Pax1 R TCTTCCATCTTGGGGGAGTA 
Pax9 F AGCAGGAAGCCAAGTACGG 33 
Pax9 R TGGATGCTGAGACGAAACTG 
Foxn1 F TGACGGAGCACTTCCCTTAC 68 
Foxn1 R GACAGGTTATGGCGAACAGAA 
Hoxa3 F CAAGGCAGAACACTAAGCAGAA 78 
Hoxa3 R GTCACCAGCGCAGCTCTC 
Foxg1 F GAAGGCCTCCACAGAACG 26 
Foxg1 R CAAGGCATGTAGCAAAAGAGC 
p63 F TGGAAAACAATGCCCAGACT 45 
p63 R CTGCTGGTCCATGCTGTTC 
Dll4 F AGGTGCCACTTCGGTTACAC 106 
Dll4 R GGGAGAGCAAATGGCTGATA 
CCL25 F GAGTGCCACCCTAGGTCATC 9 
CCL25 R CCAGCTGGTGCTTACTCTGA 
Smad7 F ACCCCCATCACCTTAGTCG 63 
Smad7 R GAAAATCCATTGGGTATCTGGA 
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Pth F CAGTCCAGTTCATCAGCTGTC 78 
Pth R GTGTTTGCAGACATCATCTTTACAT 
Tgfb2 F TCTTCCGCTTGCAAAACC 106 
Tgfb2 R GTGGGAGATGTTAAGTCTTTGGA 
HMBS F TCCCTGAAGGATGTGCCTAC 79 
HMBS R AAGGGTTTTCCCGTTTGC 
b-actin F AAGGCCAACCGTGAAAAGAT 56 
b-actin R GTGGTACGACCAGAGGCATAC 
HPRT F TCCTCCTCAGACCGCTTTT 95 
HPRT R CCTGGTTCATCATCGCTAATC 
Hey1 F AAGAGAGCTCACCCAGACTAC 17 
Hey1 R GAACACAGCGCCGAACTC 
Thap11 F CTGGTGGTGGTAGGGGAAG 21 
Thap11 R CCCGAGGACAAGGAGTACG 
Eif3a F GTCCTTGGAGACCATTTGTCA 58 
Eif3a R GTGGACCCCAACTCTCTTCTC 
Bhlhe40 F GAAGGATCTCCTACCCGAACA 50 
Bhlhe40 R GCTTTCACGTGCTTCAACG 
Tax1bp3 F GAGGGAGGTCCTGCTGAAAT 26 
Tax1bp3 R GTCCCAGCCATTCACCTG 
Ing4 F ATTGCCTTTGTCACCAGGTC 76 
Ing4 R GGAACCACTCGATGGAACAA 
Six4 F CCAGTATGGCATTGTCCAGAT 50 
Six4 R CGAAGTGCTTGGGGTAACTG 
Zfp503 F GAAGCACCCAAAGGTAGAAGG 62 
Zfp503 R AACGCAGGCGGTAATGTG 
Yap1 F CAGGAATTATTTCGGCAGGA 71 
Yap1 R CATCCTGCTCCAGTGTAGGC 
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Irf6 F AAGAGTGGCCAGATGGAAAG 85 
Irf6 R ATCATGCGAGCCACCACT 
Creb3l2 F GCTGGAGGACACCAATAGGA 9 
Creb3l2 R AGCTAACTTGCAGGTTCGAGAG 
Foxc1 F ACCACGTAAGTTTCTTGCGTTC 15 
Foxc1 R GAGGCAGAGGGGCAAGAC 
Hes6 F GGATCAACGAGAGTCTTCAGGA 66 
Hes6 R TTCTCTAGCTTGGCCTGCAC 
Eid1 F TGATCGAGAGTAAATGCTGACG 101 
Eid1 R CCCAAAATAGCAGAATGTTGAA 
Zfp36l1 F CCATTTTTGACTTGAGCGAAG 27 
Zfp36l1 R GGCAGAGTGACCGAGTGC 
Foxo1 F TGGGTGTCAGGCTAAGAGTTAGTC 68 
Foxo1 R AGGGGTGAAGGGCATCTTT 
NfiB F CCCAAGATTGAGCACTTTCC 109 
NfiB R GGAGGTGGAGTTCGAGTTGA 
Six2 F CAAGTCAGCAACTGGTTCAAGA 5 
Six2 R ACTGCCATTGAGCGAGGA 
Foxa1 F GAACAGCTACTACGCGGACA 82 
Foxa1 R CGGAGTTCATGTTGCTGACA 
Foxa2 F AAGTAGCCACCACACTTCAGG 32 
Foxa2 R TGGCCCATCTATTTAGGGAC 
Tcf3 F CGTCATCCTCAGCCTGGA 52 
Tcf3 R ACCACGCCAGACACCTTC 
p53 F ATGCCCATGCTACAGAGGAG 78 
p53 R AGACTGGCCCTTCTTGGTCT 
Fbxw7 F CTCAGACTTGTCGATACTGGAGAA 73 
Fbxw7 R GATGTGCAACGGTTCATCAAT 
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Gata3 F TTATCAAGCCCAAGCGAAG 108 
Gata3 R GTGGTGGTCTGACAGTTCG 
Kitl F TCAACATTAGGTCCCGAGAAAG 71 
Kitl R ACTGCTACTGCTGTCATTCCTAAG 
SetDB1 F CCAAAGGCTCTTTTGTCTGC 80 
SetDB1 R CAGATTTGCAAAGTACTCATCACC 
E2F3 F CAAGGACCCTCCAGCAGAG 70 
E2F3 R AGTTCCAGCCTTCGCTTTG 
Fgfr2IIIb F CCCTGCGGAGACAGGTAAC 17 
Fgfr2IIIb R CGGGGTGTTGGAGTTCAT 
Sox9 F GTACCCGCATCTGCACAAC 66 
Sox9 R CTCCTCCACGAAGGGTCTCT 
Six1 F ACCGGAGGCAAAGAGACC 63 
Six1 R GGAGAGAGTTGATTCTGCTTGTT 
Eya2 F TTCAACCTTGCTGACACACAC 85 
Eya2 R CACGTGGATTTGGTCACAGT 
Tbx1 F GCTGTGGGACGAGTTCAATC 104 
Tbx1 R ACGTGGGGAACATTCGTCT 
Fgf8 F CAGTGTCCTGCCTAAAGTCACA 70 
Fgf8 R CGGCTGTAGAGCTGGTAGGT 
Gcm2 F ACTTGATGGCAATGCAATTTT 29 
Gcm2 R GAAGCCATCTGTCTCTTGAGG 
Notch1 F GGATGCTGACTGCATGGAT 93 
Notch1 R AATCATGAGGGGTGTGAAGC 
E2F1 F TGCCAAGAAGTCCAAGAATCA 5 
E2F1 R CTTCAAGCCGCTTACCAATC 
Hoxa3 F CAAGGCAGAACACTAAGCAGAA 78 
Hoxa3 R GTCACCAGCGCAGCTCTC 
 78	
Cxcl12 F GGTTCTTCGAGAGCCACATC 21 
Cxcl12 R TTCTTCAGCCGTGCAACA 
Eya1 F ACAAAAACAACGTGGGAGGT 78 
Eya1 R GCCAGGAGTCTGTGAGTGC 
Hey1 F ACCATCGAGGTGGAAAAGG 72 
Hey1 R CTTCTCGATGATGCCTCTCC 
Smad2 F AGGACGGTTAGATGAGCTTGAG 9 
Smad2 R GTCCCCAAATTTCAGAGCAA 
Tgfb3 F CCCTGGACACCAATTACTGC 25 
Tgfb3 R TCAATATAAAGGGGGCGTACA 
Smad4 F GCCCCGGCAGAGTCTAAC 60 
Smad4 R GAATACTGGCCGGCTGAC 
Tgfbr2 F AGAAGCCGCATGAAGTCTG 69 
Tgfbr2 R GGCAAACCGTCTCCAGAGTA 
Tgfbr1 F GCAGCTCCTCATCGTGTTG 70 
Tgfbr1 R AGAGGTGGCAGAAACACTGTAAT 
Tgfb1 F TGGAGCAACATGTGGAACTC 72 
Tgfb1 R GTCAGCAGCCGGTTACCA 
Smad3 F TCAAGAAGACGGGGCAGTT 78 






3. Investigating the expression of candidate transcriptional 
regulators of Foxn1 identified during thymus development 
3.1 Introduction 
Given the importance of Foxn1 in thymus development, homeostasis, and 
regeneration, it is crucial to understand the transcriptional regulation of this gene and 
functions of the encoded protein. Studies from our lab and others have suggested that 
FOXN1 is a direct transcriptional regulator of Dll4 and CCL25 (Bleul & Boehm 
2000; Tsukamoto et al. 2005; Nowell et al. 2011). A recent elegant study showed 
that the expression of Scf (Kitl) and Cxcl12 in Foxn1-/- thymus is absent during 
development, suggesting that these genes are also likely to be regulated by FOXN1 
(Calderón & Boehm 2012). This study further demonstrated that expressing these 
four genes together under the control of a Foxn1 promoter element confers some 
thymus functionality on Foxn1-/- mice, although full functionality was not achieved 
(Calderón & Boehm 2012). This suggests that these four genes together are capable 
of compensating, to an extent, for loss of Foxn1 by carrying out some of its 
downstream functions that are important for thymocyte differentiation. Thus, at least 
a subset of functions of FOXN1 is mediated by its direct or indirect regulation of 
these four genes in TECs. On the other hand, very little is known about the 
regulation of Foxn1 expression in the thymus. Previous studies have indicated that a 
Tbx1-Six1/Eya1-Fgf8 genetic pathway, similar to that found in Drosophila, is 
important for formation of 3PP (Guo et al. 2011). However, the genetic pathway 
including these genes in mice has been shown to operate differently than that in 
Drosophila (Zou et al. 2006). Similarly Hoxa3, Pax1, and Pax9 have also shown to 
be important for 3PP formation (Manley & Capecchi 1998; Su & Manley 2000; 
Hetzer-Egger et al. 2002; Chojnowski et al. 2014). To date, distinguishing the roles 
of these genes in 3PP formation and subsequently for thymus fate-commitment and 
TEC biology has proved to be difficult as defects in 3PP formation are invariably 
linked to defects in the organs derived from it, i.e. thymus and parathyroid 
(Balciunaite et al. 2002; Wei & Condie 2011; Chojnowski et al. 2014). This has 
made it difficult to determine whether any of these genes play a role in regulation of 
Foxn1 expression in thymus. It is now clear that Foxn1 expression is initiated in the 
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absence of HOXA3 (Chojnowski et al. 2014), while our unpublished data indicate 
that in the absence of both Pax1 and Pax9, Foxn1 expression is not initiated in the 
ectopic and very hypoplastic thymus primordium that forms in these mutants. Thus, 
while the above genes may play a role in the transcriptional regulation of Foxn1, 
with the exception of Pax1 and Pax9, no clear evidence yet links this network 
directly to Foxn1. Recently, it was shown that induced expression of Tbx1 in the 
developing thymic rudiment leads to downregulation of Foxn1 expression (Reeh et 
al. 2014). Furthermore, a study focusing on the role of E2Fs and Rb proteins in the 
thymus has showed that E2Fs can regulate the expression of Foxn1 in adult thymus, 
possibly through directly binding to its promoter (Garfin et al. 2013). However, it is 
not yet clear if E2Fs also regulate Foxn1 expression during thymus development. 
Finally, HOXC13 has been suggested to be involved in regulation of Foxn1 
expression in hair follicle, however I can not detect the expression of Hoxc13 in cells 
of 3PP or subsequent TEPCs in E12.5 thymi (unpublished), suggesting that Hoxc13 
is not required for initiation of Foxn1 expression in TEPCs. 
 
To take an unbiased, independent approach, we therefore decided to identify 
candidate transcriptional regulators of Foxn1 using a bioinformatics approach. To 
this end, in work performed prior to the start of my PhD, I generated a list of 
candidate transcriptional regulators by performing correlation coefficient analysis on 
a microarray based gene expression dataset generated in the Blackburn lab. In brief, 
genes with expression patterns showing significant correlation or anti-correlation 
with that of Foxn1 were identified using Pearson Correlation Coefficient and 
bootstrap techniques. The rationale was that the expression of Foxn1 should closely 
follow the expression of its positive transcriptional regulators; whereas expression of 
a negative transcriptional regulator should be inversely correlated with Foxn1. This 
approach identified a list of genes that were positively or negatively correlated with 
Foxn1 expression across a limited number of TEC datasets. Details of this approach 
and list of candidate transcriptional regulators can be found in my Master’s thesis. As 
a central aim of my thesis was to identify transcriptional regulators of Foxn1, as a 
starting point of my studies I therefore set out to seek evidence that one or more of 
 81	
these genes might be involved in regulating Foxn1 expression during thymus 
development. 
 
Thus, in this chapter I describe the changes in expression of these genes during early 
mouse thymus organogenesis in WT and Foxn1-/- mutants, in particular detailing 
their expression over the time-point at which Foxn1 expression in TEC is initiated. 
For completeness, genes known to be important for thymus biology and expected to 
be either upstream or downstream of Foxn1 regulatory network, regardless of them 
coding for transcription factors or not, were also included in this analysis, as their 
expression has so far not been studied extensively.  
 
3.2 Expression analysis of candidate Foxn1 regulatory genes 
 
3.2.1 Sorting Strategy for Collection of 3PP cells and TEPCs 
Since the microarray datasets used for identifying candidate transcriptional 
regulators of Foxn1 were generated from E12.5 and E15.5 thymi, we decided to 
study the expression of the candidate genes during earlier developmental time points, 
including time-points immediately before and immediately after initiation of Foxn1 
expression in the thymus. To do this, timed mating of mice was set-up as described 
in Materials and Methods, and embryos were collected every 12 hours starting at 
embryonic day 9.5 (E9.5, the time of formation of 3PP). The developmental stage of 
the embryos was determined by counting the number of somites, as described in 
Theiler’s Mouse Development Atlas (Theiler 1989). The, 3PP was then isolated from 
E9.5, E10.5, E11.0, and the thymic rudiment from E11.5, E12.0, and E12.5 embryos. 
Isolated tissue was dissociated and 200 EpCAM+PLET1+ cells from each sample 
were sorted directly into reaction mix (see section 2.3.3) as described in Figure 3.1. 
Briefly, the gating strategy first excluded out the dead cells using 4` 6-diamidino-2-
phenylindole (DAPI). Viable cells were then gated to exclude cells expressing 
lineage (lin) specific markers for T-cells (CD45), endothelial cells (CD31), and 
mesenchymal cells (Ter119). These Lin-DAPI- cells were then analysed for the  
A B
C
Figure 3.1: Sorting strategy for isolation of viable EpCAM+Plet1+ third pharyngeal pouch 
endoderm cells and thymic epithelial progenitor cells.
(A) Gate showing 3PP/TEP cells gated based on size and density as determined based on forward scatter 
(FSC-A) and side scatter (SSC-A) of events regarded as single cells. (B) Gating of cells negative for dead 
cell marker DAPI and Lin (CD45: hematopoetic cells, CD31: endothelial cells, Ter119: red blood cells). 
(C) Gate for the isolation of EpCAM+Plet1+ cells. Also shown is the FMO (full minus one - lacking 
primary antibody for Plet1) control for comparison.
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presence of EpCAM and the TEPC marker PLET1 and cells positive for both these 
marker were isolated by flow cytometry. The sorted samples were then used for 
qPCR based gene expression analysis using the Fluidigm platform. An important 
caveat to this strategy is the presence of Plet1 expressing parathyroid cells, as 
parathyroid and thymus are not separated during early developmental stages, in the 
sorted samples, which can influence the observed results. 
 
3.2.2 Gene Expression Changes in Developing 3PP and TEPCs. 
The gene expression profiles generated from E9.5, E10.5, E11.0, E11.5, E12.0, and 
E12.5 showed two major patterns: 1) an increase in expression during development 
and 2) a decrease in expression during development or at E12.5. Foxn1 expression 
was extremely low during the formation and early development of 3PP (expression 
relative to housekeeper: 0.017 (E9.5) and 0.077 (E10.5)), with higher level detected 
from E11.0 and then increased gradually till E12.5 (Figure 3.2A). The expression of 
most of the candidate transcriptional regulators of Foxn1 showed a gradual increase 
in their expression across the developmental stages analyzed. These included genes 
such as Pax1 (Figure 3.2B), Pax9 (Figure 3.2C), p63 (Figure 3.2D), Eya2 (Figure 
3.2E) Foxo1 (Figure 3.2F), Foxg1 (Figure 3.2G), Sox9 (Figure 3.2H), and Six1 
(Figure 3.2I). Note that the expression of these genes is detectable prior to E11.5, the 
developmental stage at which Foxn1 expression increases sharply throughout the 




Figure 3.2: Analysis of Foxn1, Pax1, Pax9, p63, Eya2, Foxo1, Foxg1, Sox9, Six1, 
and Fgfr2IIIb expression patterns during normal thymus organogenesis. 
 
See following page 
 
Relative expression levels in 3PP and TEP cells were determined by QRT-PCR. 
Graphs show the expression patterns in WT thymus for (A) Foxn1, (B) Pax1, (C) 
Pax9, (D) p63, (E) Eya2, (F) Foxo1, (G) Foxg1, (H) Sox9, (I) Six1, and (J) Fgfr2IIIb. 
Data are shown relative to the geometric mean Ct value for three housekeeping genes 
(HMBS, b-actin, TBP). Data shown are representative of two biological replicates 
and three technical replicates. Error bars show standard deviation (SD).  
Expression 








This is in accordance with the argument that a positive transcriptional regulator of 
Foxn1 would be expressed prior to detectable levels of Foxn1 expression. 
Furthermore, Pax1, p63, Foxo1, and Eya2 showed increasing expressing from E11.5 
to E12.5, similar to that observed for Foxn1, as would be expected of a positive 
transcriptional regulator of Foxn1. Thus, these genes represent strong candidates as 
transcriptional regulator of Foxn1. The expression of Pax9, Foxg1, Sox9, and Six1 
increased between E9.5 and E11.5, after which their expression remained relatively 
unchanged. A similar increase in expression was also observed for Fgfr2IIIb (Figure 
3.2J), which is required for thymus development (Revest et al. 2001). Fgfr2IIIb was 
included in this analysis, as it has been suggested to be a target of FOXN1 
(Bredenkamp, Nowell, et al. 2014), however its expression during development was 
unknown. The expression pattern of Fgfr2IIIb suggested that its expression is likely 
to be regulated by FOXN1 in the developing thymic rudiment. The expression of 
Pax9, Foxg1, Sox9, and Six1 showed increased between E9.5 and E11.5, however 
their expression remained relatively constant thereafter. Whether the increased 
expression levels of these genes are important for initiation of high level expression 
of Foxn1 can not be determined from the present data alone. 
 
3.2.2.1 Foxa1 and Foxa2: genes important for endoderm 
development 
The expression of Foxa1 increased gradually from E9.5 to E11.0 after which its 
expression decreased until E12.5 (Figure 3.3A). The increase in expression of Foxa1 
until E11.0 suggests that Foxa1 may play an important role in generation of 3PP 
endoderm and acquisition of competence to respond to subsequent commitment and 
differentiation signals, similar to its role in liver development (Lee et al. 2005). 
Beyond E11.0, Foxa1 may be less important, or indeed detrimental, for further 
development of 3PP into thymus, as suggested by its declining expression. 
Interestingly, this is also the developmental time point when the expression of 
several genes important for thymic epithelial differentiation and function, such as 
Foxn1 and its targets, is initiated. Thus, it is likely that the endodermal gene 
programme in 3PP endoderm is replaced by thymic epithelial cells specific gene 
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programme around E11.0. The expression level of Foxa2 in PLET1+ TEC (Figure 
3.3B) was much lower than that of Foxa1 at all the time points analysed, suggesting 
that Foxa1 is potentially more important in 3PP endoderm. While the expression 
level of Foxa2 varied at different time points, the presence of considerable biological 
variations (as represented by the error bars) made it difficult to interpret these results.  
 
3.2.2.2 Tbx1 and Fgf8: genes important for pharyngeal arch and 
pouch formation 
Tbx1 has been shown to be important for the formation of pharyngeal arches and 
pouches (Jerome & Papaioannou 2001; Xu et al. 2005; Reeh et al. 2014). Consistent 
with this, Tbx1 expression was substantially higher at E9.5 than at other stages of 
thymus development and showed a 16-fold reduction between E9.5 and E12.5 
(Figure 3.3C). The temporal regulation of Tbx1 expression has previously been 
shown to be important for normal pharyngeal development (Okubo et al. 2011). The 
decrease in Tbx1 expression after E9.5 is consistent with published data showing that 
induced expression of this gene after E11.5 is detrimental for thymus development 
(Reeh et al. 2014). Such induced expression of Tbx1 in thymic epithelial cells has 








Figure 3.3: Analysis of Foxa1, Foxa2, Tbx1, Fgf8, Pth, Gcm2, Gata3, Notch1, 
Hes1, and Hes6 expression patterns during normal thymus organogenesis. 
 
See following page 
 
Relative expression levels in 3PP and TEP cells were determined by QRT-PCR. 
Graphs show the expression patterns in WT thymus for (A) Foxa1, (B) Foxa2, (C) 
Tbx1, (D) Fgf8, (E) Pth, (F) Gcm2, (G) Gata3, (H) Notch1, (I) Hes1, and (J) Hes6. 
Data are shown relative to the geometric mean Ct value for three housekeeping genes 
(HMBS, b-actin, TBP). Data shown are representative of two biological replicates 
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Whether the low level Tbx1 expression observed till E11.0 is sufficient to inhibit 
initiation of Foxn1 expression remains to be determined. Studies on DiGeorge 
syndrome have previously shown the importance of Tbx1-Six1/Eya1-Fgf8 pathway 
in cardiovascular and craniofacial morphogenesis (Guo et al. 2011) and a possible 
Tbx1-Fgf8 pathway also exists in 3PP development as demonstrated by a defect in 
3PP development in Fgf8 hypomorphic mutants (Abu-Issa et al. 2002; Frank et al. 
2002). Therefore, I decided to also analyse the expression of Fgf8 during thymus 
development. Similar to Tbx1, the expression of Fgf8 is highest at E9.5 and 
decreases significantly (p-value = 0.016 (vs E11.5); p-value = 0.023(vs E12.0)) 
during development (Figure 3.3D), such that its expression was not detected at 
E12.5. Increased FGF signaling activation in TEPCs in Sprouty mutant mice has 
been shown to result in delayed initiation of Foxn1 expression in the developing 
thymic primordium (Gardiner et al. 2012), suggesting that the observed 
downregulation of Fgf8 expression is crucial for normal development.  
 
3.2.2.3 Pth and Gata3: genes important in parathyroid 
development and function 
Given that Plet1 expression during development is not restricted to 3PP and the 
parathyroid domain within the 3PP also expresses Plet1, I tested for expression of 
parathyroid hormone (Pth) gene to determine whether the sorted PLET1+ cells may 
also contain parathyroid cells. Pth expression was not detected at E9.5, E10.5, and 
E11.0, after which the expression increased sharply till E12.5 (Figure 3.3E). The 
observed Pth expression is indicative of presence of parathyroid cells in the sorted 
population. On the other hand, analysis of the expression of the parathyroid specific 
marker, Gcm2, showed an absence of Gcm2 expression in E12.5 samples (Figure 
3.3F). Gcm2 expression was detectable from E10.5 and increased by around 2-fold at 
E11.0 (p-value = 0.042), after which it remained constant till E12.0. The 
development of 3PP and subsequent expression of Gcm2 in the parathyroid domain 
requires expression of Gata3 within the cells of the common primordium (Grigorieva 
et al. 2010). Gata3 is also important for postnatal thymus homeostasis (Blackburn 
lab unpublished) and thymocyte maturation (Ting et al. 1996; Hendriks et al. 1999). 
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Gata3 expression was detectable from as early as E9.5 and continued until E12.5 
(Figure 3.3G). However, Gata3 expression decreased significantly from E12.0 to 
E12.5 (p-value = 0.0006) indicating dynamic regulation of this gene beyond E12.0. 
Since GATA3 is required for Gcm2 expression, one possibility is that its expression 
is down-regulated in TECs to prevent ectopic expression of parathyroid genes or to 
allow up-regulation of thymus genes. Together, these results suggest the presence of 
parathyroid cells within the analysed samples, however, the proportion of 
parathyroid cells within each sample cannot be determined based on the flow 
cytometry and gene expression data presented here. 
 
3.2.2.4 Notch1, Hes1, and Hes6: genes involved in Notch-signaling 
Notch signaling is critical for commitment of ETPs to the T-lymphocyte lineage, 
however its role in TEC biology remains less well characterized (Felli et al. 1999; 
Masuda et al. 2009; Lmmerts van Beuren et al. 2010; Shakib et al. 2009). 
Interestingly, the expression of Notch1 was significantly up-regulated from E12.0 to 
E12.5 (p-value = 0.029) (Figure 3.3H), suggesting that Notch signaling pathway may 
play an important role in thymus development beyond E12.0. The up-regulation of 
Notch1 at E12.5, a time point with highest expression of Foxn1, is consistent with 
the regulation of Notch1 expression in hair follicle by FOXN1 (Cai et al. 2009). 
Thus, these results suggest that the expression of Notch1 in TECs might also be 
regulated by FOXN1. The expression of Hes1, one of the key target genes of the 
Notch signaling pathway in neural cells, was detected from E9.5 and increased 
gradually till E12.5 (Figure 3.3I). HES6, a negative regulator of Notch signaling, has 
been shown to suppress the transcriptional activity of HES1 during neurogenesis, 
thus promoting neuronal differentiation (Bae et al. 2000; Koyano-Nakagawa et al. 
2000). Biological replicates showed considerable variation in Hes6 expression at 
E9.5 making it difficult to determine whether or not this gene was expressed at this 
developmental time point (Figure 3.3J). However, Hes6 expression was detected 
from E10.5 and showed generally increasing expression until E12.5, except at E11.5 
when its expression dropped transiently. Of note, the expression levels of Hes6 are 
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several order of magnitude lower that that of Hes1. Thus, it is likely that Notch 
signaling is important in thymus development.  
 
3.2.2.5 Other genes 
It has recently been shown that E2F3 and E2F4 can regulate Foxn1 expression in 
postnatal TECs (Garfin et al. 2013). The E2F transcription factors play an important 
role in the control of cell cycle progression, via binding to the Rb family of proteins. 
However, the phenotypic difference in the mutant mice used in this study is only 
evident postnatally, suggesting that E2F3 and E2F4 mediated regulation of Foxn1 
expression may not be important in TEPCs of the developing thymus. The 
expression of E2F3 was unchanged in TEPCs across the developmental time points 
analyzed (Figure 3.4A). Interestingly, the authors suggested a requirement of 
FOXN1 for up-regulation of E2F1 expression in mutant TECs (Garfin et al. 2013). 
Analyzing the expression of E2F1 in developing TEPCs revealed an interesting 
pattern with a modest decrease in expression after E11.0 (Figure 3.4B). 
Subsequently, the expression of E2F1 increased modestly from E11.5 to E12.5, 
concomitant with up-regulation of Foxn1 expression. While the expression patterns 
for E2F3 and E2F1 do not suggest involvement in regulating initiation of Foxn1 
expression, it is possible these transcription factors are still involved in regulating 
Foxn1 expression as their activities are regulated through post-translational by Rb 
proteins. 
 
Figure 3.4: Analysis of E2F3, E2F1, Hoxa3, Dll4, Kitl, Cxcl12, Bhlhe40, Irf6, 
Six2, and Six4 expression patterns during normal thymus organogenesis. 
 
See following page 
Relative expression levels in 3PP and TEP cells were determined by QRT-PCR. 
Graphs show the expression patterns in WT thymus for (A) E2F3, (B) E2F1, (C) 
Hoxa3, (D) Dll4, (E) Kitl, (F) Cxcl12, (G) Bhlhe40, (H) Irf6, (I) Six2, and (J) Six4. 
Data are shown relative to the geometric mean Ct value for three housekeeping genes 
(HMBS, b-actin, TBP). Data shown are representative of two biological replicates 
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Hoxa3, a gene important for 3PP and thymus development (Manley & Capecchi 
1995; Manley & Capecchi 1998; Su et al. 2001), was expressed at relatively constant 
but very low levels from E9.5 to E12.5 (Figure 3.4C). This is consistent with it not 
being required for initiation of Foxn1 expression (Chojnowski et al. 2014). As 
mentioned above, Dll4, Cxcl12, and Kitl are thought to be direct targets of FOXN1. 
Consistent with this, Dll4 and Kitl expression was not detected prior to E11.0 and 
their expression increased from E11.0 to E12.5 (Figure 3.4D & Figure3.4E). The 
expression of Cxcl12 was detectable from E9.5, before the initiation of Foxn1 
expression, and increased from E11.5 to E12.5 (p-value = 0.046 (E11.5 vs E12.5)) 
(Figure 3.4F). This suggests that its expression prior to E11.5 might be Foxn1 
independent. Bhlhe40 (Figure 3.4G) also showed expression pattern similar to 
FOXN1 target genes, suggesting it too might be regulated by FOXN1. The 
expression of Irf6 was similar to that expected of a positive transcriptional regulator 
of Foxn1 (Figure 3.4H).  
 
Six2 was expressed at low levels till E12.0, however its expression was sharply (but 
not significantly) up-regulated at E12.5 (Figure 3.4I), similar to the observation for 
Notch1. Another gene belonging to the sine oculis-related homeobox family, Six4 
was expressed at much higher levels than Six2. Six4 expression increased slightly 
from E9.5 to E10.5 and peaked at E12.0 (Figure 3.4J). Six4 has previously been 
suggested to be important for organ-specific gene regulation in 3PP (Xu et al. 2002; 
Zou et al. 2006), however its expression during thymus development beyond E10.5 
was previously not studied. The expression pattern observed here suggests that Six4 
is unlikely to be involved in regulation of Foxn1 expression. 
 
It has previously been shown that Eya1 is required for normal development of the 
thymus and parathyroid from 3PP (Xu et al. 2002; Zou et al. 2006). Eya1 expression 
increased significantly from E9.5 to E10.5 (p-value = 0.014) and then decreased after 
E12.0 to a level similar to that seen at E9.5 (Figure 3.5A). Thus, expression of Eya1 
seemed to be anti-correlated with that of Foxn1, suggesting a possible negative 
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Figure 3.5: Analysis of Eya1, Foxc1, Tax1bp3, Tcf3, Thap11, Yap1, and Ing4 expression profiles 
during normal thymus organogenesis.
Relative expression levels in 3PP and TEP cells were determined by QRT-PCR. Graphs show the 
expression profiles in WT thymus for (A) Eya1, (B) Foxc1, (C) Tax1bp3, (D) Tcf3, (E) Thap11, (F) Yap1, 
and (G) Ing4. Data are shown relative to the geometric mean Ct value for three housekeeping genes 
(HMBS, b-actin, TBP). Data shown are representative of two biological replicates and three technical 
replicates. Error bars show standard deviation (SD).
 94	
activities and prognosis of thymic epithelial tumor progression, was expressed from 
E9.5 and its expression was lower from E10.5 to E11.5 as compared to other time 
points analyzed (Figure 3.5B). Other genes, such as Tax1 (human T cell leukemia 
virus type I) binding protein 3 (Tax1bp3; Figure 3.5C), Transcription factor 3 (Tcf3; 
Figure 3.5D), THAP domain containing 11 (Thap11; Figure 3.5E), and Yes-
associated protein 1 (Yap1; Figure 3.5F) showed no or little change in expression 
between the time points analyzed, suggesting that these genes are unlikely to be 
involved in regulating Foxn1 expression. The expression of inhibitor of growth 
family, member-4 (Ing4) – a tumor suppressor gene important for prostate epithelial 
cell differentiation – remained constant from E9.5 to E11.5 after which it increased 
slightly at E12.0 (Figure 3.5G). Whether the observed upregulation is important for 
Foxn1 expression or is a result of increased FOXN1 levels remains to be determined. 
 
Together, the above gene expression analysis identified several genes whose 
expression is similar to an expected expression pattern for positive transcriptional 
regulator of Foxn1. On the other hand, it also identified genes whose expression 
pattern suggest that they are unlikely to be involved in this process.  
 
3.2.3 Comparison of gene expression between WT and Foxn1-/- 
TEPCs. 
The above analysis revealed several interesting patterns. Most of the genes analyzed 
showed at least some degree of expression before the onset of Foxn1 expression. 
While genes such as Hoxa3, Pax1, Pax9, Bmp4, Fgf8, Eya1, and Six1 have been 
shown to be important for 3PP formation, the detailed expression of these genes, 
except Hox3, Pax1, and Pax9, during thymus development was not previously 
studied. Thus, while identifying new genes and demonstrating their expression 
patterns during thymus development, the above data also provide novel insights into 
the expression of genes with known thymus phenotypes. However, the above 
approach fails to distinguish between transcriptional regulators of Foxn1 and 
transcriptional targets of FOXN1. For example, the increase in expression of genes 
from E11.0 to E12.5 could either result from an increase in the expression of Foxn1, 
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or vice versa. Also, transcriptional regulatory networks often contain feedback and 
feed-forward loops, which further complicates this issue. The presence of genes such 
as Dll4, Kitl, and Cxcl12, whose expressions is FOXN1 dependent, in the list of 
genes from my initial correlation analysis exemplifies this issue. Thus, it was 
important to determine whether the expression of any of the proposed transcriptional 
regulators of Foxn1 in TEPCs were FOXN1-dependent. To do this, I sorted 
EpCAM+PLET1+ TEPCs from WT and Foxn1-/- embryos at two developmental 
stages: E11.5, the time of initiation of Foxn1 expression, and E12.5, when most of 
the cells in thymic primordium express high levels of Foxn1. These time points also 
allow comparison between results from this analysis and those from the above time 
series analysis, thus improving the confidence in the observed results. 
 
The Foxn1 allele used for generating Foxn1-/- embryos was a knock-in, knock-out 
allele which disrupts exon3 of Foxn1 with an IRES-LacZ cassette (Nehls et al. 
1996). Thus, as would be expected since the probe was located in exon2, Foxn1 
expression was detectable in both WT and Foxn1-/- TEPCs (Figure 3.6A). The 
expression of Foxn1 was slightly lower in Foxn1-/- than WT TEPC, consistent with 
the proposed positive auto-regulation of Foxn1 by FOXN1 protein (Zook et al. 2011; 
Bredenkamp, Nowell, et al. 2014). Of note, a 10-fold decrease in the expression level 
was observed for all genes analysed here, compared to their expression in the 
previous analysis during thymus development, however the reason for this is unclear. 
One possibility is that the  
 
Figure 3.6: Analysis of Foxn1, Dll4, Ccl25, Kitl, Pax1, p63, Foxo1, Eya2, Hes6, 
and Gata3 expression patterns in E11.5 and E12.5 TEPCs isolated from wild 
type and Foxn1 null thymi. 
 
See following page 
Relative expression levels in wild type and Foxn1 null E11.5 and E12.5 TEPCs were 
determined by QRT-PCR. Graphs show the expression patterns for (A) Foxn1, (B) 
Dll4, (C) Ccl25, (D) Kitl, (E) Pax1, (F) p63, (G) Foxo1, (H) Eya2, (I) Hes6, and (J) 
Gata3. Data are shown relative to the geometric mean Ct value for three 
housekeeping genes (HMBS, b-actin, TBP). Data shown are representative of two 
biological replicates and three technical replicates. Error bars show standard 
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The expression of Dll4 (Figure 3.6B) and Ccl25 (Figure 3.6C) was significantly 
lower in Foxn1-/- TEPCs compared to WT (p-value < 0.05). This is in accordance 
with proposed transcriptional regulation of Dll4 and Ccl25 by FOXN1. A similar 
pattern was observed for Kitl expression (Figure 3.6D), however substantial variation 
between two biological replicates of E12.5 Foxn1-/- TEPCs was observed. 
Surprisingly, there was an 8-fold reduction in the expression of Pax1 in Foxn1-/- 
TEPCs at both E11.5 and E12.5, compared to age-matched WT TEPCs (p-value = 
0.06 (E11.5); p-value = 0.018 (E12.5)) (Figure 3.6E), suggesting that FOXN1 
reinforces the expression of Pax1 in TEPCs through feedback mechanism. 
 
As described above, the expression of p63 increased from E11.5 to E12.5. However, 
this increase in expression was not evident in Foxn1-/- TEPCs (Figure 3.6F). In fact, 
the expression of p63 at both E11.5 and E12.5 was significantly lower in Foxn1-/- 
compared to WT TEPCs (p-value = 0.04 (E11.5); p-value = 0.015 (E12.5)). This 
suggest that p63 is downstream of Foxn1 in the transcriptional network prevalent in 
TEPCs. Other genes that showed a similar pattern of reduced expression in Foxn1-/- 
vs WT TEPCs include Foxo1 (p-value = 0.004) (Figure 3.6G), Eya2 (p-value = 
0.003) (Figure 3.6H), and Hes6 (p-value = 0.0004) (Figure 3.6I). Of interest is that 
the expression of Hes6, a negative regulator of Hes1, appears to be FOXN1-
dependant, suggesting a role of Foxn1 in regulating the downstream Notch pathway. 
On the other hand, the expression of Gata3 decreased from E11.5 to E12.5 in WT 
TEPCs, with no detectable expression at the later time point, but its expression 
remained unchanged in Foxn1-/- TEPCs (Figure 3.6J) suggesting that FOXN1 
represses Gata3 expression in these cells. The expression profiles of the above-
mentioned genes were significantly correlated with each other (or anti-correlated in 
the case of Gata3) as evident from gene-wise correlation coefficient analysis carried 
out using the R package, Hmisc (details below). 
 
Other genes that showed a decrease in expression from E11.5 to E12.5 in WT but not 
Foxn1-/- TEPCs include Eya1 (Figure 3.7A), Eid1 (Figure 3.7B), p53 (Figure 3.7C), 
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Tax1bp3 (Figure 3.7D), and Thap11 (Figure 3.7E). The decrease in expression of 
Eya1 and Thap11 from E11.5 to E12.5 WT TEPCs is consistent with the previously 
described expression profile during thymus development and appears to be 
dependent on the presence of a functional FOXN1 protein. Thus, these genes are 
likely to be regulated by FOXN1 in TEPCs. 
 
Interestingly, Foxc1 (Figure 3.8A) was expressed more highly in WT than Foxn1-/- 
TEPCs. The role of these Forkhead genes in thymus development is not yet known, 
however these results suggest that FOXN1 could play a role in regulating the 
expression of Foxc1 in TEPCs. Another member of the Forkhead gene family, 
Foxg1, showed an increase in expression from E11.5 to E12.5 in Foxn1-/- TEPCs 
while its expression remained unchanged in WT TEPCs, suggesting possible 
compensation mechanism between the two genes (Figure 3.8B). Thus, these results 
indicate a complex regulatory network involving the various Fox genes. Further 
experiments involving knock-out/knock-down of each of these genes are required to 
better understand these relationships. Similar to the developmental time point 
analysis, considerable variation was observed in the expression of Foxa2 (Figure 
3.8C). However, its expression decreased from E11.5 to E12.5 in both WT and 
Fxon1-/- cells, suggesting that the down-regulation of its expression during 
development is Foxn1 independent. As mentioned previously, Six1 and Six4 play an 
important role in 3PP development and thymus organogenesis. The expression of 
both these genes was higher at E11.5 in WT TEPCs as compared to Foxn1-/- TEPCs 
(p-value = 0.036 (Six1); p-value = 0.047 (Six4)) (Figure 3.8D and Figure 3.8E), 
however no difference in expression was observed at E12.5. The expression of Fgf8 
was detectable at E11.5 but not at E12.5 in both WT and Foxn1-/- TEPCs (Figure 
3.8F), consistent with its regulation by TBX1 (Vitelli et al. 2002; Huh & Ornitz 
2010; Guo et al. 2011).  
 
Bhlhe40, a member of basic helix-loop-helix transcriptional regulators, which are 
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Figure 3.7: Analysis of Eya1, Eid1, p53, Tax1bp3, and Thap11 expression profiles in E11.5 and E12.5 
TEPCs isolated from wild type and Foxn1 null thymi.
Relative expression levels in wild type and Foxn1 null E11.5 and E12.5 TEPCs were determined by QRT-
PCR. Graphs show the expression profiles in WT thymus for (A) Eya1, (B) Eid1, (C) p53, (D) Tax1bp3, 
and (E) Thap11. Data are shown relative to the geometric mean Ct value for three housekeeping genes 
(HMBS, b-actin, TBP). Data shown are representative of two biological replicates and three technical 
replicates. Error bars show standard deviation (SD).
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by acting as both transcriptional activators and repressors, has been shown to be 
important for normal T cell function (Lin et al. 2014). However, its role in TECs is 
not yet known. Interestingly, the expression of Bhlhe40 increased from E11.5 to 
E12.5 independently of Foxn1 (Figure 3.8G). Such an expression pattern would be 
expected for a transcriptional regulator of Foxn1, in the absence of any immediate 
feedback mechanism, suggesting Bhlhe40 could be involved in regulating Foxn1 
expression. The expression of SetDB1, a gene encoding a H3K9 methyltransferase 
was detectable in Foxn1-/- TEPCs but not in WT TEPCs (Figure 3.8H), suggesting a 
potential role of Foxn1 in regulating epigenetic modification in developing TECs. 
Contrary to the previous observation, the expression of Irf6 did not change between 
E11.5 and E12.5 WT TEPCs (Figure 3.8I), suggesting variability in analyzing its 
expression. On the other hand, the increase in Irf6 expression at E12.5 compared to 
E11.5 in Foxn1-/- TEPCs is consistent with the previous observation (Figure 3.4H). 
Thus, its expression in TEPCs appears to be independent of Foxn1.  
 
The final class of genes in this analysis was the genes whose expression did not 
change substantially between the analyzed samples. Thus, these genes appear to be 
insensitive (or less sensitive) to loss of functional FOXN1 protein, however their role 
in regulating Foxn1 expression cannot be excluded based on current analysis alone. 
These genes include Zfp36l1 (Figure 3.9A), Hey1 (Figure 3.9B), Eif3a (Figure 3.9C), 
Fbxw7 (Figure 3.9D), Creb3l2 (Figure 3.9E), Zfp503 (Figure 3.9F), Hoxa3 (Figure 
3.9G), Ing4 (Figure 3.9H), and NfiB (Figure 3.9I). 
 
Figure 3.8: Analysis of Foxc1, Foxg1, Foxa2, Six1, Six4, Fgf8, Bhlhe40, SetDB1, 
and Irf6 expression patterns in E11.5 and E12.5 TEPCs isolated from wild type 
and Foxn1 null thymi. 
 
See following page 
Relative expression levels in wild type and Foxn1 null E11.5 and E12.5 TEPCs were 
determined by QRT-PCR. Graphs show the expression patterns for (A) Foxc1, (B) 
Foxg1, (C) Foxa2, (D) Six1, (E) Six4, (F) Fgf8, (G) Bhlhe40, (H) SetDB1, and (J) 
Irf6. Data are shown relative to the geometric mean Ct value for three housekeeping 
genes (HMBS, b-actin, TBP). Data shown are representative of two biological 
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3.2.3.1 Gene-wise correlation analysis to clusters of genes with 
significantly correlated expression. 
The above analysis of WT and Foxn1-/- TEPCs generated expression profiles for 
more than 40 genes at two developmental time points in both WT and Foxn1-/- 
TEPCs. These profiles can be used to infer complex patterns of gene regulatory 
network prevalent in the cells. To do this, I used Hmisc, a R-package for data 
analysis, to generate gene-wise correlation coefficient values and corresponding p-
values to determine the statistical significance of each correlation coefficient. Figure 
3.10 shows the correlation coefficient for all gene pairs, with statistically significant 
coefficients being highlighted in green. As noted above, the Foxn1- allele is 
transcribed and the transcript detected by the primer pairs used in this analysis. Thus, 
the correlation coefficients generated using Foxn1 do not truly represent the 
conditions in-vivo, which hinders identification of genes within in the same 
transcriptional network as Foxn1. To partly overcome this issue, I decided to use the 
expression of two Foxn1-dependant genes, Ccl25 and Dll4 as they resemble the 
expected expression pattern for Foxn1 as shown above. This approach could help 
identify other genes whose expression is also dependent on FOXN1. Figure 3.11 




Figure 3.9: Analysis of Zfp36l1, Hey1, Eif3a, Fbxw7, Creb3l2, Zfp503, Hoxa3, 
Ing4, and NfiB expression patterns in E11.5 and E12.5 TEPCs isolated from 
wild type and Foxn1 null thymi. 
 
See following page 
 
Relative expression levels in wild type and Foxn1 null E11.5 and E12.5 TEPCs were 
determined by QRT-PCR. Graphs show the expression patterns for (A) Zfp36l1, (B) 
Hey1, (C) Eif3a, (D) Fbxw7, (E) Creb3l2, (F) Zfp503, (G) Hoxa3, (H) Ing4, and (J) 
NfiB. Data are shown relative to the geometric mean Ct value for three housekeeping 
genes (HMBS, b-actin, TBP). Data shown are representative of two biological 
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of Ccl25 or Dll4. Genes whose expression was significantly correlated to that of 
either Ccl25 or Dll4 include Eya2, Foxo1, Hes6, Kitl, p63, Pax1, and Foxc1. 
Interestingly, Gata3 was the only gene whose expression is significantly negatively 
correlated with that of both Ccl25 and Dll4. This suggests that these genes are targets 
of FOXN1 in TEPCs. Of note, the expression of genes, which are either significantly 
correlated (or anti-correlated) with Ccl25 or Dll4, was also significantly correlated 
(or anti-correlated in the case of Gata3) with each other. This further supports the 
argument that these genes are a part of the same genetic network and their expression 
being regulated by a common transcriptional regulator (possibly Foxn1) in TEPCs. 
 
3.3 Discussion 
The data shown here constitute the first high-throughput gene expression analysis 
carried out in TEPCs. This approach has allowed identification of the dynamic 
changes in expression of a large number of genes during thymus development and is 
a significant advance from the previously published results, which include detection 
of presence of absence of transcripts using in-situ hybridization for a very small 
number of genes. Furthermore, the data from time-series analysis combined with that 
from comparing WT and Foxn1-/- TEPCs has allowed for identification of a potential 
genetic network in this cell type (Figure 3.12). 
 
Several papers published since 2013 have identified candidate regulators of Foxn1 
expression using a combination of in-vitro and in-vivo approaches. Tbx1, a gene 
important for the formation of third pharyngeal pouch (Jerome & Papaioannou 
2001), has recently been shown to be involved in regulating Foxn1 expression in 
thymus (Reeh et al. 2014). Forced expression of Tbx1 in thymus-fated domain of 
3PP severely down-regulated the expression of Foxn1, indicating a role of Tbx1 in 
antagonising thymus fate (Reeh et al. 2014). This is consistent with the observed 
expression profile for Tbx1 described here, suggesting a strong down-regulation of 
this gene at the onset of Foxn1 expression. Another interesting study showed that 
deletion of RB family of proteins results in increased E2F transcription factors  
Figure 3.12: Predicted genetic network in TEPCs.
Genetic network predicted based on gene expression analysis of 3PP and TEPCs in WT and nude mice. 
Genes predicted to be transcriptional regulators of Foxn1 or targets of FOXN1 protein are shown here. 
Also shown is regulation of Pax1 by Hoxa3 and that of Foxn1 by Pax1 known from previous studies. 
Interactions predicted from in this thesis are shown by solid lines whereas those known from literature are 
shown as dashed lines.
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activity, leading to an enlarged thymus possibly resulting from increased expression 
of Foxn1 in TECs (Garfin et al. 2013). This study further showed, using in-vitro 
approaches, that E2F3 and E2F4 could bind to conserved E2F binding sites near the 
transcriptional start site of Foxn1 and thus regulate its expression. The expression of 
E2F3 did not change substantially across the developmental time points analysed 
herein. This could be because the activity of E2F proteins is regulated through post-
translational regulation or it could indicate different regulatory mechanisms 
governing Foxn1 during development and homeostasis, as the enlarged thymus 
phenotype in Rb mutant mice is not evident at 3 weeks of age. Of note is that the 
above mentioned studies lacked evidence of direct in-vivo regulation of Foxn1 
expression by any of these genes due to difficulties in performing a transcription 
factor ChIP using isolated TEPCs or TECs. 
 
Pax1 and Pax9, genes shown to be important for normal thymus development, were 
recently identified as being important for maintenance (and possibly initiation) of 
Foxn1 expression in the developing thymic primordium (Michelle Kelly, PhD thesis; 
Blackburn and Vaidya unpublished). The data shown here suggests that Pax1 and 
Foxn1 are members of a complex transcription factor network and that Foxn1 may 
positively regulate Pax1, forming a feedback loop to increase the expression of Pax1. 
Pax9 expression, on the other hand, does not appear to be dependent on FOXN1, 
suggesting that these two Pax genes are regulated differently. Furthermore, the data 
shown here are the first to suggest that FOXN1 may regulate Gata3 expression. This 
is consistent with unpublished data in the lab showing that in adult thymus, the cells 
expression the highest levels of Foxn1 have the lowest levels of Gata3 expression 
and vice versa. Whether Gata3 also plays a role in regulating Foxn1 expression 
remains to be determined and would require analysing Gata3 mutant thymi.  
 
The presence of Pth expression in the analysed samples up to E12.0 indicates 
presence of parathyroid cells, which also express PLET1. However, it is not possible 
to determine the extent of contribution of parathyroid cells to the observed gene 
expression patterns in the above analyses. Identification of thymus specific cell-
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surface marker or use of Gcm2-GFP alleles would be required to obtain samples free 
from parathyroid cells.  
 
While a detailed analysis of the functions of FOXN1 in thymic epithelial cells has 
been hindered by lack of appropriate tools and reagents, its importance in regulating 
Dll4 expression has been unequivocally demonstrated. The Dll4 and other Notch 
ligands secreted by TEPCs and TECs have been studied in the context of importance 
for T-cell development, but the importance of Notch signalling pathway in TEPCs 
and TECs has not been extensively studied. Mice mutant for Notch receptors exhibit 
medullary defects postnatally (Liu, O`Neill and Blackburn, unpublished). 
Interestingly, Foxn1 is required to maintain Notch1 expression in the hair follicle 
matrix (Cai et al. 2009). This study suggested that FOXN1 could bind to one or more 
of its consensus binding sites in vitro within the mouse Notch1 promoter to regulate 
its activity. The up-regulation of Notch1 expression at E12.5 suggests that similar to 
hair follicle matrix, the expression of Notch1 in TEPCs could also be regulated by 
Foxn1. It would also be interesting to determine if Notch1 is expressed 
homogeneously in all TEPCs or weather TEPCs represent a heterogeneous 
population with varied levels of Notch-signalling activities.  Flow cytometry analysis 
using fluorescently labelled antibody against NOTCH1 or a fluorescent Notch1 
reporter allele could be used to answer this question.  
 
One of the key limitations of this chapter is that only a small number of genes were 
analysed based on the list of candidate transcriptional regulators generated 
previously using bioinformatics approach. Thus, there is a possibility that the 
transcriptional regulator of Foxn1 might be absent from this analysis if its expression 
does not correlate with that of Foxn1 in the samples (E12.5 MTS20+ and E15.5 
MTS20+ and MTS20- TECs) used for microarray based gene expression analysis. 
One way to overcome this would be to perform whole transcriptome analysis using 
microarray or RNA-seq during thymus development in WT mice, which can help 




The focus of this chapter was to generate expression profiles, during development of 
both WT and Foxn1-/- thymus, of genes present in the list of candidate transcriptional 
regulators of Foxn1. The rationale for this work was that the expression of these 
genes has not previously been studied using quantitative gene expression approaches 
and a better understanding of this was required to identify whether these genes play a 
role in regulating Foxn1 expression and to distinguish between transcriptional 
activators and targets of Foxn1. The results generated from these experiments have 
shed light on the dynamic nature of transcriptional regulation in developing thymus 
and have allowed identification of potential transcriptional interactions between key 
genes. The proposed transcriptional network diagram, shown in Figure 3.12, is the 
first to connect the genes known to be important for TEPC and TEC formation or 
function with those involved in the upstream network required for thymus 
primordium formation. The network diagram shows presence of feed-forward and 
feed-back mechanisms in the predicted genetic network. Of note is that the proposed 
transcriptional network is based only on gene expression analysis and further work is 




4. Identification of genome-wide transcriptional regulatory 
regions active in TEPCs by mapping histone modifications 
using ChIP-seq 
4.1 Introduction 
The gene expression analysis shown in Chapter-3 led to identification of potential 
genetic interactions in TEPCs. However, it did not allow for identification of 
transcriptional regulatory regions, which could in turn be used to test these 
interactions in-vivo. Genetic interactions have traditionally been characterised 
through generation of mutant mice either lacking or over-expressing a gene of 
interest. However, this does not allow differentiating between direct and indirect 
interactions between transcription factors and their potential target genes. Binding of 
transcription factors to DNA can be identified using Chromatin ImmunoPrecipitation 
(ChIP). This approach, which has been widely used in a number of cell types and 
model organisms, is limited by availability of ChIP-grade antibodies for the 
transcription factor under study and thus cannot yet be applied to all transcription 
factors without further genetic modification. As ChIP-grade antibodies for the 
transcription factors I wished to study further were not available, I chose as an 
alternative approach to identify active transcriptional regulatory regions on a 
genome-wide basis. This would allow subsequent testing of whether a particular 
transcription factor could bind to and regulate the function of a given gene or set of 
genes.  
 
The temporally and spatially restricted transcription of genes is governed by binding 
of transcription factors to enhancers and promoters of the gene. The core promoter is 
defined as the minimal DNA sequence around the transcriptional start site (TSS) that 
accurately directs initiation of transcription by binding of core transcriptional 
machinery. On the other hand, enhancers can be located much further away, ranging 
from tens to hundreds or thousands of kilobases, from the gene and are thus more 
difficult to identify. Traditional approaches have focused on identification of 
enhancers for one gene at a time, however, the latest advancements in epigenetics 
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and next generation sequencing now allows for genome wide identification of a 
subset of putative enhancer regions. This combined with the ease of genome 
manipulations provided by the CRISPR-Cas9 system can be used to test a large 
number of identified regions for their function in-vivo. This approach has so far not 
been applied to TECs. Thus, it provided a unique opportunity for identification of 
molecular mechanisms governing thymus development. I therefore decided to apply 
this approach to identify genome wide promoters and enhancers for TEPCs.  
 
To this end I used specific histone modifications to identify active promoters and 
enhancers in TEPCs, an approach that has been widely employed for this purpose in 
various cell types and model systems. It has been well established that active 
promoters and enhancers are flanked by histones containing H3K4me3-H3K27ac 
and H3K4me1-H3K27ac modifications respectively (Heintzman et al. 2007; Rada-
Iglesias et al. 2011). Thus, mapping these modifications, most commonly achieved 
using ChIP-seq, on the genome of a particular cell type can be used to identify the set 
of candidate promoters and enhancers that are active in that cell-type. I, therefore, 
decided to perform ChIP-seq for these histone modifications on TEPCs isolated from 
the E12.5 thymus, since this population is the most homogenous population of fetal 
TEPCs currently identified, and is known to express high levels of Foxn1. The 
rationale behind this approach was that identification of these regulatory regions and 
the transcription factors that can bind to these (through bioinformatics approaches) 
could help filter the list of candidate transcriptional regulators of Foxn1 for genes 
with highest probabilities of this function in TEPCs and also identify genes that 
could have been missed by the previous approach. 
 
4.2 Optimisation of ChIP protocol for use with TEPCs isolated 
from E12.5 thymi 
Shen and colleagues have previously generated histone modification profiles using 8-
weeks old whole thymus (Shen et al. 2012). Given that the developing T-
lymphocytes constitute the majority of cells (>95%) in an 8-weeks old thymus, this 
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data set is not of use for identification of TEC-specific histone modifications. 
Furthermore, histone modifications observed at TEC-specific genes in those data 
represent an average of modifications presents in various TEC sub-populations. A 
more recent study performed ChIP-seq for H3K4me3 and H3K27me3 on mature and 
immature mTEC subpopulations from 4-weeks old mice (Sansom et al. 2014). This 
study, however, did not analyse histone modifications in TEPCs and did not perform 
ChIP for histone modifications that can identify enhancers. To overcome these 
limitations, I decided to generate TEPC-specific histone modification profiles.  
 
An important technical limitation to this approach was that, of necessity, it required 
working with samples obtained from a very low number of cells. We therefore 
obtained a ChIP protocoal optimised for low-cell (~100,000 cells) number ChIP-seq 
from the Wysocka lab (Stanford University). This number of TEPCs cells can be 
obtained from around 4 mice litters at E12.5. While enough TEPCs could be 
obtained for the actual ChIP-seq experiment, the availability of additional sample for 
protocol testing and optimisation was limited. Thus, the ChIP protocol was tested 
and optimised using ~100,000 E14/T embryonic stem cells (ES) cells. To ensure 
minimal difference in sample processing between TEPCs and the ES cells, I sorted 
and stored ~100,000 ES cells for subsequent ChIP, using equivalent protocols to 
those used for TEPCs. Figure 4.1 shows a flowchart representation of the optimised 
ChIP protocol. The first key step in ChIP, after fixation, is sonication of the fixed 
chromatin. The efficiency of downstream protocol is influenced by the size 
distribution of DNA fragments and the classic ChIP protocol includes a gel-based 
size selection prior to IP. Effective sonication was even more important when 
starting with ~100,000 cells as it was advisable to avoid sample loss resulting from 
gel purification of the sonicated chromatin. In these experiments, the sonication 
conditions resulted in DNA fragments between 100bp and 300bp for both E14/T and 
TEPCs (Figure 4.2), which is optimal for subsequent IP and sequencing library 
generation.  
  
Figure 4.1: Schematic of ChIP-seq protocol
A schematic of the protocol used for chromatin immunoprecipitation of thymic epithelial progenitor cells. 
~100,000 epithelial cells were used per sample. The entire protocol takes four days from sample 
collection to sequencing library generation.
1KB+ marker 500bp markerE14/T E14/T
A
1KB+ marker 500bp markerTEPC
B
Figure 4.2: Sonication efficiency for ChIP samples.
~100,000 cells were sorted for ChIP. Four rounds of 10 sonication cycles (30sec "on", 30sec "off") were 
performed on formaldehyde crosslinked samples. Sonicated chromatin was purified from decrosslinked 
samples and analysed using agarose gel elcetrophoresis. Data shown are agarose gel images 
demonstrating the size of frgamented chromatin from (A) mouse ES cells: seven ES cells samples 
containing 100,000 cells each were pooled together after DNA purificaiton and (B) TEPCs: single sample 









The immunoprecipitation (IP) was also optimised using E14/T ES cells. A detailed 
protocol for ChIP is described in Chapter 2. The success of IP for histone 
modifications was determined by real time-PCR of purified, de-crosslinked genomic 
DNA fragments, using primers against Glyceraldehyde-3-phosphate dehydrogenase 
(Gapdh) and Actin, beta (b-actin) promoters and Nanog homeobox (Nanog) and 
Estrogen related receptor, beta (Esrrb) enhancer regions known to contain the 
appropriate histone modifications (personal correspondence, Chambers group). 
Intergenic regions devoid of promoter or enhancer related histone modifications were 
chosen as negative controls (personal correspondence, Chambers group). As shown 
in Figure 4.3A and Figure 4.3B, a significantly higher enrichment was observed for 
positive control loci versus negative controls for both H3K4me3 and H3K27ac. 
Furthermore, the fold enrichment observed for positive control loci relative to IgG 
indicated that the efficiency of IP was suitable for generating samples for preparation 
of sequencing libraries.  
 
Following establishment of the optimal IP conditions, I tested these conditions for 
TEPCs by performing ChIP-qPCR. The data shown in Figure 4.3C show that 
efficient IP was achieved for H3K4me3 in the TEPC samples. On the other hand, the 
fold enrichment observed for H3K27ac in TEPC samples was substantially lower 
than that observed in ES cells. Similar results were obtained for the first batch of 
ChIP-seq data (rep-1) generated from TEPCs (details below). This ChIP-seq rep-1 
data showed excellent enrichment for H3K4me3 and H3K4me1 but suffered from 
low signal (enrichment) for H3K27ac. It has been suggested that acetylation of 
histone residues is more dynamic than methylation, and that endogenous deacetylase 
enzymes could affect the efficiency of H3K27ac IP. Thus, to determine whether the 
enrichment for H3K27ac in TEPC samples could to be improved through the use of 
histone deacetylase inhibitor, I decided to perform ChIP in the presence sodium 
butyrate (NaBu), a commonly used histone deacetylase inhibitor. NaBu was added at 
a concentration of 20mM to all solutions and buffers used for dissecting, sorting, 
formaldehyde fixation, and IP of TEPCs. Addition of NaBu had modest to 
substantial positive effect on the H3K27ac enrichment in TEPCs, as detected by 
ChIP-qPCR (Figure 4.3D). However, NaBu can also cause changes in transcription  
A: ES cells - H3K4me3 B: ES cells - H3K27ac
C: TEPC - H3K4me3 D: TEPC - H3K27ac (log10 transformed)
Fold enrichment over IgG
Primer pair
Figure 4.3: Enrichment of positive and negative control loci for H3K4me3 and H3K27ac following 
ChIP in ES cells and TEPCs.
ChIP was performed on ~100,000 ES cells and TEPCs and enrichment of immunoprecipitated DNA was 
determined using QRT-PCR. Data shown are fold enrichment over IgG control at positive and negative 
control loci for H3K4me3 in (A) ES cells (E14/T) and (C) TEPCs and for H3K27ac in (B) ES cells and 
(D) TEPCs. Fold enrichment for H3K27ac in TEPCs is shown both in presence and absence of histone 
deacetylase inhibitor, sodium butyrate (NaBu) (D). Data shown are representative of at least two 
biological replicates.
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of genes when used for preventing histone deactylase activity in in-vitro cultures 
(Zhang & Wu 2013). Given that the TEPC samples were treated with NaBu during 
sample preparation stages for cell sorting (dissection, dissociation, staining, and cell 
sorting), when the cells are alive and could respond to presence of NaBu, an 
appropriate control was to perform panH3 ChIP on TEPCs treated in the same way. 
Thus, I decided to perform the second batch of ChIP-seq in presence of NaBu for all 
histone modifications. The rationale behind this approach was that treatment of the 
control sample with NaBu would normalise for any possible effect on histone 
occupancy. Thus, the second batch of ChIP samples, for H3K4me3, H3K27ac, and 
H3K4me1 histone modifications and pan-H3, were treated with 20mM NaBu during 
the entire ChIP protocol. The results from both batches of ChIP-seq are discussed 
below. 
 
4.3 Generation of ChIP sequencing libraries from ~100,000 
TEPCs 
Following ChIP, sequencing libraries were generated using Diagenode’s Microplex 
Library Preparation Kit which allows generation of sufficient quantity of high-
quality sequencing library for good genome-wide coverage from very small amounts 
of DNA obtained by ChIP. The libraries were sent for sequencing to a commercial 
sequencing centre where the size distribution of the different libraries was 
determined using Agilent Bioanalyser. The size distribution traces for one set of 
ChIP-seq libraries are shown in Figure 4.4. As seen in this figure, the average size 
distribution for each library was between 200 and 230bp, which is optimal for 
sequencing on the Illumina HiSeq 2000 platform. The size distribution trace for the 
H3K4me3 sequencing library showed multiple peaks of higher fragment size (Figure 
4.4A), which were most likely caused by slight over-amplification of the library. 
However, this was not expected to adversely influence the results and each set of 
libraries (one biological replicate for each of the histone modifications and panH3) 
was pooled and sequenced on one lane of HiSeq2000 sequencer. The libraries were 
sequenced to a depth of approximately 30 million reads per library for rep-1 and 
approximately 38 million reads per library for rep-2. Fastq files containing adapter- 
A: H3K4me3 (peak at 208bp)  B: H3K4me1 (peak at 214bp)
C: panH3 (peak at 231bp) D: H3K27ac (peak at 222bp)
E: pooled library (peak at 254bp)
Figure 4.4: Bioanalyser traces of ChIP sequencing libraries
The size distribution of the ChIP sequencing libraries was determined using Agilent Bioanalyser. Data 
shown are size distribution traces of sequencing libraries for rep-1. (A) H3K4me3, (B) H3K4me1, (C) 
panH3, and (D) H3K27ac. (E) shows size distribution of the pooled library used for sequencing. Also 
shown are DNA fragment lenghts at which peaks are observed in these Bioanalyser traces (i.e. median 
frgament size for each sequencing library).
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trimmed sequenced reads were obtained from the sequencing company for 
downstream bioinformatics analysis. 
 
4.3.1 Quality control analysis of the sequenced reads 
The data generated from sequencing of the ChIP-seq libraries was uploaded to 
GeneProf, an online platform for analysis of high-throughput sequencing data (Link: 
http://www.geneprof.org/GeneProf/show?id=gpXP_002962) (Halbritter et al. 2011). 
Sequenced reads quality control and alignment to mouse reference genome 
NCBIm37/mm9 were carried out using “Quality Control & Bowtie Alignemt” 
module using default parameters (Langmead et al. 2009; Halbritter et al. 2011). 
Figure 4.5 shows both the total and distinct sizes for each library. The total library 
size represents the number of sequenced reads for a library whereas the distinct size 
represents the number of distinct reads (differing by at least 1bp) sequenced. A 
comparable number of total reads was obtained between libraries within each batch 
(except panH3 rep-2, details below), indicating appropriate pooling of the libraries 
prior to sequencing (Figure 4.5). An important measure of the efficiency of IP and 
subsequent library generation is the presence of unique reads in the sequenced 
sample. Duplicate reads usually arise from PCR amplification bias or library 
generation from insufficient amount of starting material and can affect the reliability 
of peak identification (increased false positive) (Chen et al. 2012). The panH3 rep-1 
library generated a very high proportion of distinct reads (~90%), whereas the panH3 
rep-2 library generated a lower proportion of distinct reads (~80%). This was 
because the panH3 rep-2 library was sequenced at a higher sequencing depth (39M 
reads v/s 28M reads) than the panH3 rep-1 library, and increasing the sequencing 
depth increases the proportion of duplicate reads (Chen et al. 2012). The proportion 
of distinct reads for the histone modification ChIP-seq libraries ranged from 30-65%, 
possibly reflecting the differences in efficiency of IP and the abundance of these 
histone modifications within TEPCs, which would influence the amount of ChIP-
generated DNA available as starting material for library generation in each sample. 
 
  
Figure 4.5: Number of total and distinct sequenced reads for ChIP-seq samples.
Data shown are the number of total and distinct sequenced reads obtained for each ChIP-seq sample as 
(A) bar graph and (B) table. The number of total reads (total library size) represents the number of reads 
sequenced from a ChIP-seq library, whereas the number of distinct reads (distinct library size) represents 




A measure of quality of sequenced reads is the Phred-like score generated during 
sequencing. The Average Quality Score Per (sequencing) Cycle data (average quality 
score along the length of sequenced reads; Figure 4.6A) and number of reads per 
quality scores (distribution of average quality score for each read; Figure 4.6B) 
indicated that high quality sequenced reads had been generated for both sets of 
sequencing libraries. 
 
An important factor influencing the identification of peaks from a ChIP-seq 
sequencing library is its complexity. ENCODE defines library complexity as the 
fraction of DNA fragments that are nonredundant and suggests the use of complexity 
metric (nonredundant fraction, NRF), calculated as the ratio between the number of 
positions in the genome that uniquely mappable reads map to and the total number of 
uniquely mappable reads, to determine library complexity (Landt et al. 2012). A low 
complexity library is likely to yield little biological information due to increased 
proportion of redundant reads, which would be ignored during peak calling. The 
library complexity depends on a number of factors, including quality of antibody, 
number of cells used for IP, fixation and IP conditions, etc. ENCODE recommends 
obtaining sequencing libraries with NRF ≥ 0.8 for 10 million uniquely mapped reads, 
for point source libraries, such as the histone modifications studied here. To 
determine library complexities, I decided to perform a retrospective analysis on 
sequenced libraries by randomly sampling 10 million reads from each library (for 
consistency with ENCODE guidelines) and then aligning these subsample of 
sequenced reads using the parameter used for original libraries.  
Figure 4.6: Quality control of sequenced reads and libraries 
 
See following page 
(A) A plot of quality score per sequencing cycle (i.e. per base pair position) averaged 
for all the reads within a sequenced library. (B) A plot showing the distribution of 
average quality scores for sequenced reads within a library. The quality scores shown 
represent Phred-like scores, which measures the probability that a base is called 
incorrectly. Higher scores represent a smaller probability of error. A quality score of 
10 (indicating a 90% base call accuracy) is generally used as a cut-off. (C) The non-
redundant fraction (NRF), calculated as per ENCODE guidelines, indicating 
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Since GeneProf currently does not allow creation of random samples with more than 
250,000 reads, random sampling was carried out in R using the Bioconductor 
package ShortRead (Morgan et al. 2009). Three independent random samples of 10 
million reads each were generated from each sequenced library. These were 
subsequently aligned and an average of their alignment statistics, i.e. number of 
distinct regions identified, was taken to determine NRF. As shown in Figure 4.6C, 
both the panH3 libraries have a very high NRF, indicating highly complex libraries. 
The NRF for the remaining libraries, except H3K4me1 rep-1, was lower than the 
recommended 0.8, suggesting that these libraries were less complex than that 
recommended by ENCODE. The lower complexities of these libraries are most 
likely the result of low-cell numbers used for ChIP, a limitation that cannot be easily 
overcome in this case. Interestingly, the NRF for H3K27ac sequencing libraries was 
lower when NaBu was used to prevent histone deacetylase activity, however this did 
not affect identification of peaks from this sample as described below. 
 
4.4 Identification of peaks from ChIP-seq data 
Following alignment of sequenced reads, uniquely aligned reads were used as input 
to the peak-calling algorithm MACS v1.4 (Zhang et al. 2008; Feng et al. 2012) for 
identification of peaks using default Geneprof parameters (described in Chapter 2) 
(Figure 4.7A). Despite the apparently low complexity of the H3K4me3 sequencing 
libraries, 23,348 and 12,613 peaks were identified for H3K4me3 rep-1 and 
H3K4me3 rep-2, respectively. Thus, the lower complexity of this sequencing library 
did not appear to have significant adverse effect on peak identification. Similarly, 
33,842 and 21,490 peaks were identified for H3K4me1 from rep-1 and rep-2, 
respectively. On the other hand, the lower complexity H3K27ac sequenced libraries 
identified 168 peaks for rep-1 and 44,618 peaks for rep-2. This discrepancy in the 
number of peaks identified between the two replicates is discussed in detail below. 
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4.4.1 NaBu improves the ratio of reads count to genomic region 
for H3K27ac  
As discussed above, the use of NaBu significantly increased the number of peaks 
identified for H3K27ac with only 168 peaks identified for the samples prepared 
without NaBu, as opposed to 44,618 peaks identified from the samples prepared in 
the presence of NaBu (using the appropriate panH3 control samples). Identification 
of peaks depends, to a large extent, on the number of reads aligned to a particular 
genomic location. A visual inspection of differences in number of reads aligned at 
any genomic location can be carried out using a genome browser. As an example, 
Figure 4.8A shows the alignment of H3K27ac sequenced reads at the Pax1 locus in 
the presence and absence of NaBu. The top plot (dark blue track) shows the 
distribution of reads for the sample prepared without NaBu, while the bottom plot 
(green track) shows the distribution for the sample prepared with NaBu. As evident 
from comparing the two tracks, the distribution of the sequenced reads for both 
samples is highly similar, however the two tracks differ in the number of reads 
aligned at any genomic location, as evident from the scale on Y-axis. A similar 
pattern was observed for other genomic locations inspected visually by using the 
Genome Browser in GeneProf, two more examples are shown in Figure 4.8B and 
Figure 4.8C.This suggests that the increase in the number of peaks identified in the 
presence of NaBu is due to improved signal-to-noise ratio as a result of preventing 
histone deacetylation rather than changes in H3K27ac distribution. Another possible 
explanation for the differences observed between rep-1 and rep-2 would be technical 
variations associated with IP, which can affect subsequent library generation and 
peak detection. However, several factors support the conclusion that the observed 
differences are due to the positive effect of NaBu on maintaining histone acetylation. 
Firstly, results shown in Figure 4.3B suggests that the H3K27ac antibody and the 
ChIP protocol employed in this study are suitable for efficient IP. Secondly, the 
increased signal/noise ratio and number of peaks identified in presence of NaBu is 
consistent with the increased fold-enrichment observed for H3K27ac at positive 
control loci in ChIP-qPCR, as shown in Figure 4.3D. Therefore, I conclude that 
further analysis of sample prepared in NaBu was appropriate. 
 
Figure 4.7: ChIP-seq peaks and comparison of panH3 samples
The number of peaks identified from each ChIP-seq library using MACS. Also shown are the number of 
genes associated with these peaks.
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4.5 Identification of promoters active in TEPC by analysis of 
H3K4me3 and H3K27ac ChIP-seq data 
 
4.5.1 Comparison of H3K4me3 rep-1 and rep-2 
H3K4me3 ChIP data can be used to identify gene promoters (Heintzman et al. 2007; 
Rada-Iglesias et al. 2011). To this end, I first compared the data from the two 
H3K4me3 ChIP-seq samples described above. Peak calling was performed using 
MACS v1.4 as described in Chapter 2 (Zhang et al. 2008; Feng et al. 2012). The 
number of peaks identified in the H3K4me3 rep-2 (12,613; using panH3 rep-2 as 
control) dataset was lower than in H3K4me3 rep-1 (23,348; using panH3 rep-1 as 
control) (Figure 4.7A). Further analysis showed that this reflected a lower number of 
reads aligned at any genomic location in rep-2 than in rep-1 (values for Y-axis in 
examples shown in Figure 4.9A and Figure 4.9B). To determine the similarities 
between H3K4me3 rep-1 and H3K4me3 rep-2, I compared the genes associated with 
peaks from both these samples. To this end, H3K4me3 peaks were assigned to a gene 
if they were within 1000bp of the gene’s transcriptional start site or if the peaks 
overlapped with either exons or introns of the gene. This resulted in 12,828 and 
8,399 genes being associated with peaks in H3K4me3 rep-1 and rep-2 respectively. 
Approximately 92% of the genes associated with peaks in H3K4me3 rep-2 were also 
associated with peaks in H3K4me3 rep-1, indicating that peaks from both these 
samples are located within promoter regions of similar sets of genes (Figure 4.10A). 
Furthermore, analysis of shared peaks (at least 1bp overlap) between H3K4me3 rep-
1 and rep-2 showed that the number of tags at these shared peaks was higher in rep-1 
than in rep-2 (Figure 4.10B), suggesting lower signal/noise ratio in rep-2. These 
differences between H3K4me3 rep-1 and rep-2 could either be an effect of the use of 
NaBu during dissociation and subsequent ChIP protocol or represents biological 
and/or technical variations between samples. However, more biological replicates are 
required to determine unambiguously between these alternative possibilities. Given 
that H3K4me3 rep-1 showed higher number of tags than H3K4me3 rep-2 at shared 
peaks, I decided to use H3K4me3 rep-1 for further analysis. 
 
A: H3K27ac tracks at Pax1 locus
B: H3K27ac tracks at Pax9 locus
C: H3K27ac tracks at Gapdh locus
Figure 4.8: Comparison of H3K27ac rep-1 and rep-2
(A), (B), and (C) Comparison of genome browser traces for H3K27ac rep-1 (no NaBu) and rep-2 (with 
NaBu) at (A) Pax1, (B) Pax9, and (C) Gapdh genomic loci. Note the difference in the Y-axis values 
between the two samples, indicating higher number of reads aligned in rep-2 compared to rep-1 at each 
genomic loci. Genome browser tracks produced using GeneProf.
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4.5.2 Identification of active promoters using H3K4me3 rep-1 and 
H3K27ac rep-2 
Given that H3K4me3 rep-1 and H3K27ac rep-2 showed a good signal/noise ratio, I 
used these samples to identify active promoters. As expected, the majority (81%) of 
the H3K4me3 peaks were located within either “narrow” or “wide” promoter of 
genes (Figure 4.11A), as defined by GeneProf. On the other hand, since H3K27ac is 
not restricted to promoters, the peaks for this histone modification were widely 
distributed across the genome (Figure 4.11A).  
 
To identify peaks associated with gene promoters, overlapping H3K4me3 and 
H3K27ac peaks were assigned to genes if they were within 1kb of the transcriptional 
start site (TSS), including all alternate TSSs. Promoters were classified as 
transcriptionally “active” if they contained overlapping H3K4me3 and H3K27ac 
histone modifications (Heintzman et al. 2007; Rada-Iglesias et al. 2011). In this 
analysis, peaks were considered to be overlapping if they shared at least 1bp. Using 
these criteria, 11,258 genes were identified as having active promoters in E12.5 
TEPCs. Figure 4.11B and Figure 4.11C show two examples of genes with H3K4me3 
and H3K27ac histone modifications. Figure 4.11D shows an example of a gene with 
H3K4me3 modification but no significant enrichment for H3K27ac modification, 
suggesting that the promoter may not be actively transcribing. These analyses 
provided a genome-wide indication of promoters that were likely to be active in 
TEPCs. Further analysis of the promoters of a selection of genes known to be 
important for TEPCs is described below. 
 
4.6 Identification of putative active enhancers using 
H3K4me1 and H3K27ac 
Similar to H3K4me3, more peaks were identified for H3K4me1 rep-1 than for 
H3K4me1 rep-2. Thus, H3K4me1 rep-1 was used for identification of putative active 
enhancers. Figure 4.12A shows the distribution of H3K4me1 rep-1 peaks relative to 
gene bodies. As expected, the location of H3K4me1 peaks showed a wide  
A: H3K4me3 tracks at Hmbs locus
B: H3K4me3 tracks at Trp63 locus
Figure 4.9: Comparison of genome browser tracks for H3K4me3 rep-1 and rep-2
Genome browser tracks comparing read densities for H3K4me3 rep-1 and rep-2 at (A) Hmbs and (B) 
Trp63 genomic loci. Note the differences in Y-axis values.
A: H3K4me3 rep-1 and rep-2 genes B: number of tags per H3K4me3 peak
Figure 4.10: Comparison of H3K4me3 rep-1 and rep-2 peaks
(A) Overlap of genes associated with H3K4me3 peaks in rep-1 and rep-2. (B) Comparison of number of 
tags associated with peaks shared between H3K4me3 rep-1 and rep-2.
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distribution, with only 22.18% located within “narrow” and “wide” promoters, 
34.9% located within gene exons or introns, and the remaining peaks distributed such 
that they do not overlap any gene.  
 
To identify putative active enhancers, the following workflow was applied: regions 
with overlapping H3K4me1 and H3K27ac peaks were identified and were required 
not to overlap with H3K4me3 peaks. Overlapping H3K4me1 and H3K27ac peaks 
passing this filter were then assigned to genes if they were within a 100kb window 
centred on transcriptional start sites. Peaks were assigned to only the nearest genes to 
avoid assigning a peak to multiple genes. Using the above criteria, 7,755 regions 
containing overlapping H3K4me1 and H3K27ac peaks were identified as active 
enhancers. These peaks mapped to 4,192 genes using the assignment criteria 
mentioned above. Figure 4.12B and Figure 4.12C show two examples of enhancers 
identified by this approach and their closest genes. 
 
4.6.1 Identified putative enhancers are associated with genes 
important for thymus development 
To investigate whether the putative enhancers identified in the above analysis were 
associated with genes with particular classes of functional annotations, I used the 
genomic regions corresponding to the identified peaks for ontology analysis with 
Genomic Regions Enrichment of Annotations Tool (GREAT) (McLean et al. 2010). 
Genomic regions were assigned to genes using the default gene regulatory domain 
definition used by GREAT (basal plus extension). In this assignment approach, a 
basal region of 5kb upstream + 1kb downstream of TSS is assigned to each gene. 
The basal regions for a gene is then extended in both directions to the nearest gene’s 
basal domain but no more than 1000kb in any direction (McLean et al. 2010). The 
genomic regions falling within this extended regulatory domain of a gene are 
assigned to that gene. This analysis revealed that the majority of regions (~85%) 
were associated with two genes (Figure 4.13A). The assignment of regions to only 
the closest gene, as described in the workflow above would result in loss of 
information when using the resulting associated genes list for ontology analysis.  




Figure 4.11: Identification of active promoters using H3K4me3 and H3K27ac
(A) Distribution of H3K27ac rep-2 and H3K4me3 rep-1 peaks with respect to gene bodies. (B), (C), and 
(D) H3K27ac rep-2 and H3K4me3 rep-1 tracks at Ccl25 (B), Dll4 (C), and Spry1 (D) genomic loci 
showing enrichment of these histone modifications at gene promoters. 
A: Distribution of H3K27ac and H3K4me3 peaks with respect to gene bodies
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Therefore, where a putative enhancer was associated with two genes, both were 
included in the GREAT analysis discussed below. Furthermore, analysis of the 
distribution of the regions relative to the TSS of associated genes (Figure 4.13B) 
showed that more than half the regions were at least 50kb away from TSS, thus 
supporting the use of default association parameters of GREAT.  
 
The genes associated with identified enhancer regions showed the highest 
enrichment for the Mouse Phenotype term: “thymus hypoplasia” (based on MGI 
phenotype ontology) (Figure 4.13C). This suggested that the ChIP-seq data generated 
here had successfully identified enhancers for genes important for thymus and T-cell 
development, as a defect in the later process can also lead to a hypoplastic thymus 
(Table 4.1). It is important to note that no peaks for either of the histone 
modifications under study were assigned to the CD45 gene, which is expressed in T-
cells but not in TECs. This suggests that the samples used for ChIP-seq did not 
contain any thymocytes and the enrichment observed here represents enrichment in 
TEPCs. Interestingly, among the enriched GO terms for Biological Process were 
terms such as “hair follicle development” and “hair cycle” (Figure 4.13D and Table 
4.1) suggesting similarities between the development of TEPCs and hair follicle. 
Since Foxn1 is expressed in both TEC and in hair follicle epithelium, this might 
reflect common genetic targets of FOXN1 in these cell types. Other enriched GO 
terms for Biological Process included “somatic stem cell maintenance” and 
“regulation of stem cell differentiation” (Figure 4.13D and Table 4.1), supporting the 
progenitor state of TEPCs and the initiation of their differentiation and potentially 
identifying genes involved in these processes; plus several terms associated with cell 
junctions, possibly reflecting the importance of genes associated with cell-cell 
junctions in the dramatic changes in structure associated with thymus organogenesis 
at E12.5. However, the association of genes to GO terms are based on different 
evidences and thus the importance and roles of genes associated with the above GO 
terms in thymus development need to be tested experimentally. 
 
  
H3K27ac rep2 H3K4me1 rep1
A: Distribution of H3K27ac rep-2 and H3K4me1 rep-1 peaks with respect to gene bodies
B
C
Figure 4.12: Identification of active enhancers using H3K4me1 and H3K27ac
(A) Distribution of H3K27ac rep-2 and H3K4me1 rep-1 peaks with respect to gene bodies. (B) and (C) 
H3K27ac rep-2 and H3K4me3 rep-1 tracks at (B) Eya1 and (C) HMBS genomic loci showing enrichment 
of these histone modifications at putative enhancers.. 
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Figure 4.13: Analysis of putative enhancer regions using GREAT(1): mouse phenotype and 
biological process
The putative enhancer identified using H3K4me1 and H3K27ac data were analysed using the 
bioinformatics tool GREAT. Enhancers were assigned to genes using the default GREAT parameters that 
assigns a genomic region (enhancer regions in this case) to a gene if its wihtin a certain distance of the 
gene (distances varies for each gene). (A) The number of genes associated with each region. Most of the 
enhancer regions were assigned to two genes. (B) Distribution of distances of enhancer regions to the 
transcription start sites (TSS) of the assigned genes. The enhancers regions are spread over large distances 
from TSS. (C) Enrichment of genes that are assigned to enhancer regions for Mouse Phenotype GO 
terms. Highest enrichment observed was for genes associated with thymus hypoplasia phenotype. (D) 
Enrichment of Biological Process GO terms. Note the enrichment for terms associated with skin 
development.
Table 4.2: Genes contributing to enrichment of Mouse Phenotype and Biological process terms in 
results from GREAT analysis.
The genes contributing to the enrichment of the following terms in results from GREAT analysis: 
"thymus hypoplasia" in Mouse Phenotype; "hair follicle devleopment", "somatic stem cell maintenance", 
and "stem cell differentiation" in Biological Process. Shown here are genes that were assigned one or 
more enhancer regions and contributed to enrichment. 
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Analysis of genomic regions using GREAT also allowed identification of enriched 
signalling pathways using various pathway datasets. The use of one such datasets, 
MSigDB Pathway, indicated a strong enrichment for, among others, TGFβ 
signalling, BMP signalling, Notch signalling, p38 MAPK signalling, and NFκB 
signalling (Figure 4.14A), all of which have been implicated in thymus development 
or function. Terms associated with TGFβ and SMAD also showed strong enrichment 
in Molecular Functions ontology (Figure 4.14B). Together, this suggested that TGFβ 
signalling, through its downstream SMAD-dependant and p38 dependant functions, 
might play an important role in regulation of TEPCs. The enrichment of Notch 
signalling pathway is consistent with the upregulation of Notch1 gene observed in 
Chapter 3. Similarly, the other enriched pathways too are likely to be important for 
thymus development. Of note is that the use of a different pathway dataset, 
PANTHER pathway, indicated enrichment only for the Notch signalling and p38 
MAPK signalling pathways (Figure 4.14C). The genes with assigned enhancer 
regions and associated with each of these enriched terms are shown in Table 4.2. 
Finally, it is also important to note that while the GO and Pathway terms mentioned 
above are manually curated, the relevance of the genes associated with these terms 
and the function of the respective pathways in the cell-type under study needs to be 
experimentally validated.  
 
4.7 Identification of Foxn1 promoter and enhancers 
Given the importance of Foxn1 in thymus development and maintenance, I focused 
on identification of putative promoter and enhancers for this gene. Promoter and 
enhancers were identified from ChIP-seq datasets as described above. A detailed 
analysis of these regions is mentioned below: 
 
4.7.1 Foxn1 promoter 
Figure 4.15A shows H3K4me3 rep1 and H3K27ac rep2 tracks at the Foxn1 locus 
and the region designated as the active promoter for Foxn1. This analysis identified a 




Figure 4.14: Analysis of putative enhancer regions using GREAT(2): signalling pathway and 
molecular function.
The putative enhancer identified using H3K4me1 and H3K27ac data were analysed using the 
bioinformatics tool GREAT. Enhancers were assigned to genes using the default GREAT parameters that 
assigns a genomic region (enhancer regions in this case) to a gene if its wihtin a certain distance of the 
gene (distances varies for each gene). (A) Enrichment of genes that are assigned to enhancer regions for 
MSigDB Pathways. MSigDB provides curated lists for genes involved in signalling pathways. 
Highlighted are enrichments for TGFbeta, Notch, NF-kB, and BMP signalling due to their importance in 
the thymus. (B) Enrichment of Molecular Function GO terms. Note the enrichment for terms associated 
TGFbeta signalling and SMAD binding, consistent with enrichment of this signalling pathway. (C) 
Alternative pathway enrichment analysis using PANTHER pathway. 
Table 4.3: Genes contributing to enrichment of signalling pathways in results from GREAT 
analysis.
The genes contributing to the enrichment of the following signalling pathways in results from GREAT 
analysis: TGFbeta, BMP, Notch, p38, and NF-kB signalling. Shown here are genes that were assigned one 









Figure 4.15: Identification of Foxn1 promoter
(A) Genome browser tracks for H3K4me3 and H3K27ac showing the active Foxn1 promoter. The 
enrichment of these histone modifications at a second region wiht intron-1 is likely to indicate limited 
transcription from alternative first exon of Foxn1. (B) ChIP-qPCR validation of H3K4me3 enrichment at 
active Foxn1 promoter. Data shown indicate fold enrichment over IgG control. Also shown are genomic 
regions ampliefied by each positive control primer pairs. Negative control primer pairs amplified regions 
outside the identified promoter. Error bars indicate technical variability of qPCR. (C) UCSC browser 
image of the identified Foxn1 promoter, represented by H3K4me3 peak. Also shown is track for 
mammalian conservation. The red box indicates the genomic region used as Foxn1 promtoer for 
subsequent analysis, which was exentended to include conserved regions on either side of H3K4me3 
peak.
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indicating the presence of second promoter region. This promoter region most likely 
corresponds to exon-1b, an alternate first exon, of Foxn1, which has been reported in 
the literature and corroborated by our own studies, but is not curated in any genomic 
database. Transcripts utilising exon-1b are found in skin, where as thymic epithelial 
cells shown only minimal expression of this transcript with most of the Foxn1 
transcript starting at exon-1a. The presence of the second promoter region in this 
dataset suggests that transcripts starting at exon-1b might be made in TEPCs, albeit 
at much lower rate than those starting at exon-1a. The absence of mature transcripts 
starting at exon-1b in TECs further suggests that transcripts generated using the 
second promoter are likely to be prematurely terminated, leading to their 
degradation. The enrichment of H3K4me3 across the identified peak region was 
validated using ChIP-qPCR (Figure 4.15B). Based on these analyses I concluded that 
the H3K4me3 marked region as Foxn1 promoter and further extended to include the 
highly conserved region to the 5` end (negative strand) of this region (Figure 4.15C). 
Thus, the coordinates of the genomic region defined as the Foxn1 promoter in all 
subsequent analyses were as follows: (in mm9/GRCm37) Chr11: 78196637 – 
78200589 or (in mm10/GRCm38) Chr11: 78383135 – 78387087.  
 
I then tested the above-defined Foxn1 promoter for TFBS using the Match 
programme, with parameters set to minimize the sum of false positive and false 








Table 4.3: Summary of transcription factor binding sites identified in Foxn1 
promoter 
 
See following page 
Foxn1 promoter was analysed for presence of transcription factor binding sites using 
Match algorithm and TRANSFAC professional database. This table lists the 





Table 4.3 shows a summary of the identified TFBSs. Similar to the promoters of 
other genes mentioned above, the only over-represented TFBS in Foxn1 promoter 
was BRCA1:USF2. Among the genes analysed in Chapter 3, only Inhibitor of 
growth family, member 4 (Ing4) had binding sites in Foxn1 promoter, suggesting that 
this gene could be involved in regulating Foxn1 expression. Of particular interest are 
SMAD4 binding sites identified in this region (Table 4.3). Given the role of SMAD4 
as a common mediator-SMAD for both BMP and TGFβ signalling pathways, the 
above results suggest that these pathways could be involved in regulation of Foxn1 
expression in TECs. As discussed in Chapter 1, both BMP and TGFβ signalling play 
important roles in thymus development, maintenance, and function and BMP 
signalling has been suggested to be required for initiation of Foxn1 expression in 
TEPCs. Thus, whether TGFβ signalling is also involved in regulation of Foxn1 
expression remains to be determined. 
 
4.7.2 Putative Foxn1 enhancers 
Using the genomic regions assignment criteria mentioned above, four putative 
enhancer regions, with overlapping H3K4me1 and H3K27ac peaks, were assigned to 
Foxn1 (Figure 4.16A). Both the H3K4me1 and H3K27ac tracks showed high signal 
throughout intron-1 of Foxn1, which could result from transcription of the alternate 
first exon 1b. The genomic coordinates (in mm9/GRCm37) for the predicted 
enhancer regions assigned to Foxn1 were as follows:  
Region-1: Chr11: 78185221 – 78186298 
Region-2: Chr11: 78188296 – 78188610  
Region-3: Chr11: 78189231 – 78189789  
Region-4: Chr11: 78200392 – 78201601  
These regions lie within the 30kb region shown to be able to recapitulate Foxn1 
expression during thymus development (Schlake 2005). A summary of the TFBSs 
present within these regions is shown in Table 4.4 to Table 4.7. Among the genes 
analyzed in Chapter 3, Foxa2, Hes1, Foxc1, E2Fs, p53, and Ing4 had binding sites in 
the identified enhancer regions, suggesting their involvement in regulation of Foxn1  
A
B
Figure 4.16: Identification of putative Foxn1 enhancers
(A) Genome browser tracks for H3K4me1 and H3K27ac at Foxn1 genomic locus. Also shown are 
identified putative enhancers as determined by overlapping H3K4me1 and H3K27ac peaks. Five putative 
enhancher regions were identified. (B) UCSC genome browser view of Foxn1 genomic locus with 
identified enhancers shown as blue bars (marked by red boxes).
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expression. E2Fs have previously been shown to be able regulate the expression of 
by binding to their consensus sequence in the vicinity of Foxn1 transcription start 
site in vitro (Garfin et al. 2013). Whether E2Fs and the other genes bind to the 
identified binding sites in putative enhancer regions remains to be determined. 
Interestingly, no TFBS was found to be over-represented in any of the predicted 
enhancer regions. Figure 4.16B shows that the identified putative enhancer regions 
either overlap or are very close to regions of high conservation, suggesting that these 
regions could play a role in regulating Foxn1 transcription. As mentioned previously, 
FOXN1 appears to regulate the expression of its own gene. However, no FOXN1 
binding site was identified in any of the predicted enhancer regions, possibly because 
of availability of only a poorly characterized binding site matrix for FOXN1. 
 
Besides the above mentioned putative enhancer regions, another region with 
overlapping H3K4me1 and H3K27ac histone modifications was found between 
exon-8 and exon-9 of Foxn1. This putative enhancer region is, however, not assigned 
to Foxn1 using the above mentioned assignment criteria. This is due to the region 
being closer to the TSS of a neighboring gene. Given that this region is located 
within Foxn1 locus, I decided to assign it as the fifth putative enhancer region for 
Foxn1. The genomic coordinates for this region are (in mm9/GRCm37): 
Region-5: Chr11: 78173017 – 78173239  
 
The TFBSs identified in this region are listed in Table 4.8. Interestingly, the region 
between exon-8 and exon-9 of Foxn1 contained enrichment for H3K4me3, 
H3K4me1, and H3K27ac in a study that analysed histone modifications in whole 
adult thymus (Shen et al. 2012). The H3K4me3 data generated here does not show 
any enrichment in this region, suggesting that H3K4me3 enrichment observed in the 
above mentioned study results from either the difference between TEPCs and adult 
TECs or corresponds to another cell-type present in the adult thymus. Region-5 does 
not contain any over-represented TFBS, nor any binding sites for FOXN1, as 
determined using Match programme. 
  
Table 4.4: Summary of transcription factor binding sites identified in Foxn1 enhancer-1
Foxn1 enhancer-1 was analysed for presence of transcription factor binding sites using Match algorithm 
and TRANSFAC professional database. This table lists the matrices, the associated transcription factors, 
and number of sites identified for each matrix.
Table 4.5: Summary of transcription factor binding sites identified in Foxn1 enhancer-2
Foxn1 enhancer-2 was analysed for presence of transcription factor binding sites using Match algorithm 
and TRANSFAC professional database. This table lists the matrices, the associated transcription factors, 
and number of sites identified for each matrix.
Table 4.6: Summary of transcription factor binding sites identified in Foxn1 enhancer-3
Foxn1 enhancer-3 was analysed for presence of transcription factor binding sites using Match algorithm 
and TRANSFAC professional database. This table lists the matrices, the associated transcription factors, 
and number of sites identified for each matrix.
Table 4.7: Summary of transcription factor binding sites identified in Foxn1 enhancer-4
Foxn1 enhancer-4 was analysed for presence of transcription factor binding sites using Match algorithm 
and TRANSFAC professional database. This table lists the matrices, the associated transcription factors, 
and number of sites identified for each matrix.
Table 4.8: Summary of transcription factor binding sites identified in Foxn1 enhancer-5
Foxn1 enhancer-5 was analysed for presence of transcription factor binding sites using Match algorithm 
and TRANSFAC professional database. This table lists the matrices, the associated transcription factors, 
and number of sites identified for each matrix.
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4.8 Discussion 
The aim of the work described in this chapter was to identify putative transcriptional 
regulatory regions in TEPCs. To this end, ChIP-seq data was generated for 
H3K4me3, H3K4me1, and H3K27ac from isolated TEPCs, permitting identification 
of active promoters and putative active enhancers. This chapter also discusses the 
difficulties and limitations associated with this approach. One of the key limitations 
was the availability of material for ChIP. Isolated TEPCs were used for ChIP in 
order to ensure that the results closely match the actual biology of the developing 
thymus. An alternate source of material for ChIP would be thymic epithelial cell 
lines, however TEC are known to lose key features of their in-vivo phenotype 
extremely quickly upon establishment of primary cultures, indicating that analysis of 
TEC lines is of limited use. Furthermore, several protocols have been published on 
differentiation of pluripotent stem cells into thymic epithelial-like cells but so far 
bona fide TEPC have not been generated (Bredenkamp, Ulyanchenko, et al. 2014). 
Thus, the use of isolated TEPCs was the best approach for the questions I set out to 
address.  
 
The advancements in ChIP-seq protocols now enable this technique to be performed 
on much smaller number of cells, as described here. This has led to this technique 
being applied to various tissues and organs in the last few years (Adli et al. 2010; 
Adli & Bernstein 2011). Here, I demonstrate, for the first time, the application of this 
technique for the identification of genome wide transcriptional regulatory regions in 
TEPCs. Of note is that ChIP-seq for histone modifications has previously been 
applied to whole adult thymus (Shen et al. 2012) and to mature mTECs (Sansom et 
al. 2014). However, the presence of other cell types in the adult thymus, which 
constitutes the majority of adult thymus cellularity, confounds the results presented 
in the former study, preventing identification of histone modifications relevant to 
thymic epithelial cells. This is evident from an absence of H3K4me3 enrichment at 
Foxn1 TSS in this dataset. However, as mentioned previously, the enrichment for 
H3K4me1 and H3K27ac observed towards the 3` end of Foxn1 might represent a 
TEC specific enrichment. On the other hand, the later study by Sansom et al. only 
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analysed H3K4me3 and H3K27me3 histone modifications in mTECs and thus does 
not enable identification of active enhancers. Furthermore, mTECs express a large 
number of tissue-restricted antigens (TRAs), that are important for negative selection 
of developing thymocytes, and are thus expected to present histone modifications at 
promoters and enhancers for these genes. This further complicates identification of 
histone modifications relevant to the aim of this Chapter. The results described in 
this Chapter overcome both these issues and thus represent a significant 
advancement to our understanding of TEPC epigenetics. 
 
4.8.1 The effect of NaBu on ChIP 
NaBu was added to all rep-2 samples used for ChIP. Whether the above-mentioned 
differences observed between rep-1 and rep-2 are a result of NaBu or of technical 
variation cannot be confidently determined without the use of more biological 
replicates. Furthermore, whether NaBu is required during the entire isolation, sorting, 
and subsequent ChIP protocol, as done here, is not clear. Comparison of samples 
treated at different stages (isolation, sorting, or ChIP) with NaBu could help resolve 
this issue. However, this requires the use of more animals for optimization and was 
thus avoided in the present study.  
 
4.8.2 Identified putative transcriptional regulatory regions are 
important for genes involved in thymus development 
The ChIP-seq approach employed here allowed for the identification of genome-
wide promoters and enhancer elements. This enables testing of various genetic 
interactions prevalent within a particular cell type. Determining the exact function of 
identified genomic regions, however, requires genetic manipulations. Here, I carried 
out preliminary analysis of the identified putative enhancer regions by determining 
ontology enrichment for genes in the vicinity of these regions, as per the default 
parameter in GREAT bioinformatics package. This analysis showed that many of the 
identified putative enhancer regions were in the vicinity of genes involved in thymus 
development. Changing the genomic region assignment parameters such that each 
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region was only assigned to its nearest gene changed the list of enriched terms. The 
“thymic hypoplasia” term was replaced by “abnormal thymus morphology” 
suggesting that the observed enrichment for genes important in thymus was not an 
artefact of assigning regions to genes. However, these two phenotype terms also 
include genes involved in T-cell development defects, which result in abnormal 
thymus development. Thus, the role of these genes in TECs remains to be 
determined experimentally. 
 
Of particular interest was the enrichment for TGFβ signalling pathway. Analysing 
the genes leading to this enrichment revealed genes specific to TGFβ pathway and 
not the BMP, Nodal, or Activin pathway, which are also members of transforming 
growth factor superfamily. This suggests an important role for TGFβ signalling 
pathway in TEPCs. Several studies have demonstrated the importance of TGFβ in 
postnatal thymus maintenance and function (Sempowski et al. 2000; Kumar et al. 
2006; Hauri-Hohl et al. 2008; Odaka et al. 2013; Hauri-Hohl et al. 2014). Thus, its 
role, if any, during thymus development warrants further study. TGFβ signals 
through various downstream effectors of which SMAD- and p38-dependant 
pathways were highly enriched. SMAD4 binding sites were found to be present 
within the promoter regions of various genes important for thymus development, 
suggesting that SMAD4 is important for this process. Some of the other pathways 
enriched in the present analysis included the BMP, Notch, and Wnt signalling 
pathways. It is well established that BMP signalling is important for thymus 
development and normal Foxn1 expression (Bleul & Boehm 2005; Patel et al. 2006; 
Gordon et al. 2010; Neves et al. 2012). Furthermore, the Wnt signalling pathway has 
been suggested to be important for TEPCs/TECs (Huh & Ornitz 2010; Bredenkamp, 
Nowell, et al. 2014), and the Notch signalling is currently being investigated in our 
lab for its role in thymus development and maintenance.   
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4.8.3 Additional techniques for interogating chromatin 
accessibility and enhancers 
While the histone modification ChIP-seq technique used here allowed identification 
of putative global enhancers, identification of p300 binding sites and/or open 
chromatin structures in TEPCs can further complement the data presented in this 
Chapter. The transcriptional coactivator and acetyltransferase p300, which binds to 
enhancers, has been used extensively for identification of genome-wide enhancers 
(Rada-Iglesias et al. 2011). However, given its transient interaction with DNA, 
identification of p300 binding sites through ChIP-seq on small number of cells, such 
as those used in this Chapter, presents additional challenges. On the other hand, the 
development of ATAC-seq protocol now allows studying chromatin accessibility 
without the need of millions of cells (Buenrostro et al. 2013). Combining chromatin 
accessibility data together with the histone modification data presented in this 
Chapter could further filter for regions that are most likely to act as active enhancers. 
Thus, ATAC-seq and p300 ChIP-seq could be performed on TEPCs to further 
support the identification of enhancers. 
 
4.8.4  Concluding remarks 
The importance of Foxn1 in thymus has been realised since its discovery as the nude 
gene. Understanding its regulation and function in TEPCs and TECs has become 
even more important in recent times since discoveries of its involvement in 
regenerating the thymus in-vivo and to reprogramme MEFs to iTECs (Bredenkamp, 
Nowell, et al. 2014; Bredenkamp, Ulyanchenko, et al. 2014). Here, I have identified 
genomic regions in the vicinity of Foxn1 locus marked by H3K4me3, H3K4me1, and 
H3K27ac histone modifications. The identified promoter and putative enhancers, 
except for Region-5, lie within the 30kb region shown to be able to recapitulate 
Foxn1 expression during thymus development. Whether the regions identified as 
putative enhancers are able to recapitulate this expression pattern remains to be 
determined. Interestingly, Region-5 was also detected by Shen et al. in adult thymus 
and could thus represent an enhancer important for the maintenance of Foxn1 
expression. Similarly, whether the region identified as the promoter is sufficient for 
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basal transcription remains to be determined. The luciferase assay can be employed 
to test the promoter and enhancer functions of these regions. However, this assay 
only addresses the function of these regions in-vitro, which could be different from 
their activity in-vivo. Further validation for enrichment of H3K4me1 and H3K27ac 
should be carried out using ChIP-qPCR. Comparison of enrichment of these histone 
modifications at putative enhancer regions to that in TEPCs isolated from E10.5-
E11.0, i.e. before the initiation of Foxn1 transcription, should be carried out to test 
whether these regions behave as true enhancers. 
 
The advance in genome engineering resulting from the discovery of Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 as genome-editing 
tool provides a unique opportunity to test the in-vivo functionalities of regions 
identified through such ChIP-seq approaches. Thus, deletion of the identified 
putative enhancers, singly and in pairs, using CRISPR-Cas9 system should be 
performed to determine their roles in regulating Foxn1 expression. As shown in the 
tables above, the identified promoter and enhancer regions each contain binding sites 
for many transcription factors. Whether all of these transcription factors are 
expressed in TEPCs is not yet known. The mentioned CRISPR-Cas9 system can also 
be used to either delete or mutate the binding sites for these transcription factors to 




5. Transcriptional regulation of TEPC development and 
differentiation 
5.1 Introduction 
In Chapter 3, I described identification of a potential transcription factor network 
governing TEPC differentiation, while in Chapter 4, I identified, on a global basis, 
putative transcriptional regulatory regions active in TEPC. From this information, I 
predicted signalling pathways and transcription factors with potential roles in TEPC 
regulation. However, while Chapter 4 identified transcription factors with physical 
binding sites within transcriptional regulatory regions of Foxn1, with the exception 
of the factors analysed in Chapter 3, very little is known about their expression 
during thymus development. The same is true for the genes involved in the signalling 
pathways predicted to be important for TEPC in Chapter 4. This Chapter therefore 
describes analysis of the transcriptome of developing 3PP cells and TEPCs using 
RNA-seq, which was performed in order to resolve these issues. The 3PP undergoes 
several morphological changes during development into the thymic rudiment, which 
are likely to be accompanied by a change in transcriptional programme from one that 
is important for endoderm development and/or tissue/organ development to one that 
is required for TEPC specification and differentiation. To test this hypothesis and to 
determine the genes involved in these processes, I performed enrichment analysis on 
the RNA-seq data using bioinformatics approaches. The outcomes of these analyses 




5.2.1 Sample preparation 
Advances in the field of transcriptomics, particularly RNA-seq, have now made it 
possible to characterize transcriptomes of even difficult to obtain cell types, such as 
adult stem and progenitor cells. The ability to obtain global transcriptome data from 
very small number of cells (even single cells) using advanced chemistries such as 
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SMART-seq2 (Picelli et al. 2014) has opened up the possibility of characterising the 
transcriptome of defined subsets of thymic epithelial cells (TEC). Thus, I isolated 
100 TEPCs from E10.5, E11.5, and E12.5 thymic primordial, using flow cytometry 
as described in Chapter 3, and processed the cells for RNA-seq. Three independent 
biological replicates were collected for each sample, in order to allow statistical 
interpretation of the resulting data. The selected developmental time points cover 
both Foxn1-independent development and Foxn1-dependent differentiation of 
TEPCs. This work was carried out in collaboration with Prof. Sten Eirik Jacobsen’s 
laboratory at the Karolinska Institute and the University of Oxford. Cell sorting was 
performed at the University of Edinburgh (by myself). Preparation of these sorted 
samples for RNA-seq and subsequent sample preparation and sequencing were 
carried out at University of Oxford using Smart-seq2 protocol (Picelli et al. 2014). 
The Smart-seq2 protocol is optimized for use with very small cell numbers, even 
single cells and demonstrates better sensitivity, accuracy, and full-length transcript 
coverage than other protocols (Picelli et al. 2014). The current limitations of this 
protocol are that it does not retain strand specificity of RNA samples and is unable to 
detect nonpolyadenylated RNA (Picelli et al. 2014). 
 
5.2.2 Comparison of biological replicates 
The sequenced reads generated from each sample were obtained from Oxford in 
fastq format. These files were uploaded to GeneProf (Halbritter et al. 2011) for 
quality control assessment of the sequenced reads and their alignment to transcripts 
using the TopHat 1.2.0 algorithm (Trapnell et al. 2009). The raw read counts (RC) 
and read counts normalized for library sizes and gene lengths (RPKM; reads per 
kilo-base of exon model (entire annotated transcript) per million mapped reads) were 
generated, subsequent to reads alignment, using the “Quantitate Gene Expression” 
module of GeneProf (Halbritter et al. 2011). The global RC and RPKM values were 
downloaded and used for further analysis. The sequenced reads were of high quality 
(Figure 5.1A-B) and between 55 and 65% of all aligned reads for each sample were 
aligned uniquely in the genome (Figure 5.1C), suggesting that the samples used for 
generating sequencing libraries were of good quality. 
A: Quality score per base position 
B: Distribution of mean read quality scores
C: Distribution of number of matches in genome for sequenced reads
Figure 5.1: Quality control of RNA-seq data
(A) A plot of quality score per sequencing cycle averaged for all the sequenced reads for each RNA-seq 
sample. (B) A plot showing the distribution of average quality scores for sequenced reads for each RNA-
seq sample.The quality scores shown represent Phred-like scores which measures the probability that a 
base is called incorrectly. Higher scores represent a smaller probability of error. (C) Distribution of 
number of matched in genome for sequenced reads for each RNA-seq sample. Note that most of the 
sequenced reads aligned to a single location in the genome.
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I first tested the reproducibility of the RNA-seq data generated from each replicate 
by calculating the correlation coefficient for RPKM counts between biological 
replicates (Figure 5.2A-C). This ranged from 0.88 to 0.98, indicating a very high 
degree of similarity between normalised read counts among biological replicates. 
The most commonly used diagnostic plots for RNA-seq data include principal 
component analysis (PCA) and sample clustering. Therefore, the matrix of raw read 
count obtained from GeneProf was converted into a DESeqDataSet object using the 
DESeq2 package (Anders & Huber 2010; Love et al. 2014) in the statistical 
computing language R (Core Team 2015). The raw read counts were subsequently 
normalized using the regularized logarithm transformation (rlog) approach of 
DESeq2, which prevents the results being dominated by genes on either end of the 
expression range and has been shown to perform equally well or better than other 
normalisation approaches (Love et al. 2014). Analysis of variance in rlog-
transformed data through PCA showed that the majority (75%) of variance could be 
accounted for by two principal components (Figure 5.3A). Furthermore, the PCA 
analysis revealed that based on these two principal components, the biological 
replicates for the E12.5 and E11.5 samples were highly similar. On the other hand, 
E10.5 rep2 appeared more similar to the E11.5 samples than to E10.5 rep1 and rep3 
(Figure 5.3A). Similarly, a heatmap of rlog-transformed samples, generated using the 
pheatmap function (Kolde 2015), clustered E10.5 rep2 closer to the E11.5 samples 
than to the other two E10.5 replicates (Figure 5.3B). Thus, the E10.5 rep2 sample 
appeared to be of a developmental time point between E10.5 and E11.5 and was 
therefore not included in subsequent analyses. The heatmap also showed a high 
degree of similarity between the biological replicates of both the E12.5 and E11.5 
samples, consistent with the PCA results. Thus, all the biological replicates for both 
E12.5 and E11.5 were suitable for downstream analysis. Finally, consistent with 
previous suggestions (Nowell et al. 2011), the E11.5 samples clustered closer with 
the E10.5 samples than with the E12.5 samples, suggesting that the global 






Figure 5.2: Correlation analysis between biological replicates for RNA-seq samples
Correlation coefficients between biological replicates for RNA-seq samples were calculated as one 
measure of reproducibility between replicates. Shown are scatter plot demonstrating correlation between 
RPKM values and respective correlation coefficients between each pair of biological replicates for (A) 




Figure 5.3: Principal component and clustering analysis of RNA-seq biological replicates
(A) Principal component analysis based on rlog-transformed values for all RNA-seq samples. Note the 
clustering of samples based on developmental time point, except E10.5 rep-2. (B) Heatmap demonstrating 
the similarities between biological replicates based on clustering of samples. Clusters were genereated 
using rlog-transformed values. Note that E10.5 rep-2 does not cluster with other E10.5 samples.
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5.2.3 The top 500 most variable genes identify transcriptional 
changes associated with TEPC generation and 
differentiation 
Patterns of changes in gene expression can provide useful insight into changes 
associated with experimental variables - in this case, development from E10.5 3PP 
cells to E12.5 TEPCs. I therefore decided to analyse patterns of gene expression in 
the transcriptome data generated here. A closer inspection of the PCA plot shown in 
Figure 5.3 suggested that the top 500 most variable genes contribute to most of the 
variance in the data. Thus, I identified the top 500 genes with the highest variability 
between the samples based on rlog-transformed data, and clustered these genes on a 
heatmap using the pheatmap function (Figure 5.4). The heatmap shows the deviation 
of genes in each sample from the average expression across all samples. Genes were 
divided into three clusters depending on their expression levels: 1) genes with 
transient increase in expression at E1.5; 2) genes with decreasing expression from 
E10.5 to E12.5; and 3) genes with increasing expression from E10.5 to E12.5. The 
biological processes GO terms enriched for each cluster, at the Benjamini value cut-
off (FDR) of 0.1, as determined by the DAVID tool (Huang et al. 2008; Huang et al. 
2009) are shown in Figure 5.4.  
 
Cluster 1 showed enrichment for genes involved in the GO term “positive regulation 
of biosynthetic process” (p-value = 0.001). Cluster 2 is enriched for genes involved 
in biological processes such as “cell fate commitment”, “embryonic morphogenesis”, 
“sensory organ development”, “cell migration”, “embryonic organ development” and 
other development related terms. Finally, Cluster 3 is enriched for genes involved in 
“immune response” and “antigen processing and presentation of exogenous peptide 
antigens”, functions performed by differentiated, functional TECs. Thus, this cluster 
identifies genes that are important for differentiation of TEPCs and/or the normal 
function of the differentiating TECs. These results suggests that there indeed is a 
decrease in the expression of genes associated with 3PP development and a 
subsequent increase in the expression of genes important for thymus development 
and/or function.  
Figure 5.4: Heatmap of top 500 most variable genes.
The top 500 genes with most variablibility in expression between samples, and contributing to most of the 
variance observed in PCA plot shown previously, were identified using DESeq2. Shown here is a 
heatmap clustering these genes into three main clusters based on thier expression profiles. The biological 
processes terms enriched for each cluster are as follows - Cluster-1: nill ; Cluster-2: cell fate commitment, 
embryonic morphogenesis, sensory organ development, cell migration, embryonic organ development, 
etc.; Cluster-3: immune response, antigen processing and presentation of exogenous peptide antigens
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To ensure that increased expression of genes in Cluster 3 at E12.5 is not a result of 
presence of contaminating thymocytes in the samples, I analysed the expression of 
CD45, which is expressed by the developing thymocytes but not TECs. The RPKM 
values for CD45 was zero in all samples, indicating an absence of expression of this 
gene and suggesting that samples did not contain any thymocytes.  
 
Nkx2.6 has shown to be expressed widely across the 3PP at E9.0 and E10.0 (Wei & 
Condie 2011). At E10.0, Nkx2.6 is expressed throughout the ventral part of 3PP, 
overlapping the expression of Isl1, another gene important for thymus development. 
My analysis showed that the expression of Nkx2.6 was decreased from E10.5 to 
E11.5 (although this was not statistically significant), while its expression was absent 
at E12.5. Contrary to this, a previous report suggested the absence of Nkx2.6 
expression in E11.5 3PP, based on in-situ hybridization (Wei & Condie 2011). This 
difference might be due to the higher sensitivity of RNA-seq technique employed 
here compared to in-situ hybridization. Whether the decrease in expression of Nkx2.6 
from E10.5 to E11.5 and its subsequent absence at E12.5 is necessary for normal 
differentiation of TEPCs remains to be determined. No binding sites were found for 
Nkx2.6 in the Foxn1 promoter and enhancers identified in Chapter 4. Finally, the role 
of other transcription factors in Cluster 4 in 3PP formation and/or thymus 
development is not yet known.  
 
Cluster 3 represents genes whose expression increases from E10.5 to E12.5. Thus, 
these genes could represent transcriptional regulators or targets of Foxn1. Consistent 
with this hypothesis, this cluster contains genes such as Dll4, Ccl25, Kitl and H2-
Ab1, whose expression in TEPC is Foxn1-dependent. Bhlhe40, a gene analysed in 
Chapter 3 as candidate transcriptional regulator of Foxn1 is also present in this 
cluster. Finally, Il7 a gene whose expression is independent of Foxn1 but crucial for 
thymocyte development is also present in this cluster. Together, this suggest that 
Cluster 3 contains genes which are likely to be important for thymus development 
and may be involved in the same genetic network as Foxn1.  
 
 167	
Thus, the transcriptome data generated using RNA-seq revealed discrete gene 
expression patterns that distinguished E10.5 and E11.5 3PP cells from TEPCs. 
Furthermore, the clusters in the heatmap identify genes that could have important 
roles in either development/fate commitment of 3PP cells or the differentiation 
and/or function of TECs.  
 
5.2.4 Analysis of differential gene expression in 3PP cells and 
TEPC from E10.5 to E12.5 
To gain further information regarding genes that were differentially expressed 
between the E10.5 3PP, E11.5 3PP and E12.5 TEPC samples, I used DESeq2 (Love 
et al. 2014), an improved version of the DESeq algorithm. DESeq2 identifies 
differentially expressed genes and provides information on fold change and its 
statistical significance (Anders & Huber 2010). The DESeqDataSet object generated 
above was used for these analyses. Pairwise differential gene expression analysis was 
carried out for all pairs of the three different samples used for RNA-seq. A summary 
of the results from the DESeq2 analysis is shown in Figure 5.5A.  
 
Six hundred and eighty five, nine hundred, and one thousand six hundred and thirty 
genes were differentially expressed in the E11.5 vs E10.5, E12.5 vs E11.5, and E12.5 
vs E10.5 comparisons respectively, using fold change ≥ 2 and p-value ≤ 0.01 as the 
cut-off at a 10% FDR (false discovery rate). For the E11.5 vs E10.5 comparison, 488 
genes were up-regulated at E11.5, while 197 genes were down-regulated. In the 
E12.5 vs E11.5 comparison, 480 and 421 genes were up- and down-regulated 
respectively at E12.5. Finally, for the comparison between E12.5 and E10.5, the two  
  
A: Number of differentially expressed genes in each comparison
B: Molecular functional terms enrichment at E12.5 (vs E10.5)
C: Molecular functional terms enrichment at E10.5 (vs E12.5)
Figure 5.5: Enrichment of Molecular Functions GO terms for genes expressed differentially 
between E10.5 and E12.5.
(A) Number of differentially expressed genes for each comparison of developmental time points 
analysed. (B) and (C) Enrichment of Molecular Functions GO terms for genes significantly upregulated at 
(B) E12.5 compared to E10.5 and (C) E10.5 compared to E12.5. Terms were considered enriched if p-
value <= 0.01 and q-value (FDR) <= 0.25. Enrichment plots and genes contributing towards the 
enrichment are shown for the Molecular Functions terms enriched at (B) E12.5 compared to E10.5.
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furthest developmental time-points in the series, 1026 genes were up-regulated at 
E12.5, while 604 genes were down-regulated.  
 
Foxn1 was not expressed significantly differentially between E11.5 and E12.5 (1.8 
fold higher at E12.5, p-value 0.18), while its target genes Dll4 (6.52 fold), Ccl25 
(8.35 fold), and Cxcl12 (2.5 fold) showed significantly higher expression at E12.5 
compared to E11.5 with p-values less than 0.01. This may be due to the large 
variation in expression of Foxn1 observed between biological replicates (RPKM 
values for E11.5: 1.39 (rep1), 0.9 (rep2), and 2.56 (rep3); RPKM values for E12.5: 
1.84 (rep1), 4.26 (rep2), 3.73 (rep3)), suggesting that more precise staging of 
embryos may be required to detect stage-specific changes in Foxn1 expression. In 
this study, the embryos were staged based on days post coitum and a more rigorous 
staging using number of somites is recommended for the future. On the other hand, 
Foxn1 expression was 8.75 fold higher at E11.5 (p-value = 6.25E-06) and 15.87 fold 
higher at E12.5 (p-value = 8.57E-09) than at E10.5.  
 
Studies on RNA-seq have not yielded a consensus on a method to determine the 
presence or absence of transcripts for genes within the samples being analysed. A 
common parameter used for this purpose is RPKM count for genes; however, 
different studies have used and recommended different thresholds for RPKM counts, 
ranging from 0.2 to 3 RPKM (Sultan et al. 2008; Ramsköld et al. 2009). These 
studies also showed that the optimal RPKM threshold varies between experiments 
(and between samples within an experiment) and various models have been proposed 
for determining experiment specific cutoffs (Ramsköld et al. 2009; Rau et al. 2013). 
For the purpose of this thesis, I have used a RPKM cut-off of 0.3, which has been 
proposed by Ramsköld and colleagues as the optimal cut-off which balances the 
numbers of false positive and false negatives across most samples used in their study 
(Ramsköld et al. 2009). Using this cut-off, Gcm2 was expressed in the E10.5 
(geometric mean of RPKM = 0.8) and E11.5 (geometric mean of RPKM = 4.2) 
samples but not in the E12.5 samples (geometric mean of RPKM = 0.17); whereas, 
Pth was expressed in the E11.5 (geometric mean of RPKM = 22) and E12.5 
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(geometric mean of RPKM = 1) samples but not in the E10.5 sample (geometric 
mean of RPKM = 0). This suggested that all of these samples contained some 
parathyroid cells, with the E11.5 samples showing a higher proportion of parathyroid 
cells than the other samples. Thus, some of the transcriptional changes described 
below might reflect this contamination. Using the threshold of 0.3 RPKM, 62.3% of 
the genes identified in Chapter 4 as having active promoters at E12.5 were 
designated as being expressed in E12.5 TEPCs, supporting the Chapter 4 analysis. 
On the other hand, 41% of the genes identified in Chapter 4 as being associated with 
putative active enhancers were expressed in E12.5 TEPCs, suggesting that 
identification of enhancer regions might suffer from a higher false positive rate.  
 
5.2.4.1 Enrichment analysis of differentially expressed genes 
The Gene Set Enrichment Analysis (GSEA) software allows interpretation of gene 
expression data by performing enrichment analysis using gene sets available from 
the MSigDB database (Subramanian et al. 2005; Mootha et al. 2003; Liberzon et al. 
2011). One of the key advantages of GSEA over similar methods is that it assesses 
the statistical significance associated with an observed enrichment by permuting the 
class labels, thus preserving gene-gene correlation important for biological processes 
and pathways. Secondly, the MSigDB database presents a comprehensive database 
of curated gene sets. On the other hand, a key limitation of enrichment analysis tools 
such as GSEA is that the ranking statistics used by such tools were selected for their 
effectiveness with DNA microarray data and their appropriateness for use with 
RNA-seq data has not been formally tested. Thus, instead of relying on GSEA’s 
intrinsic ranking statisitcs, it is recommended to generate a pre-ranked list of genes 
from RNA-seq data, based on one of the test statistics generated from differential 
analysis, for use with GSEA. Analysis of molecular function enriched at E12.5 vs 
E10.5 comparison showed that genes up-regulated in E12.5 TEPCs were enriched (p-
value < 0.05) for the GO terms “DNA Binding” and “transcription factor activity” at 
the 25% FDR (FDR cut-off as recommended by software developers) (Figure 5.5B). 
This suggests that E12.5 TEPCs are transcriptionally very different from E10.5 3PP 
cells, and that the expression of a large number of transcription factors is upregulated  
Figure 5.6: Enrichment of Molecular Functions GO terms for genes expressed differentially 
between E10.5 and E11.5.
Enrichment of Molecular Functions GO terms for genes significantly upregulated at E11.5 compared to 
E10.5. Terms were considered enriched if p-value <= 0.01 and q-value (FDR) <= 0.25. No enrichemnt 
was observed for genes upregulated at E10.5. Enrichment plots are shown for enriched terms. Also shown 
are the genes contributing towards the enrichment of "Transcription Factor Binding" term.
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during development from E10.5 to E12.5. On the other hand, compared to E12.5 
TEPCs, E10.5 3PP cells were enriched (p-value < 0.05) for genes annotated to the 
GO molecular function terms “Receptor Activity”, “Transmembrane Receptor 
Activity” and “Protein Kinase Activity” at 25% FDR, suggesting significant changes 
in cell-surface receptors and signalling pathways between these two cell 
developmental stages (Figure 5.5C). Similarly, differential analysis of E11.5 vs 
E10.5 comparison showed enrichment for genes with transporter activity molecular 
function (Figure 5.6). Interestingly, the genes up-regulated at E12.5 compared to 
E11.5 (i.e. E12.5 vs E11.5 comparison) were not enriched for transcription-
associated (or any other molecular function) terms (results from DAVID and GSEA).  
 
Given that Foxn1 expression in the thymic rudiment is initiated around E11.25, the 
transcription factors that are significantly up-regulated at E11.5 compared to E10.5 
could be important for Foxn1 expression. Analysis of genes significantly up-
regulated at E11.5 vs E10.5 comparison showed that fifty-one TFs were up-regulated 
at E11.5 (results from DAVID). Of these, eleven transcription factors were found to 
have physical binding sites in the Foxn1 promoter and enhancers regions identified 
in Chapter 4 (Table 5.1). These transcription factors are thus strong candidate 
regulators of fetal thymus development and of Foxn1 expression in TEPCs. 
However, the expression of four out of the eleven TFs, namely Gata3, Ebf1, Egr1, 
and Maf, was significantly down-regulated at E12.5 compared to E11.5 (Table 5.1), 
suggesting that these TFs are not required for the maintenance of Foxn1 expression 
and/or that their expression is repressed by FOXN1. These results for Gata3 are 
consistent with the FOXN1-mediated repression of Gata3 shown in Chapter 3. 
Furthermore, the expression of Maf and Ebf1 were also up-regulated in E12.5 nude 
TEPCs compared to WT TEPCs (Stephanie Tetelin, Blackburn lab, unpublished), 
consistent with their repression by FOXN1.  
 
Of the 51 TF genes up-regulated in E11.5 vs E10.5, only Nfatc2 showed increased 
expression at E12.5 compared to E11.5 and had physical binding sites (NFAT1) in 
Foxn1 promoter region identified in Chapter 4 (Table 5.1); although these were not 
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over-represented, further supporting it as potential transcriptional regulator of Foxn1 
in TEPCs. However, the expression profiles for Nfatc2 (Figure 5.7) also suggest that 
this gene could be a target of Foxn1. This is consistent with the absence of 
expression of Nfatc2 in E12.5 nude TEPCs (Stephanie Tetelin, Blackburn lab, 
unpublished). Thus, Nfatc2 appears to be downstream of Foxn1 in genetic network, 
rather than upstream. However, Nfatc2 mutant mice models would be required to 
determine whether is involved in regulating Foxn1 expression in TEPCs.  
 
Of note, the RPKM values for Nfatc2 were below the cut-off used above for 
determining whether a gene is expressed or not. However, the identification of 
differentially expressed genes using DESeq2 involves filtering out genes predicted to 
be not expressed, based on their raw read count (RC) values (Love et al. 2014). 
DESeq2 determines a dataset specific cut-off to determine the RC threshold and only 
returns Log2FoldChange (differential expression) for genes above this threshold 
(Love et al. 2014). Thus, it is likely that the RPKM cut-off of 0.3 could be too high 
for the dataset in this study, and that Nfatc2 is expressed at low levels in the samples 
analysed here.  
  
The gene Nfatc2 is a member of the nuclear factor of activated T cells (NFAT) 
family. It encodes a DNA-binding protein with a REL-homology region (RHR) and 
an NFAT-homology region (NHR). The hyperphosphorylated form of NFATC2 
protein is present in the cytosol and translocate to the nucleus upon 
dephosphorylation by phosphatase calcineurin. The NFAT family of proteins are 
important in many cellular processes, such as development and activation of 
lymphocytes, differentiation of cardiac muscle cells etc. (Crabtree & Olson 2002; 
Hogan et al. 2003). However, this transcription factor has not been previously 




Table 5.1: Summary of transcription factors significantly upregulated at E11.5 compared to E10.5
Shown are all the transcription factors whose expression is significantly upregulated in E11.5 cells 
compared to E10.5 cells. Also indicated is whether these transcription factors have binding sites within 
the Foxn1 promoter or enhancers identified in Chapter 4 and whether they are differentially expressed 
between E11.5 and E12.5.
Geometric mean 
of RPKM values Developmental stage
Figure 5.7: Expression of Nfatc2 and Stat4 in E10.5 and E11.5 third pharyngeal pouch endoderm 
cells and E12.5 thymic epithelial prgoenitor cells.
Shown are geometric mean of RPKM values for all biological replicates at each developmental time point 
analysed for Nfatc2 (A) and Stat4 (B).
A B
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5.2.4.2 Identification of co-regulation of differentially expressed 
genes 
Genes involved in a genetic network are often co-regulated by one or more 
transcription factors. Such transcription factors regulating the expression of a set of 
genes can be identified by enrichment analysis of TFBSs within the promoter regions 
of a set of genes. In order to determine whether the genes that are differentially 
expressed between E11.5 and E10.5 might be co-regulated, I analysed the 
enrichment of TFBSs present in the promoter regions of these genes using GSEA. 
This analysis revealed a significant enrichment in genes that are up-regulated at 
E11.5 for binding motifs corresponding to NFATC2 (p – value = 0.002; q-value = 
0.248) and STAT4 (p-value = 0.008; q-value = 0.117) at a FDR ≤ 25%. As 
mentioned above, the Nuclear factor of activated T cells, cytoplasmic, calcineurin 
dependent 2 (Nfatc2) gene, which encodes the NFATC2 protein, is itself 
significantly up-regulated at E11.5 and also has putative binding sites within the 
Foxn1 promoter (Table 5.1). A closer analysis of the above results showed that sixty-
six genes significantly up-regulated at E11.5 compared to E10.5 contributed to the 
enrichment of NFATC2 motif (Table 5.2), suggesting that the up-regulation of these 
genes could result from increased NFATC2 activity. Thus, this transcription factor is 
likely to be important for thymus development.  
 
In the above analysis, fifteen genes contributed to the enrichment of STAT4 motif 
(Table 5.2). The TFBS analysis in Chapter 4 showed that the identified Foxn1 
promoter and enhancers did not contain any STAT4 binding sites. The Janus Kinase-
Signal Transducers and Activators of Transcription (JAK-STAT) pathways play 
critical roles in the immune, neuronal, hematopoietic and hepatic systems.  The 
STAT family of transcription factors are phosphorylated by the receptor-associated 
kinases in response to cytokines and growth factors. Phosphorylated STAT proteins 
then form homo- or heterodimers that translocate to the cell nucleus to regulate their 
target genes. Stat4 was significantly up-regulated in E12.5 TEPCs compared to both 
E10.5 and E11.5 3PP cells and was also up-regulated at E11.5 compared to E10.5, 
although this up-regulation was not statistically significant (p-value = 0.015; padj 
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(FDR) = 0.21). The expression profile for Stat4 is shown in Figure 5.7. Similar to 
Nfatc2, the expression of Stat4 was absent in E12.5 nude TEPCs (Stephanie Tetelin, 
Blackburn lab, unpublished), suggesting Stat4 as a target of Foxn1.  
 
Finally, analysis of genes expressed differentially between E12.5 and E11.5 or E10.5 
showed that genes down-regulated at E12.5 were enriched for binding motifs for a 
number of different transcription factors. These TFs include: LEF1, E12, FOXO4, 
FOXO1, MAZ, FOXC1, FOXF2, NFAT1, TST1, MYOD, STAT5A (for E12.5 vs 
E11.5); and LEF1, HNF1, AP3, TAL1, E12, CEBPGAMMA, SOX9, ZID, FOXD1, 
FOXO4 (for E12.5 vs E10.5). Given the enrichment of the NFAT1 motif in the genes 
down-regulated at E12.5 compared to E11.5, it was important to determine whether 
there was an overlap between these genes and the genes contributing to NFAT1 
motif enrichment in E11.5 vs E10.5 analysis described above, in order to determine 
whether genes with an NFAT1 motif are transiently up-regulated at E11.5. There 
were sixty-four genes significantly down-regulated at E12.5 compared to E11.5 that 
contributed to the enrichment for the NFAT1 motif. Of these, only eight genes were 
shared between the two lists: Esr1, Il1rapl1, Spag6, Flrt3, Fst, Gata3, Esrrg, and 
Khdrbs2. The absence of a significant overlap between these two sets of genes with 
NFAT1 motif suggested that NFAT1 may be involved in activating or suppressing 
the expression of different sets of genes during thymus development.  
 
The enrichment of LEF1 and E12/TCF3 motifs in genes down-regulated at E12.5 
compared to both E11.5 and E10.5 suggests that there is a dynamic regulation of the 
Wnt signalling pathway during these stages. Among the Wnt ligands, Wnt4 was 
expressed in E12.5 TEPCs (geometric mean of RPKM = 2) and in E11.5 3PP cells 
(geometric mean of RPKM = 0.7), but not in E10.5 3PP cells (geometric mean of 
RPKM = 0.1). No other Wnt ligands were expressed at any of the time points 
analysed. The expression of Fzd1 decreased from E10.5 (geometric mean of RPKM 
= 12) to E12.5 (geometric mean of RPKM = 5), with a spike at E11.5 (geometric 
mean of RPKM = 23). On the other hand, Fzd3 was not expressed at any stage and 
the expression of Fzd4 was detectable at E10.5 (geometric mean of RPKM = 2) but 
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not at E11.5 or E12.5. Finally, the expression of Gsk3b increased from E10.5 
(geometric mean of RPKM = 4.5) to E11.5 (geometric mean of RPKM = 9.7) and 
remained unchanged between E11.5 and E12.5 (geometric mean of RPKM = 8.65). 
The increase in Gsk3b expression after E10.5 suggests that the activity of Wnt 
signalling pathway is downregulated after E10.5. Thus, E11.5 3PP cells and E12.5 
TEPCs appear to be less able to respond to Wnt signalling compared to E10.5 3PP 
cells. 
 
The above analyses of differentially expressed genes revealed important insights into 
transcriptional changes associated with development of E10.5 3PP cells to E12.5 
TEPCs. The TFs whose expression is significantly up-regulated at E11.5 compared 
to E10.5, hence strong candidate regulators of Foxn1, were identified. The above 
results suggest an important role of Nfatc2 in thymus development, evidenced by the 
enrichment of its binding motif in the promoters of genes regulated differentially 
between the analysed time points. An important limitation of the above analyses is 
the quality of PWMs for the TFs being analysed. This is likely to affect the 
enrichment for TFs such as FOXN1 and PAX1, which lack a good quality PWM but 
are known to be important for thymus development.  
 
5.2.5 Identification of differentially regulated signalling pathways 
To determine additional functional and mechanistic differences in 3PP cells and 
TEPCs isolated from various developmental time points, the list of differentially 
expressed genes obtained from DESeq2 was used as input data for Generally 
Applicable Gene-set Enrichment analysis (GAGE) (Luo et al. 2009) and  Gene Set 
Enrichment Analysis (GSEA) (Subramanian et al. 2005; Mootha et al. 2003). 
Pathway enrichment was carried out against Kegg pathways using these two 
software tools. An advantage of the GAGE package is its integration with the RNA-
seq data analysis pipeline, as it can take the results object generated using DESeq 
function as input data. Furthermore, unlike other methods, GAGE allows 
identification of gene sets whose genes show differential expression in both 
directions (i.e. gene could either be up- or down-regulated), which is frequently the  
Figure 5.8: Enrichment of signalling pathway at E11.5 compared to E10.5
Analysis of signalling pathway enrichment showed enrichmnet of MAPK signalling at E11.5 compared to 
E10.5. Terms were considered enriched if p-value <= 0.01 and q-value (FDR) <= 0.25. Shown are p-
value, q-value, enrichment plot, and genes contributing towards enrichment of this pathway.
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case for canonical signalling pathways. On the other hand, GSEA has been used 
extensively for analysing gene set enrichments from gene expression and its 
“Preranked workflow” allows its use in RNA-seq data analysis. This workflow takes 
a list of genes and associated numerical values (such as fold change, p-value, etc.) as 
an input and sorts the genes based on the values in the numerical column for 
enrichment analysis. 
 
GSEA or GAGE analysis of genes differentially expressed at E12.5 vs E11.5 did not 
identify any signalling pathways enriched at FDR ≤10% for GAGE and FDR ≤25% 
for GSEA. Similarly, GAGE analysis of genes expressed differentially between 
E11.5 and E10.5 did not identify any significantly enriched pathway at FDR ≤10%. 
On the other hand, the GSEA analysis of these genes showed that they are enriched 
for genes involved in MAPK signalling pathway (p-value = 0.024; q-value = 0.026). 
Figure 5.8 shows the enrichment plot and the differentially expressed genes involved 
in this pathway. There appears to be an increase in the activity of MAPK signalling 
at E11.5 compared to E10.5.  
 
GSEA identified three pathways that were enriched at E10.5 versus E12.5 at a 25% 
FDR: the “Axon Guidance” (p-value = 0.01; q-value = 0.053), “Focal Adhesion” (p-
value = 0.013; q-value = 0.069), and “Regulation of Actin Cytoskeleton” (p-value = 
0.046; q-value = 0.112) pathways. The enrichment values and plots for these 
pathways are shown in Figure 5.9. The importance of these pathways in thymus 
development is yet to be determined.  
 
On the other hand, GAGE analysis of the E12.5 vs E10.5 data showed significant 
enrichment for “mmu04064 NF-Kappa B Signalling Pathway” (p-value=0.0003 and 
q-value=0.071) at a FDR ≤10%. The enrichment of NFκB signalling in E12.5 TEPCs 
is consistent with the enrichment for this pathway observed in Chapter 4 (section 
4.6.1). Enriched pathways identified using the GAGE package can be visualized 
using a pathway data visualization package called pathview (Luo & Brouwer 2013). 
Pathview allows integration of user data onto the relevant pathway and supports  
Figure 5.9: Enrichment of signalling pathways at E10.5 compared to E12.5
Analysis of signalling pathway enrichment showed enrichment of Focal Adhesion, Axon Guidance, and 
Regulatin of Actin Cytoskeleton at E10.5 compared to E12.5. Terms were considered enriched if p-value 
<= 0.01 and q-value (FDR) <= 0.25. Shown are p-values, q-values and enrichment plots for enriched 
pathways.
Figure 5.10: Kegg view of NF-kB pathway enrichment at E12.5 compared to E10.5
GAGE algorithm was used to analyse pathway enrichment between E12.5 and E10.5. GAGE determines 
pathway enrichment using fold differences for all genes. Genes contributing towards the observed 
enriched are shown in the Kegg graph with either green, red, or grey colour. Genes with higher 
expression in E12.5 TEPCs are shown in red and those with higher expression in E10.5 are shown in 
green. The colour intensities correspond to differences in expression between E10.5 and E12.5. 
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visualization of the rendered pathway graphs with mapped data. Figure 5.10 show 
the differential gene expression data rendered onto the Kegg view of the NFκB 
signalling pathway. As evident from this graph, the expression of a number of genes 
involved in this pathway changes between E10.5 and E12.5. The genes highlighted 
in red are more highly expressed in E12.5 TEPCs, while those highlighted in green 
are expressed more highly in E10.5 3PP cells. Based on this, the pathway seemed to 
be more active in E12.5 TEPCs compared to E10.5 3PP cells.  
 
The rendered Kegg pathways provide a visual overview of the changes in expression 
of all the genes involved in the pathway. However, it is important to note that the 
GAGE analysis performed here only utilizes log2FoldChange and does not account 
for p-value or FDR. Thus, while the colour codes (red and green) represent the 
general direction of difference in expression between two samples, they do not 
necessarily represent statistically significant differences in gene expression. An 
advantage of rendering the data onto Kegg pathways is that the resulting pathway 
view retains pathway meta-data such as protein interactions, spatial information for 
proteins within a cell, and interactions with other signalling pathways. This is evident 
from the various interactions between NFκB and other signalling pathways shown in 
Figure 5.10. This figure suggests that there is an up-regulation at E12.5 compared to 
E10.5 of genes involved in cell survival (such as Birc3, Gadd45b, Traf1, and Traf2), 
non-canonical NfκB pathways (such as p100/Nfkb2), feedback mechanisms (such as 
A20/Tnfaip3 and Nfkbia/IκBα) and lymphocyte attraction and activation (such as 
Cxcl12/Sdf1, Cxcl2/Mip2, Vcam1, Baff, Icam1, and Cox2/Ptgs2). Of these, Nfkb2 
(log2FoldChange = 2.7), Cxcl12 (log2FoldChange = 1.5), Vcam1 (log2FoldChange = 
3.87), Icam1 (log2FoldChange = 2.88), Nfkbia (log2FoldChange = 2.98), and Ptgs2 
(log2FoldChange = 3.88) were significantly up-regulated at E12.5 compared to 
E10.5 at FDR ≤ 10%. Thus, activation of NFκB signalling in E12.5 TEPCs causes 
significant up-regulation of negative feedback gene (Nfkbia) and genes promoting 
the non-canonical pathway (p100), suggesting that similar to observations in other 
cell types, the canonical NFκB signalling pathway might oscillate between active and 
inactive state in developing TECs. The remaining genes too were up-regulated, 
however, their fold increase was not significant at FDR ≤ 10%. The log2FoldChange 
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in the expression of these genes was as follows: Birc3 (1.5), Gadd45b (0.44), Traf1 
(0.31), Traf2 (0.75), Cxcl2 (0.53), Baff/Tnfsf13b (1.45), Tnfaip3/A20 (0.45).  
 
A number of signalling pathways converging on NFκB activation have been shown 
to be important in mTEC development, particularly those involving the tumour 
necrosis factor family of receptors (Rossi et al. 2007; Akiyama et al. 2008; Hikosaka 
et al. 2008). A closer analysis of the receptor involved in activation of the NFκB 
pathway, as shown in Figure 5.10, showed significantly up-regulated expression (at 
FDR ≤ 10%) of the Interleukin 1 receptor 1 (Il1r1; log2FoldChange = 4.67) and Toll 
like receptor 4 (Tlr4; log2FoldChange = 2.53) genes at E12.5 compared to E10.5. 
However, the reduction (although statistically insignificant) in expression of Lbp and 
Md2 (Figure 5.10) at E12.5 compared to E10.5, suggests that IL1R1 is the major 
activator of NFκB signalling in these cells. While activation of the NFκB signalling 
pathway in E12.5 TEPCs appears to be mediated through activation of one or both of 
these two receptors, its importance and function in TEPCs remains unknown. These 
pathway analyses suggest that there is increased activation of NFκB in E12.5 TEPCs 
as compared to E10.5 3PP cells and thus that this pathway is likely to be involved in 
subsequent thymus development. Of note is that analyses in Chapter 4 identified 
several binding sites for the p65/RELA protein, which is involved in NFκB 
signalling, within the Foxn1 promoter and putative enhancers identified in that 
chapter. Thus, the role of NFκB signalling in thymus development warrants further 
investigation.   
Figure 5.11: Analysis of transcription factor activities using RNA-seq. 
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(A) Top four transcription factor motifs with highest Z-score in ISMARA results. 
The Z-score is a representation of significance of a motif’s activity. Higher score 
indicate more significance. Also shown are transcription factors associated with the 
respective motifs, the motif activity profile (left to right: E10.5 to E12.5), and the 
matrix logo representing the position weight matrix. (B) Line graph demonstrating 
motif activity, for motifs with increasing activity from E10.5 to E12.5, in the 
analysed samples. Order of samples on X-axis: (left to right) E10.5 rep1, E10.5 rep3, 
E11.5 rep1, E11.5 rep2, E11.5 rep3, E12.5 rep1, E12.5 rep2, and E12.5 rep3. Top 





5.2.5.1 Identification of transcription factor networks in TEPCs 
To identify networks of transcription factors important in TEPCs, I further analysed 
the RNA-seq data using the Integrated System for Motif Activity Response Analysis 
(ISMARA) tool, which models gene expression in terms of genome-wide predictions 
of regulatory sites to make detailed predictions regarding the roles of key TFs and 
direct interactions between regulators (Balwierz et al. 2014). ISMARA takes mapped 
reads as an input and then quantifies the activity of promoters in each sample 
(defined in ISMARA as 1000bp region centred on TSS) by determining the 
logarithm of the estimated number of transcripts per million transcripts (similar to 
RPKM). Direct regulatory interaction between motifs is predicted between two 
motifs when one of the motifs is predicted to target the promoter of at least one of 
the TFs associated with the second motif (Balwierz et al. 2014). ISMARA provides 
these predictions as a local network picture for individual motifs that show all 
predicted regulatory connections with other motifs (Balwierz et al. 2014).  
 
Analyses of the RNA-seq data generated in this chapter using ISMARA identified 
motifs for IRF and NFKB/REL TFs as the two most significant motifs (Figure 
5.11A; Z-score represents the importance of the motif for explaining expression 
variation across the sample). This analysis predicted an increase in the activity of 
NFKB motif at E12.5 compared to E10.5 and E11.5 (Figure 5.11B), consistent with 
the enrichment of the NFκB signalling pathway described above. Similarly, the IRF 
motif activity was also predicted to increase from E10.5 to E12.5 (Figure 5.11B). 
ISMARA also determines correlation coefficients between the expression of the TFs 
associated with a motif and its predicted activity (activity is based on the changes in 
expression of a motif’s predicted target genes). The expression of all three genes 
associated with the IRF motif, Irf1, Irf2 and Irf7, showed significant correlation with 
its predicted activity (Figure 5.12A; Figure 5.12B-D). On the other hand, the genes 
Rela and Nfkb1, but not Rel, showed significant correlation between their expression 
and the activity of the NFKB motif (Figure 5.12A; Figure 5.12E-F). 
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Finally, ISMARA provides a graphical view of predicted direct regulatory 
interactions between motifs, i.e. transcription factors network. Thus, I investigated 
the regulatory interactions of significant motifs (score threshold of 0.9) to identify 
TF networks involving the genes associated with these motifs. The predicted 
regulatory interaction for NFKB motif suggested Irf1 and Nfatc2 as targets of TFs 
associated with NFKB motif (Figure 5.13A). Such interaction between NFκB 
signalling and Irf1 gene has been demonstrated previously in other cell type (Harada 
et al. 1994). Furthermore, the transcription of Nfatc2 in TEPCs appears to be under 
the control of NFκB signalling. Similarly, the predicted regulatory interactions for 
IRF motif suggested Arid5b, Stat1, and Nfkb1 as direct targets of the TFs associated 
with this motif (Figure 5.13B). Furthermore, both NFKB and IRF motifs showed 
positive feedback on the expression of associated TFs: Nfkb1 and Rel in the case of 
NFKB motif and Irf7 in case of IRF motif.  
 
Another significant motif identified from the above analysis was a HOX motif 
(Figure 5.11A). However, the activity of the Hox motif showed an opposite profile 
compare to that for the IRF and NFKB motifs, i.e. the predicted activity of HOX 
motif decreased from E10.5 to E12.5. Among the Hox genes associated this motif, 
the expression of only Hoxa7 showed a significant (anti)correlation with the motif 
activity (i.e. expression of its predicated target genes) (Correlation Coefficient: -0.74; 
p-value = 3.4E-02). These results suggested that the expression of HOX motif target 
genes decreased from E10.5 to E12.5 and that this decrease was at least partly a 
result of increased expression of Hoxa7, which acts a repressor for the HOX motif 
target genes. The predicted network interaction for the HOX motif suggested that the 
TFs associated with this motif could act as transcriptional regulators of Nr2f2, 
Tcfap2, Sox2, Sox5, Msx2, Hoxb5, Hoxa5, Nhlh2, Tcfap2b, and Prrx1 (Figure 
5.13C).  
 
The above results therefore suggest that the development of the thymic primordium 
from E10.5 to E12.5 is accompanied by a reduction in the activity of a TF network 
regulated by HOXA7 and an increase in activity of TF networks regulated by Irf and 
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NFKB. The ISMARA analysis did not predict an interaction between the IRF/NFKB 
and HOX motifs, thus the prevalence of potential crosstalk between the TF networks 
involving these motifs remains to be determined. It is important to note that these 
predicted regulatory interaction networks were generated using an arbitrary threshold 
for significance values associated with individual interactions and changing this 
threshold leads to increase or decrease in the number of predicted interactions.  
 
5.3 Discussion 
The RNA-seq data described in this chapter provide an opportunity to study 
transcriptional changes associated with developing and differentiating TEPCs. 
Indeed, comparison of the transcriptomes of 3PP cells and TEPCs isolated from 
E10.5, E11.5, and E12.5 identified thousands of differentially expressed genes. An 
important caveat in the present study is the presence of parathyroid cells in the 
collected samples. The thymus and parathyroid are generated from a common 
primordium arising from 3PP and only begin to separate around E12.0. This common 
primordium expresses Plet1 (Depreter et al. 2007), which was used for sorting cells 
for RNA-seq. Thus, the sorted cells also contain some proportion of parathyroid 
cells, although this proportion is likely to be small as the thymus fated domain of 
3PP is larger than the parathyroid fated domain. However, it is not possible to 
confidently determine the contribution of parathyroid cells to the gene expression  
 
Figure 5.12: Analysis of contribution of transcription factors to motif activity. 
 
See following page 
 
(A) Pearson correlation coefficient representing the correlation between motif 
activity and the gene expression of associated transcription factors. Positive 
correlation coefficient indicates an increase in gene expression for a transcription 
factor with an increase in motif activity. The p-values represent the significance of 
the observed correlation. (B), (C), (D), (E), and (F) Correlation graphs showing 
transcription factor gene expression on Y-axis and motif activity in X-axis for (B) 
Irf1, (C) Irf2, (D) Irf7, (E) Nfkb1, and (F) Rela. Graph for Rel is not shown as its 
expression is not significantly correlated to motif activity. 
 










Figure 5.13: Predicting transcription factor network from RNA-seq. 
Transcription factors network diagram showing predicted interactions between transcription factors. 
Interactions are predicted based on the presence of binding sites for transcription factor associated with 
one motif within the promoters of genes associated with another motif. Shown here are networks centered 
on NFKB1_REL_RELA (A), IRF1,2,7 (B), and HOX{A6,A7,B6,B7} (C) motifs. Only interactions with 
a Z-score of at least 0.9 are shown here. The colour intensities are representative of Z-score, higher 
intensity representing higher Z-score. Regulation by central motif are shown in shades of red, while 
regulation of central motif by other motifs is shown in blue. Interactions between motifs not involving 
central motifs are also shown.
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changes observed here. Interestingly, no clear relationship between genes that are in 
the vicinity of an active enhancer region and genes showing a change in expression 
during development was observed upon comparison of these two sets. This could be 
due to a less than optimal filtering of genes with no changes in expression, this set 
contains more than 15,000 genes, and/or a high false discovery rate for active 
enhancers identified in Chapter 4.  
 
The results from this Chapter are summarized in Figure 5.14. The results shown in 
Figure 5.4 show that clustering of genes sharing similar expression profiles 
distinguishes between the three different developmental stages analysed, E10.5, 
E11.5 and E12.5. The enrichment of genes associated with thymocyte development 
at E12.5 suggests that even though Foxn1 expression is initiated at E11.25, the TEC 
differentiation programme is only initiated at around E12.5. This is consistent with 
the developmental arrest of nude thymic rudiment at E12.5 and with data from 
Nowell and colleagues (Nowell et al. 2011). This result also suggests that the genes 
present in Cluster 1 (and other genes with similar expression pattern) could be 
important for TEPC differentiation and might represent FOXN1 target genes or 
genes that act together with FOXN1 to promote TEPC differentiation. The genes in 
Cluster 2 show expression profiles similar to that of Foxn1. This profile is consistent 
with that expected of Foxn1 transcriptional regulators (in the absence of feedback 
loops) or early FOXN1 targets. Cluster 3 represents genes that are transiently up-
regulated at E11.5. A pulse of BMP signalling has been shown to be important for 
initiation of Foxn1 expression (Neves et al. 2012), whether a similar requirement 
exists for Cluster 3 genes remains to be tested. It is important to note, however, that 
the E11.5 samples showed the highest expression of Pth (and Gcm2) and this gene is 
indeed present in Cluster 3. Thus it is possible that some of the genes in Cluster 3 are 
required for parathyroid development and shows a subsequent down-regulation at 
E12.5 due to presence of fewer parathyroid cells in these samples. Finally, the genes 
in Cluster 4 are enriched for cell fate specification and organ development terms, 
among others, and are thus likely to represent genes important for formation of 3PP 
and its subsequent commitment to thymus and parathyroid fates. However, further 
studies are required to understand the roles of these genes. There is also a possibility  
Figure 5.14: Summary of Chapter 5 results. 
Summary of all the results obtained from comparison of E10.5 and E11.5 3PP cells and E12.5 TEPCs 
transcriptomes. Shown are the changes observed in gene expression, molecular functions, biological 
processes, signalling pathways, and transcription factor network during thymus developement. 
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of these genes acting as transcriptional repressors of genes involved in Cluster 2 (or 
vice versa), although this hypothesis can not be tested using the present data. 
 
The expression of Msx2, shown to be required for normal Foxn1 expression in hair 
follicle (Cai et al. 2009), was down-regulated from E10.5 to E12.5, suggesting that it 
is not required for Foxn1 expression in the thymus. Analysis of differentially 
expressed genes revealed several interesting patterns in the data. Firstly, compared to 
E10.5, both E11.5 and E12.5 have a significantly higher number of transcription 
factor encoding genes up-regulated. Thus, the TEPC transcriptional programme 
appears to be added onto that of E10.5 3PP cells. Therefore, analysis of E9.5 3PP 
cells would be useful in determining whether an endoderm transcriptional 
programme is down-regulated between E9.5 and E10.5. As discussed above, due to 
the presence of PT cells in the E11.5 samples, some of the genes could be up-
regulated in parathyroid cells as opposed to TEPCs. However, such genes would be 
expected to be significantly down-regulated between the E11.5 and E12.5 as the 
samples from the later time point should contain far fewer parathyroid cells. Among 
the 51 transcription factor genes up-regulated at E11.5 compared to E10.5, only 8 
were significantly downregulated at E12.5: Gata3, Ebf1, Esr1, Esrrg, Nr4a2, Cphx, 
Maf, and Mafb. As discussed above, the expression of Gata3 appears to be repressed 
in TEPCs by FOXN1. Thus, enrichment of biological processes related to 
transcription of the genes up-regulated in E11.5 vs E10.5 comparison seems to 
represent changes occurring in developing TEPCs. These 51 transcription factors are 
therefore candidate transcriptional regulators of Foxn1. Combining these results with 
the TFBS analysis in Chapter 4 showed that 11 of the 51 TFs have physical binding 
sites present in identified Foxn1 promoter and/or enhancers. Transcription factors 
such as Pax1 and Pax9, which are likely to be involved in regulation of Foxn1 
expression (unpublished data), were also significantly up-regulated at E11.5 but 
TFBS analysis did not identify any binding sites within the regulatory elements of 
Foxn1. This could either be due to poor quality of the PWM or these factors could 
bind to regions outside the putative regulatory elements identified in Chapter 4. 
Amongst the transcription factors identified, NFATC2 and STAT4 are of particular 
interest as the genes up-regulated at E11.5 are enriched for genes with binding sites 
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for these factors in their promoters. NFATC2 is significantly enriched at E11.5, 
whereas STAT4 is up-regulated by 3.4 fold but is not significant at FDR ≤10% (padj 
= 0.2). Thus, the role of these two transcription factors should be tested in more 
detail. NFATC2 also has binding sites within the identified Foxn1 regulatory regions 
raising the possibility that NFATC2 might be involved in regulating Foxn1 in TEC.  
 
The enrichment analysis also identified pathways enriched at the three different 
developmental stages under study. Interestingly, the E11.5 samples showed up-
regulation of MAPK signalling pathway compared to E10.5, suggesting that this 
pathway might be important for transcriptional changes seen at E11.5. MAPK 
signalling plays a role in various cellular processes, including proliferation and 
differentiation, which are both expected of developing thymic rudiment. Thus, this 
pathway or some of its members are likely to also be involved in proliferation and/or 
differentiation of the developing thymic rudiment.  
 
The enrichment of NFκB signalling pathway at E12.5 compared to E10.5 suggests 
that this pathway plays an important role in TEC development. Various signalling 
pathways influence the activation of NFκB pathway (Figure 5.10) and the results 
described above suggests its activation is mediated mostly through the binding of 
IL1β to its receptor. Also, while NFκB is known to be important for mTEC 
development, its role in TEPC differentiation, if any, remains unexplored. The 
results from ISMARA suggested that Nfkb1, Rela, Irf1, Irf2, and Irf7 play important 
roles in E12.5 TEPCs. Furthermore, I showed that the NFκB signalling effector TFs 
are a part of a transcriptional network involving IRF, STAT, and NFAT TFs, which 
is likely to be important for TEPC development (Figure 5.14). Finally, I showed that 
there is a shift from a TF network involving early developmental genes such as Hox 
and Sox genes to a network involving Nfkb and Irf genes (Figure 5.14). Thus, the 
gene expression changes observed in the RNA-seq data identify genes, processes, 
and pathways characteristic of each analysed developmental stage and shed new light 
on the molecular insights of TEPC generation and differentiation. 
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6. The Role of Smad and TGFβ proteins in regulation of 
Foxn1 transcription 
6.1 Introduction 
The discovery that induced over-expression of Foxn1 in an aged-involuted thymus 
can lead to regeneration makes this gene an important target for therapeutic 
interventions (Bredenkamp, Nowell, et al. 2014). One way to modulate Foxn1 
transcription in TECs would be to target its upstream transcriptional regulators; 
inhibiting the activity of its transcriptional repressor and/or increasing the activity of 
its transcriptional activator. However, a lack of understanding of the transcriptional 
regulation of Foxn1 in TECs is currently a limiting factor for this approach. An 
alternate approach to modulating Foxn1 expression levels is to stimulate or inhibit 
signalling pathways that influence the level of Foxn1 transcription. An important 
advantage of the later approach is that drug molecules capable of inhibiting or 
activating most of the signalling pathways have already been developed and tested 
extensively. Therefore, I decided to also focus on identification of signalling 
pathways that modulate the expression of Foxn1.  
 
The TGFβ signalling pathway is important for development, aging, and even cancer 
(Massagué 2012). The effects of activation of TGFβ pathway are highly cell-type 
and condition specific. The activation of this pathway has been shown to inhibit 
proliferation but also to promote cell growth; to enhance pluripotency but also to 
promote differentiation; to regulate tissue specific transcription factors; and to 
suppress pre-malignant cells but also to encourage metastasis (Massagué 2012). 
Furthermore, TGFβ signalling can have either positive or negative effects on 
transcription of particular genes depending on the target gene and cell type.  
 
There are a large number of TGFβ family proteins, which can broadly be divided 
into two ligand subfamilies, the TGFβ-activin-Nodal and BMP subfamilies. The 
TGFβ subfamily consists of three ligands, TGFβ1, TGFβ2, and TGFβ3 and two 
receptors TGFβRI and TGFβRII. The binding of the ligand assembles a receptor 
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complex consisting of two TGFβRI and two TGFβRII receptor proteins, following 
which the type-II receptors (TGFβRII) phosphorylate the type-I (TGFβRI) 
components. Phosphorylated (activated) type-I receptors subsequently bind to the 
SMAD proteins, SMAD2 and SMAD3, to phosphorylate and activate them. SMAD2 
and SMAD3 are also called R-SMADs (receptor-regulated SMADs) due to their 
interaction with TGFβ receptors (Massagué 2012). Following activation, two 
molecules of phosphorylated R-SMAD proteins form trimers with one molecule of 
SMAD4 (co-SMAD) to form functional units, which are subsequently transported in 
to the nucleus (Massagué 2012). These activated functional units, and SMAD3 by 
itself, can bind other transcription factors in the nucleus and are subsequently 
directed to target genes for transcriptional regulation (Mullen et al. 2011). Various 
mechanisms exist that target the activated SMAD complexes to promote degradation. 
Furthermore, activation of TGFβ signalling pathway induces the transcription of 
Smad7, which provides negative feedback regulation to TGFβ signalling. Finally, the 
TGFβ signalling pathway also interacts with MAPK and PI3K pathways to mediate 
SMAD-independent effects.  
 
The presence of the pathway terms “TGF-beta signalling pathway”, “TGF-beta 
receptor signalling”, “BMP receptor signalling”, and the GO Molecular Function 
terms “transforming factor beta receptor binding”, and “SMAD binding” in the 
analysis of ChIP-seq data shown in Chapter 4 suggested that the TGF-beta and BMP 
signalling pathways may be important regulators of TECs. Furthermore, Chapter 1 
describes the importance of TGFβ and BMP-signalling pathways in the thymus. The 
slower rate of thymic involution in TGFβ receptor mutant mice suggests a possible 
interaction between TGFβ signalling and Foxn1. Given the important role of Foxn1 
in thymic involution and regeneration, it was desirable to determine whether TGFβ 
signalling mediates its effect through regulation of Foxn1 expression in TECs. The 
identification of SMAD4 binding sites in Foxn1 promoter, described in Chapter 4, 
suggested that TGFβ could indeed regulate Foxn1 expression in TECs. I therefore set 




6.2 Expression of TGFβ signalling pathway genes during 
thymus development 
Some of the key genes involved in TGFβ signalling pathway are the three TGFβ 
ligands (Tgfb1, Tgfb2, and Tgfb3), the two receptors (TgfbrI and TgfbrII), and the 
genes encoding for the downstream effector SMAD proteins (Smad2, Smad3, Smad4, 
and Smad7). The RNA-seq data indicated extremely low-level expression of most of 
these genes in 3PP cells and TEPCs. The expression pattern of these genes was 
further determined by qPCR. All three TGFβ ligands were expressed in TEPC from 
as early as E9.5 (Figure 6.1A-C). Tgfb2 was the highest expressed ligand, with its 
expression being several hundred folds higher than Tgfb1 and Tgfb3. The expression 
of Tgfb1 was significantly up-regulated from E12.0 suggesting that this ligand may 
play an important role in thymus development after E12.0. Finally, Tgfb3 was 
consistently expressed at much lower levels than the other two ligands. Tgfbr2 
showed an expression pattern similar to Tgfb1, with its expression being up-regulated 
at E12.0 (Figure 6.1D). The expression of Tgfbr1 increased from E9.5 to E11.0 after 
which its expression changed every 12 hours (Figure 6.1E). However, the expression 
level of all the TGFβ ligands and receptors, except Tgfb2, was low or extremely low 
(as demonstrated by the scale of Y-axis showing relative expression levels). 
Interestingly, using RPKM cut-off of 0.3 for the RNA-seq data in Chapter 5 showed 
an absence of expression for all TGFβ ligands, expect Tgfb2 at E11.5 and receptors, 
except Tgfbr1. This discrepancy suggests that the RPKM cut-off of 0.3 might be too 
strict for the RNA-seq data. However, biological replicates for the qPCR based gene  
 
Figure 6.1: Analysis of Tgfb1, Tgfb2, Tgfb3, Tgfbr2, Tgfbr1, Smad2, Smad3, 
Smad4, and Smad7 expression profiles during normal thymus organogenesis. 
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Relative expression levels in 3PP and TEP cells were determined by QRT-PCR. 
Graphs show the expression profiles in WT thymus for (A) Tgfb1, (B) Tgfb2, (C) 
Tgfb3, (D) Tgfbr2, (E) Tgbr1, (F) Smad2, (G) Smad3, (H) Smad4, and (I) Smad7. 
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expression data shown in this Chapter (n=1 for data in Figure 6.1) are required to 
determine the variability of these results, which will allow a more robust comparison 
with the RNA-seq data. 
 
The downstream SMAD effector proteins are expressed at all time points and their 
expression showed a spike at E12.0 (Figure 6.1F-H). The negative regulator of TGFβ 
signalling, Smad7, was found to be expressed throughout all the time points analysed 
and its expression increased from E9.5 to E10.5 after which it showed minor 
variations in expression (Figure 6.1I). The expression pattern of Smad7 was similar 
to that of Tgfbr1. The presence of Smad7 expression suggests that TGFβ signalling is 
active in TEPCs during development, possibly due to autocrine and/or paracrine 
signalling by the secreted ligands. 
 
6.3 Increased TGFβ signalling suppresses Foxn1 expression 
in in-vitro culture of E12.5 thymic cells 
The above data, together with inferences from the literature and the identification of 
SMAD binding sites in the Foxn1 promoter shown in Chapter 4, suggested that 
TGFβ signalling might directly affect Foxn1 expression. To test this, I elected to use 
short term culture of E12.5 thymic cells. Thus, E12.5 thymi were isolated by 
microdissection. The dissected thymi were dissociated to form a single cell 
suspension and were plated on to a thin layer of ECM in N2B27 medium (Figure 
6.2A). The cells were then cultured for 72 hours in presence or absence of TGFβ1 or 
A8301, a TGFβRI kinase inhibitor, following which EpCAM+ TEPCs were sorted 
for RT-qPCR analysis.  
 
The cells cultured in the presence of 10µg TGFβ1 showed a significant reduction in 
Foxn1 expression (p-value = 0.008), which was rescued in the presence of 500nM of 
the TGFβ inhibitor A8301 (p-value for difference from N2B27 = 0.19)  (Figure 
6.2B). This suggested that TGFβ signalling negatively regulates the expression of 
Foxn1 in TEPCs, at least in in-vitro cultures. The expression of Smad7 was up-
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regulated in the presence of TGFβ1 but not in its absence or in the presence of 
A8301 (Figure 6.2C). The reduction in Foxn1 expression was also associated with 
reduction in functional FOXN1 protein, as inferred by the reduction in the expression 
of Dll4 (p-value = 0.002) (Figure 6.2D). Pax1 also showed similarly decreased 
expression in the presence of TGFβ (p-value = 0.02) (Figure 6.2E). This is consistent 
with the high correlation between expression of Pax1 and Foxn1 described in 
previous chapters and further supports the hypothesis that these two genes are a part 
of the same transcription factor network in TEPCs.  
 
On the other hand, the expression of Tbx1 was increased in the presence of TGFβ (p-
value = 0.03) (Figure 6.2F). As mentioned previously, ectopic Tbx1 expression in 
developing thymic rudiment results in loss of Foxn1 expression (Reeh et al. 2014). 
Thus, the observed decrease in Foxn1 expression could result from a direct effect of 
TGFβ signalling, or an indirect effect of the signalling pathway on Pax1 and/or Tbx1. 
Furthermore, the presence of TGFβ1 in culture also increased the expression of 
Gata3 (Figure 6.2G). Together, the changes in expression of the above mentioned 
genes suggests that TEPCs shift to a developmentally earlier transcriptional program 
in the presence of TGFβ1 in culture. An alternate possibility is that TGFβ1 could 
have a selective effect on the cultures, supporting parathyroid cells while leading to a 
loss of TECs. Analysis of expression of Gcm2 and/or Pth or that of parathyroid-
specific cell-surface marker through flow cytometry could help address this issue. 
 
6.4 Inhibition of TGFβ signalling in-vivo results in increased 
Foxn1 expression in several TEC subsets 
Hauri-Hohl et al. recently showed that inhibition of TGFβ signalling in-vivo resulted 
in a numerical and proportional increase in mTEC (Hauri-Hohl et al. 2014). 
However, the interaction of this signalling pathway with Foxn1 was not investigated. 
To address this issue, I injected 4 weeks old C57BL/6 (BL6) mice with either A8301 
(0.5mg/kg body weight) or vehicle only for 7 consecutive days (Figure 6.3A). The  
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Figure 6.2: Effects of TGFβ signalling on thymic epithelial cells culture.
(A) Schematic of the experimental setup used for testing the effects of TGFβ signalling on thymic 
epithelial cells culture. E12.5 thymi were isolated and dissociated into single cells suspension. Cells were 
then cultured on a thin layer of matrigel in N2B27 media in the presence or absence of TGFβ ligand and/
or inhibitor. EpCAM+ cells from the culture were sorted after 72hours for gene expression analysis. (B), 
(C), (D), (E), (F), and (G) Analysis of gene expression for (B) Foxn1, (C) Smad7, (D) Dll4, (E) Pax1, (F) 
Tbx1, and (G) Gata3 in thymic epithelial cells cultured in the presence or absence TGFβ ligand and/or 
inhibitor. DMSO was used as carrier control. Data are shown relative to HMBS. Data shown are 
representative of at least two biological replicates and three technical replicates. Error bars represent 
standard deviation. 
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injected mice were then sacrificed at either day8 or day14 after the first injection, to 
analyse the effect of inhibition of TGFβ signalling.  
 
The mice injected with vehicle only gained weight over the duration of injections. 
Their counterparts injected with A8301 also gained weight, but at much lower rate 
(Figure 6.3B). Thus, inhibition of TGFβ signalling had a systemic effect on mice. On 
the other hand, the mouse injected with A8301 had a slightly higher thymus weight 
and higher thymus vs body weight ratio at day 8 compared to that injected with 
vehicle only (Figure 6.3C&D). Both mice sacrificed at day-14 had gained similar 
amounts of weight since day-8, regardless of whether they were injected with A8301 
or vehicle only, suggesting that the observed effect of inhibiting TGFβ on body 
weight is reversible. The mice sacrificed at day 14 also did not show any substantial 
difference in thymus vs body weight ratio (Figure 6.3C). A pharmacological 
inhibition of TGFβ signalling leads to increased mTEC cellularity (Hauri-Hohl et al. 
2014), however, its effect on thymocytes has not been demonstrated. A T-cell 
specific deletion of Tgfbr1 leads to defects in specification of CD8+ T-cell fate and 
reduced frequency of FoxP3+ Treg (Liu et al. 2008; Ouyang et al. 2010; Ouyang et 
al. 2013). This suggests that pharmacological inhibition of TGFβ signalling could 
affect the thymocyte numbers and development. Thus, the effect of TGFβ inhibition 
on thymus weight observed here represents a cumulative effect on TECs and 
thymocytes.  
 
Figure 6.4A shows the sorting strategy for isolation of TEC subsets. The proportions 
of these TEC sub-populations were similar in both A8301 treated and vehicle treated 
mice analysed at day 8 and day 14 after the first injection (Figure 6.4B) (n = 1). 
While small variations were observed in proportions of cTEC MHCIIhi and 
Ly51+Plet1+ cells between A8301 treated and control mice, more biological 
replicates are required to determine whether these differences are significant.  
 
At gene expression level, the expression of Foxn1 was higher in mTEC MHCIIhi, 




Figure 6.3: Analysis of the effects of TGFβ signalling inhibition on adult thymus
(A) Schematic of the experimental setup used for testing the effects of inhibiting TGFβ signalling in adult 
thymus. (B) Comparison of changes in body weights of A8301 and vehicle only treated mice. (C) and (D) 
Bar graphs comparing the (C) thymus/body weight ratio and (D) thymus weight of A8301 and vehicle 
only treated mice at the end of the experiment period. The mice represented as control-2 and exp-1 were 
analysed 8 days after the first injection, while the mice represented as control-1 and exp-2 were analysed 
14 days after the first injection.
 204	
compared to the vehicle only control (Figure 6.5A). Interestingly, Foxn1 expression 
in cTEC MHCIIhi was lower in A8301 treated mice compared to control at day 14, 
suggesting that the upregulation of Foxn1 expression observed at day 8 is reversible 
(Figure 6.5A`). The Ly51+Plet1+ population, which contains thymic epithelial stem 
cells (Ulyanchenko et al. unpublished) showed a decrease in the expression of Foxn1 
at both day 8 and day 14 in the mouse injected with A8301 compared to the control. 
Foxn1 was expressed at similar levels between A8301 treated and control mice at 
day-14 (Figure 6.5A-A`). Thus, the expression of Foxn1 differed between A8301 
treated and control mice; however, more biological replicates are required to test the 
reproducibility and significance of these results. 
 
An increase in the expression of Foxn1 in the adult thymus has been shown to result 
in increased expression of genes such as Dll4, Ccl25, and Pax1 (Bredenkamp, 
Nowell, et al. 2014), similar to that observed during thymus development. 
Interestingly, the expression of these genes was either unchanged (or down-regulated  
in the case of Pax1) in A8301 treated mice compared to controls. (Figure 6.5B-B` to 
Figure6.5D-D`). This is consistent with the previous observation by Jeker and 
colleagues that loss of Smad4 in TECs results in an increase in Foxn1 expression in 
certain TEC subpopulations but a decrease in the expression of Ccl25 (Jeker et al. 
2008). Whether the observed increase in Foxn1 expression results in an increase in 
FOXN1 protein levels remains to be determined and could help understand the 
discrepancies in the observed results. Furthermore, another possible factor 
influencing the results is the age of the mice. Investigation of the outcome of 
inhibiting TGFβ signalling in older mice, which have a more involuted phenotype, 
would indicate whether age (and therefore the state of involution) determines the 
response to TGFβ inhibition. 
 
6.5 Discussion 
In this chapter, I show that inhibition of TGFβ signalling in the thymus leads to an 











Figure 6.4: Sorting strategy for isolation of cTECs and mTECs from adult thymus.
(A) Gates showing isolation of MHC Class II
hi
 and MHC Class II
lo
 cTECs and mTECs using flow 
cytometry. Events recorded as single cells were gated for cells negative for dead cell marker DAPI and 
Lin (CD45, CD11b, CD31, Ter119, Pdgfa). EpCAM
+
 cells within this population were gated on UEA1 
and Ly51 to identify mTECs and cTECs respectively. mTECs were further gated on MHC Class II 
expression to obtain mTEC MHC-hi and mTEC MHC-lo populations. cTECs were divided based on 
presence or absence of Plet1 and Plet1
-
 population was further gated on MHC Class II to obtain cTEC 
MHC-hi and cTEC MHC-lo populations. (B) Table showing the percentage of each mTEC and cTEC 
subpopulations within the EpCAM
+





Figure 6.5: Analysis of gene expression for Foxn1, Dll4, Ccl25, and Pax1 in TEC subpopulations in 
mice treated with A8301 or vechicle only.
Analysis of gene expression for (A) Foxn1, (B) Dll4, (C) Ccl25, and (D) Pax1 in mTEC MHC-hi, mTEC 
MHC-lo, cTEC MHC-hi, cTEC MHC-lo, and Ly51+Plet1+ cells isolated from mice treated with either 
A8301 or vehicle only. Graphs on the left and right represent results from mice sacrifised 8 and 14 days 
after the first injection, respectively. The blue bars represent vehicle only treated mice whereas the 
maroon bars represent A8301 treated mice. Data are shown relative to HMBS. Data shown are 
representative of three technical replicates. 
Expression 
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signalling on Foxn1 expression is at least partially mediated through increased 
expression of Tbx1 in TECs.  
 
6.5.1 TGFβ signalling during thymus development 
The TGFβ family of proteins play important roles in the development and 
maintenance of many cell types and tissues. However, their importance in regulation 
of the fetal and postnatal thymus has not been determined in detail. Among the 
various signalling pathways orchestrated by TGFβ proteins, the roles of BMP and 
TGFβ signalling pathways have been studied to some extent in thymic epithelial 
cells. In this chapter, I investigated the effects of TGFβ signalling on Foxn1 
expression in the developing and adult thymus. These data show that inhibition of 
TGFβ signalling pathway increases Foxn1 expression in TEPCs and some postnatal 
TEC subsets.  
 
Previous studies analysing the role of TGFβ in thymus have used Foxn1Cre to delete 
TGFβ receptors in the thymus, which results in deletion of the receptor upon 
activation of the Foxn1 gene at around E11.5 (Hauri-Hohl et al. 2008; Odaka et al. 
2013; Hauri-Hohl et al. 2014). These transgenic mice models therefore did not 
address the role of TGFβ signalling in thymus development prior to Foxn1 
expression, including in regulation of the initiation of high-level Foxn1 transcription. 
The results from above analyses suggest that down-regulation of TGFβ signalling 
activity might be required for normal thymus development. This hypothesis could be 
tested by using Foxg1Cre, which is expressed in 3PP from E9.5, to delete Tgfbr1/2. 
 
It has been shown that a short pulse of BMP signalling is required for initiation of 
Foxn1 expression during thymus development (Neves et al. 2012), however whether 
a similar temporal modulation of TGFβ signalling is also important remains to be 
determined and can not be answered using the above mentioned mouse models. Null 
mutants of either Tgfbr1 or Tgfbr2 exhibit defects in yolk sac, placenta, and various 
defects in hematopoetic and immune systems and are thus not suitable for studying 
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the role of TGFβ signalling in thymus development. Thus, new mouse models 
targeting deletion of either Tgfbr1 or Tgfbr2 specifically in the 3PP endoderm and 
TEPCs prior to initiation of Foxn1 expression are required to address the above 
issues. 
 
After the initiation of Foxn1 expression, the deletion of Tgfbr2 does not appear to 
have any adverse effect on thymus development or function (Hauri-Hohl et al. 2008; 
Hauri-Hohl et al. 2014). This suggests that TGFβ signalling is not required for 
Foxn1-dependant thymus development. However, I here show that addition of 
TGFβ1 to in-vitro cultures of developing E12.5 thymic lobes suppresses Foxn1 
expression relative to controls. It is important to note that the culture system used 
here dissociates the 3D E12.5 thymic rudiment and thus represents an artificial 
system, which may not resemble the in-vivo organ. Thus, whether TGFβ signalling 
has a similar effect on Foxn1 expression during thymus development in-vivo remains 
to be determined. This question could be approached by administration of a TGFβ 
signalling inhibitor to pregnant mice, however the outcome would depend on good 
availability of the inhibitor within the developing embryo. One approach to ensure 
good availability of the inhibitor to the developing embryo would be in-utero 
injections. Another possible in-vitro approach could employ whole embryo cultures 
in presence or absence of TGFβ1 to address the above issues. The above results 
suggest that induced activation of TGFβ signalling in the developing 3PP would 
result in ectopic expression of Tbx1 and prevent the up-regulation of Foxn1 
expression in the thymus domain. 
 
6.5.2 The importance of TGFβ signalling during thymus 
homeostasis and involution 
Thymic involution is an important aspect of thymus biology and it is desirable to 
improve our understanding of this process to enable development of therapies to 
improve thymus function in some cases of immunocompromised patients. The TGFβ 
signalling pathway has been shown to influence the rate of thymic involution (Hauri-
Hohl et al. 2008) and the distribution of TEC subsets and thymus function in adult 
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mice (Hauri-Hohl et al. 2014). The preliminary results presented herein, in which 
administration of a TGFβ signalling inhibitor was used to inhibit TGFβ signalling, 
supported the hypothesis that TGFβ signalling could regulate Foxn1 expression in 
TECs. The inhibition of TGFβ signalling using a pharmacological inhibition had a 
positive effect on Foxn1 expression in some TEC subsets. However, more replicates 
are required to determine the reproducibility and significance of the results shown 
above. Furthermore, as the mice used in these experiments were 4-weeks old, and 
had therefore not commenced thymic involution, they might be less responsive to the 
inhibition of TGFβ signalling pathway. Thus, similar A8301 administration 
experiments should be carried out in older mice. Finally, a thorough analysis should 
be carried out using different doses of A8301 inhibitor, in order to determine the 
optimal dose that shows a definitive phenotype without any adverse side effects. 
 
Together, the data presented in this chapter indicate the potential importance of 
TGFβ signalling in regulation of Foxn1 expression in TEPCs and TECs. Whether 
this regulation is mediated through SMAD proteins or through other associated 
pathways, such as p38 and MAPK pathways, remains to be determined. Regardless, 
modulation of TGFβ signalling could represent a novel mechanism for 
pharmacologically regulating Foxn1 expression in TEPCs and TECs. Whether such 
pharmacological intervention can produce sufficient up-regulation of Foxn1 
expression in TECs to lead to partial or complete thymus regeneration remains to be 
determined. It is likely that modulation of TGFβ pathway in combination with other 
signalling pathways, such as BMP, would be required to produce clinically relevant 





The field of stem cells has seen massive progress over the last few years in bringing 
regenerative and cellular therapies closer to clinics. A crucial factor in this success 
has been the improvement in our understanding of the development of different cell 
types, tissues, and organs. The thymus plays an important role in the adaptive 
immune system and it is therefore desirable to generate therapies for boosting its 
function in certain sub-groups of immunocompromised patients and potentially, the 
elderly population. Recent advances, including in differentiation of pluripotent stem 
cells and in reprogramming of MEFs to TEC-like cells, point to the capacity to 
provide cells grown in vitro for cellular therapies, aimed at boosting the thymus in 
vivo and are therefore major advances in this field (Parent et al. 2013; Bredenkamp, 
Ulyanchenko, et al. 2014). Furthermore, the study showing complete thymus 
regeneration in aged mice is the first of its kind showing the complete in vivo 
regeneration of an organ using single transcription factor (Bredenkamp, Nowell, et 
al. 2014). Thus, several different approaches are being investigated for boosting 
thymus function in patients. Importantly, the transcription factor FOXN1 is essential 
and sufficient for both the in vivo regeneration and in vitro reprogramming 
mentioned above, and is thus considered a master regulator in TECs. In this thesis, I 
set out to investigate the transcriptional regulators of Foxn1 in TEPCs, with the aim 
of improving the current understanding of the regulation of Foxn1 expression in 
TEPCs and TECs. The results from this thesis are summarised graphically in Figure 
7.1. 
 
The work described in Chapter 3 explored the transcription profiles for the candidate 
transcriptional regulators that had been predicted in a bioinformatics analysis 
performed prior to the start of this PhD. This analysis had sought to identify genes 
whose expression pattern correlated with that of Foxn1 in E12.5 and E15.5 TEPCs 
and E15.5 TECs, in an attempt to identify potential Foxn1 regulators. Thus, it was 
important to study the expression patterns of these genes during earlier thymus 
development, prior to and during the onset of Foxn1 expression. A transcriptional 
activator of Foxn1 would be expected to be expressed before, or at least immediately  
Figure 7.1: Predicted genetic interactions in TEPCs.
Shown are the genetic interactions predicted in Chapters 3 to 6 are shown as a network. Also shown is 
potential regulation of Foxn1 and Tbx1 expression by TGFβ signalling. The edges of the network are 
colour coded to represent the source of the predicted interactions: blue - this thesis, black - unpublished 
data from Blackburn lab, and brown - literature. Inputs from signalling pathways into this network are 
shown usign dashed lines. 
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prior, to the onset of Foxn1 expression in TEPCs. Chapter 3, therefore, analysed the 
expression of the candidate regulators during 3PP and TEPC development in both 
WT and nude (i.e. Foxn1 null) mice. Most of the genes studied were expressed 
before or at the time of onset of Foxn1 expression. Comparison between WT and 
nude further showed that the expression of some of these genes was sensitive to the 
presence or absence of FOXN1. These analyses allowed identification of genes 
whose expression was dependent on FOXN1, such as Gata3, Eya1 and Thap11, 
which were repressed by FOXN1. Foxn1 has been shown to be important for the 
expression of Notch1 in hair follicle (Cai et al. 2009). Notch1 expression was found 
to be upregulated substantially at E12.5, a time point at which highest expression of 
Foxn1 was observed, suggesting that FOXN1 regulates the expression of Notch1 in 
TECs, similar to that observed in hair follicle. The expression of Hes6, an effector of 
Notch signalling, appeared to be regulated by Foxn1, suggesting that Foxn1 might be 
involved in modulating Notch signalling pathway in TECs. Furthermore, these 
analyses also identified genes whose expression pattern during early thymus 
development was consistent with that expected for a transcriptional regulator of 
Foxn1, such as Pax1, Foxo1, p63, Eya2, Hes1, Bhlhe40, and Irf6. Indeed, 
unpublished data from this lab suggest that Pax1 and Pax9 are important for 
initiation of Foxn1 expression in the fetal thymus. However, the expression of some 
of these genes, such as Pax1, Foxo1, Eya2, and p63, was reduced in Foxn1-/- TEPCs, 
suggesting that these genes could also be targets of FOXN1. It is possible that some 
of these genes could act as both transcriptional regulators and targets of Foxn1, 
similar to the observations for Pax1. Another set of genes, including Pax9, Foxg1, 
Sox9, and Six1, showed an increase in expression at E12.0. Whether such an increase 
in the expression of these genes is required for upregulation of Foxn1 expression at 
this developmental stage remains to be determined.  
 
The results presented in this chapter suggested that the expression of Pax1 in TEPCs 
is positively regulated by FOXN1, whereas Pax9 expression was found to be similar 
between WT and nude thymi. Thus, Pax1 and Foxn1 can act as positive regulators of 
each other. Foxn1 has also been suggested to be show positive auto-regulation (Zook 
et al. 2011; Bredenkamp, Nowell, et al. 2014). Thus, there seems to be a highly 
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stable transcription factor network prevalent in TECs with several positive feed-
forward mechanisms strengthening the TEC transcriptional programme. The 
downregulation of Eya1 and an upregulation of Pax1 from E11.5 to E12.5 suggest 
that Foxn1 could replace Eya1 in regulation of Pax1. Since Eya1 is required for 3PP 
development, an interesting question is whether a 3PP developmental transcription 
programme is being replaced by a TEC development and differentiation programme. 
Together, the results from this chapter identified potential Foxn1 target genes and 
genes with expression profiles consistent with that expected for transcriptional 
activators of Foxn1. However, an important limitation of this approach was the 
correlation analysis used for identification of candidate transcriptional regulators of 
Foxn1. As mentioned above, the correlation analysis was performed on a small 
number of samples (5 samples) from developmental time points post initiation of 
Foxn1 expression in TEPCs and thus had limited statistical power. Furthermore, 
unlike Pax1 and Pax9, our knowledge regarding the functions of most of the 
candidate transcriptional regulators in the thymus is very limited. It was therefore 
desirable to complement this approach with genome-wide unbiased approaches for 
identification of transcriptional regulators of Foxn1. 
 
To this end, Chapter 4 focused on identification of regulatory elements governing the 
expression of Foxn1 in developing TEPCs. The approach selected for this purpose 
was identification of promoter and enhancer related histone modification through 
ChIP-seq. An advantage of ChIP-seq is that it allows identification of regulatory 
elements without a need for any prior knowledge of regulatory interactions between 
genes. The aim here was to identify small, defined regions that could act as promoter 
or enhancers to regulate Foxn1 expression in TEPCs. The commonly used 27 kb 
Foxn1 promoter region, which recapitulates Foxn1 expression in the fetal thymus, 
contains thousands of binding sites for hundreds of transcription factors and is thus 
unsuitable for identification of candidate transcriptional regulators. Thus, I reasoned 
that smaller regions identified using the above ChIP-seq approach would be better 
suited for this purpose. To this end, I identified five putative enhancers for Foxn1, 
each only a few hundred base pairs long, and the TFBSs present within these regions. 
Among the genes analysed in Chapter 3, Ing4, Foxa2, Hes1, Foxc1, E2Fs, and p53 
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had physical binding sites within the identified Foxn1 promoter or enhancers, further 
supporting their involvement in regulating Foxn1 expression. However, whether 
these genes bind in vivo to the identified sites remains to be determined. Analysis of 
the identified promoter regions for Foxn1, Pax1, Pax9, Trp63, Dll4, Ccl25, Kitl, and 
Gata3 showed that binding sites for BRCA1:USF2 complex were enriched in these 
regions. The role of Brca1 in TECs remains unknown, however the present analyses 
suggests that it could be involved in regulating gene important for thymus 
development and function. 
 
A limitation of this approach is that position weight matrices for most of the 
transcription factors studied here are derived from in-vitro or sequence alignment 
approaches, which are typically of poorer quality than those derived from ChIP-seq 
data for transcription factors. This is likely why no binding sites for FOXN1 were 
identified within the regulatory regions of genes thought to be its direct targets, such 
as Dll4 and Ccl25. Furthermore, it will be important to determine the reproducibility 
of the identified peaks for histone modifications using biological replicates.  
 
The analysis of the identified genome-wide active enhancer regions revealed that 
these regions are present in the vicinity of genes important for thymus development 
and function, supporting this approach. Enrichment analysis performed on these 
genes showed that enrichment for several signalling pathways, including TGFβ, 
BMP, Notch, NFκB and MAPK signalling. The TFBS analysis showed presence of 
several SMAD4 binding sites in the Foxn1 promoter and enhancers identified herein. 
Given the importance of both BMP and TGFβ signalling pathways in TECs, it is 
likely that SMAD proteins may be involved in regulating Foxn1 expression in these 
cells. The enrichment of Notch signalling from this analysis was consistent with the 
importance of this pathway in thymus development and its modulation by Foxn1 
predicted in Chapter 3. The enrichment analysis also suggested that some of the 
genes regulated by Foxn1 maybe be shared between the thymus and the skin.  
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In Chapter 5, I performed global transcriptome analysis on E10.5 and E11.5 3PP 
cells and E12.5 TEPCs, with the aim of identifying differences in gene expression 
between these cells. This chapter overcomes the limitations associated with the 
correlation analysis mentioned above. Furthermore, analysis of the developing 3PP 
and TEPCs at the selected time points could identify genes and signalling pathways 
important for this process. The results in this chapter showed that genes which are 
expressed at higher levels in E12.5 TEPCs compared to the 3PP cells were enriched 
for biological processes associated with T-cell development and differentiation, 
processes mediated by cross-talk between thymocytes and TECs. A closer analyses 
of these genes suggested that they were likely to be important for the antigen 
presentation function of TECs. On the other hand, genes with decreasing expression 
from E10.5 to E12.5 were enriched for biological processes related to development, 
cell fate commitment, and others, supporting the developmentally earlier state of 
these cells compared to E12.5 TEPCs. The above analysis identified genes that could 
be important for 3PP endoderm, such as Nkx2.6 and Sox2 and also those important 
for TEC function such as Cd83, Itgb2 and Prss16. The roles of these genes in the 
respective cell types remains to be determined. 
 
I also identified transcription factors expressed differentially between E10.5 and 
E11.5 3PP cells and showed that of these, Ets1, Gata3, Isl1, Ebf1, Egr1, Foxc1, Nfia, 
Nfib, Nfatc2, Srf, and Maf had physical binding sites in the Foxn1 promoter or 
enhancers identified in Chapter 4. Thus, these TFs could be involved in regulation of 
Foxn1 expression in TEPCs. Some of these TFs were among the list of candidate 
transcriptional regulators studied in Chapter 3. Of the TFs with significantly 
upregulated expression at E11.5, Nfatc2 and Stat4 are strong candidate 
transcriptional targets of FOXN1. Furthermore, these TFs may also be involved in 
regulating Foxn1 expression as the Foxn1 promoter and enhancers identified in 
Chapter 4 contained binding sites for these TFs. The results presented in this chapter 
suggest that Nfatc2 could be involved in regulating a large array of genes in TEPCs 
and thus play an important role in their development and/or differentiation. Finally, 
analysis of signalling pathways suggested that NFκB signalling is likely to be 
important for TEPC development and differentiation, consistent with the enrichment 
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of this pathway in analysis performed in Chapter 4. A closer inspection of this 
pathway suggested IL1R1 as the major activator of this pathway in TEPCs. 
Furthermore, the NFκB signalling pathways appears to be regulating genes involved 
in cell survival and lymphocyte attraction and activation in TEPCs. Genes involved 
in negative feedback of NFκB signalling were also upregulated suggesting that the 
activation of this pathway may similar oscillatin patterns as observed in other cell 
types.  
 
The analysis of predicted interactions between TFs showed that the activity of a TF 
network involving Hox genes decreased from E10.5 to E12.5, probably as a result of 
negative regulation via Hoxa7, whereas the activity of a TF network involving Nfkb 
and Irf genes increased during these developmental stages. This further supports the 
importance of NFκB signalling in these cells. Finally, Msx2 has been suggested to be 
upstream of Foxn1 expression in hair follicle, as Foxn1 expression is down-regulated 
in Msx2 mutants (Meier et al. 1999; Schlake & Boehm 2001). However, Msx2 
expression decreased from E10.5 to E12.5 in the developing thymic primordium, 
suggesting that Msx1 does not have a similar role in TEPCs. 
 
In Chapter 6, I investigated the role of TGFβ signalling in regulation of Foxn1 
transcription in TEPCs and TECs. The results from Chapter 4 strongly suggested a 
role of this signalling pathway in TEPC, while evidence from literature suggest that 
this pathway is important for thymus homeostasis and involution. Given the 
important role of Foxn1 in thymus homeostasis and involution, I wanted to 
determine whether the TGFβ signalling could influence the levels of Foxn1 
transcription in TECs. The results presented in this chapter suggested that TGFβ 
signalling could influence levels of Foxn1 expression both in-vivo and in-vitro, with 
inhibition of the signalling pathway resulting in increased expression of Foxn1. 
TGFβ signalling was also found to be able to influence the expression of Pax1, Tbx1, 
and Gata3. Of these, Pax1 and Tbx1 are known to be able to regulate Foxn1 
expression in TEPCs and Gata3 was found to be a Foxn1 target in Chapter 3. This 
suggested that the TGFβ signalling could influence the genes involved in this genetic 
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network. However, whether the effect of TGFβ signalling on Foxn1 expression is a 
direct or indirect effect remains to be determined. Given that Foxn1 promoters and 
enhancers identified in Chapter 4 contained SMAD4 binding sites, it suggested that 
the observed effects on Foxn1 expression could be a direct effect of the pathway. 
This hypothesis needs further testing through manipulation of the identified SMAD4 
binding sites. To this end, I generated ES-cell lines in which the regions containing 
SMAD4 binding sites have been deleted. Chimeric embryos generated using these 
cell lines could help determine the importance of SMAD4 in regulating Foxn1 
expression. Given that SMAD4 is also important for BMP signalling, such chimeric 
embryos could also be used to determine whether the role of BMP signalling in 
initiation of Foxn1 expression is dependant on SMAD4.  
	
7.1 Future experiments 
The data presented in Chapter 4 were obtained through analysis of a single sample 
for each histone modification. It will therefore be important to determine the 
reproducibility of these results after incorporation of biological replicates into the 
study; this would allow identification of high-confidence reproducible peaks for 
histone modifications under study. The identified regulatory regions should also be 
tested for their respective promoter or enhancer activities using a combination of in 
vitro (for example, Luciferase reporter assays) and in vivo approaches (for example, 
deletion of these regions) to determine the effect on target gene expression during 
thymus development. The binding sites for the candidate regulators of Foxn1 shown 
in Figure 7.1 should be tested using the above approaches in order to determine 
which of these TFs are involved in regulation of Foxn1 expression in the thymus. To 
this end, I have generated an ES cell lines in which the SMAD4 binding sites in the 
Foxn1 promoter have been deleted (see Appendix for details). These cell lines should 
be used to generate high contribution chimeras, an analysis of which would indicate 
the effect of deleting these TFBSs on Foxn1 expression during thymus development.  
 
Furthermore, studying the epigenetic changes associated with TEPC development 
could help identify important regulatory regions that govern the transcriptional 
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changes associated with this process. It would, therefore, be important to perform 
ChIP-seq for histone modifications on E10.5 and/or E11.5 3PP cells to carry out a 
comprehensive analysis of the epigenome of developing TEPCs. This indeed 
presents additional challenges, as the E10.5 and E11.5 primordium are considerably 
smaller than the E12.5 thymic rudiment and thus the cell numbers would be even 
more limiting. An alternative approach, discussed in Chapter 4, would be to 
characterize the open-chromatin profiles of 3PP cells and TEPCs using ATAC-seq. 
The combination of the histone modification data generated here and corresponding 
ATAC-seq data for E12.5 TEPCs could help identify regulatory regions with high 
confidence. 
 
In Chapter 5, it would be important to test the predicted interactions between TFs 
using in vivo and in vitro approaches. The expression of Nfatc2 and Stat4 in the 
developing thymic rudiment should be validated using qRT-PCR, in-situ 
hybridization or immunohistochemistry. It would be important to test the predicted 
transcriptional regulators of Foxn1 through deletion of their binding sites, as 
described above, or through use of conditional mutants for these genes. The 
importance of NFκB signalling in TEPC development could be tested through 
deletion of conditional Nfkb1 and Rela alleles using Foxg1-Cre, which in 3PP is only 
active in the endodermal cells. To further investigate the predicted interactions 
between TFs, it would be interesting to determine whether these TFs exhibit 
overlapping expression in the thymus domain during organogenesis. Direct targets of 
these TFs could be identified using ChIP as ChIP-grade antibodies for some of these 
are commercially available.  
 
The transcription profile for TEPC generated here could be used to determine the 
relation between TEPCs and more differentiated TEC subpopulations found in the 
adult thymus through comparison of global trancscriptome data. Transcriptome data 
for adult TEC subpopulations was recently generated in our lab (Kathy O’Neil, 
unpublished) and could be used for this purpose. The regulatory networks governing 
the early development of blood tissue has been identified using gene expression 
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profiling of hundreds of single cells (Moignard et al. 2013; Moignard et al. 2015). 
Whether a similar approach could be applied to determine the regulatory networks 
important for thymus development based on a considerably smaller sample set 
(consisting of TEPCs and TECs) available in our lab should be explored.  
 
In Chapter 6, it will be important to determine the role, if any, of TGFβ signalling in 
3PP and thymus development. This could be done through inhibition or activation of 
this pathway using either genetic approaches or through the use of chemical 
inhibitors, as described in this chapter. Analysis of nuclear SMAD2 and/or SMAD3 
in the developing thymic primordium could help determine whether this pathway is 
active during development. Data from biological replicates should be generated to 
reproducibly determine the effect of TGFβ inhibition on Foxn1 in adult TECs. An 
important question is whether the observed effect of TGFβ inhibition on Foxn1 
expression is a direct or indirect. Comparison of the nuclear localization of SMAD2, 
SMAD3, and SMAD4 between inhibitor treated and control samples could help 
address this issue. Comparison of results from performing similar experiments using 
SMAD specific inhibitors and those for other downstream transduction pathways 
activated by TGFβ receptors could also help address this issue. Finally, it would be 
interesting to determine whether a simultaneous activation of BMP signalling and an 
inhibition of TGFβ signalling could further increase the expression of Foxn1 in 





8.1 Identification and manipulation of SMAD4 binding sites in 
Foxn1 promoter 
SMAD4 is a key downstream effector protein of both TGFβ and BMP signalling 
pathways. While these pathways have been implicated in regulation of Foxn1, in the 
case of BMP signalling in the literature, and in the case of TGFβ signalling through 
the results shown in Chapter 6, the mechanisms underpinning these effects have not 
yet been reported. To determine whether the TGFβ and BMP signalling pathways 
regulate Foxn1 expression directly through SMAD proteins, I identified SMAD4 
binding sites within Foxn1 promoter as described in Chapter 4. Figure 8.1A shows 
the position weight matrix (PWM) for SMAD4 in the TRANSFAC database. Several 
SMAD4 binding sites were identified in the Foxn1 promoter, as shown in Table 8.1. 
All of the identified sites had a high degree of match with the SMAD4 PWM 
suggesting that these sites could be occupied by SMAD4. The locations of these 
binding sites relative to Foxn1 TSS and the H3K4me3 marked region is shown in 
Figure 8.1B and Figure 8.2A. Of these sites, only 2 sites showed perfect match to the 
SMAD4 PWM (identified by the red box in Figure 8.2A). 
 
The physical binding of SMAD4 on DNA has been investigated in various cell types 
using ChIP-seq allowing the identification of its target genes. However, given the 
difficulties in obtaining sufficient number of cells for performing ChIP on 
transcription factors, this approach was not pursued here. An alternate in-vivo 
approach is to delete or mutate the binding sites for a particular transcription factor in 
the vicinity of its potential target gene, to determine the functional significance of 
these sites. The advances in gene editing technologies such as zinc finger nucleases 
(ZFNs), transcription activator-like effector nucleases (TALENs), and clustered 
regularly interspersed short palindromic repeats (CRISPR)-Cas9 now allows rapid 
and precise editing of the genome using these techniques. Thus, I decided to use the 
CRISPR-Cas9 system to test the importance of the selected SMAD4 binding sites in 
regulation of Foxn1 expression in TEPCs.  
B
A: SMAD4 position weight matrix
Figure 8.1: Identification of SMAD4 binding sites within Foxn1 promoter.
The Foxn1 promoter identified in Chapter 4 was analysed for presence of SMAD4 binding sites using 
Match algorithm and TRASFAC professional database. (A) SMAD4 position weight matrix in 
TRANSFAC professional database used to identify binding sites. (B) UCSC genome browser image 
showing individual SMAD4 binding sites as verticle bars above Foxn1 gene. Also shown is the 
H3K4me3 marked region and sequence conservation tracks.  
A
B
Figure 8.2: Deletion of SMAD4 binding sites within Foxn1 promoter.
(A) UCSC genome browser view showing the location of individual SMAD4 binding sites within Foxn1 
promoter. The red box shows two SMAD4 sites with 100% match to SMAD4 position weight matrix. 
Also shown are locations of guide RNAs designed to delete the genomic regions containing SMAD4 
binding sites using CRISPR-Cas9. (B) Schematic diagram showing the expected deletions using two 
guide RNA combinations: gR5 + gR6 and gR1 + gR6. The red arrows show the location of deletion in 
Foxn1 locus. 
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To this end, I designed guide-RNAs (gRNA) spanning the identified SMAD4 
binding sites in Foxn1 promoter using E-CRISP (Heigwer et al. 2014), a web-based 
application for designing gRNAs. E-CRISP allows identification of target sequences 
complementary to gRNAs and ending in 3` protospacer-adjacent motif (PAM) and 
evaluates the off-target effects and target-site homology using Bowtie2 (Heigwer et 
al. 2014). The Foxn1 promoter sequence described above was used as the target 
sequence for E-CRISP, and gRNAs were identified using the default parameters. The 
identified gRNAs were further filtered for those with the strongest PAM site (NGG) 
to allow for efficient binding of S.pyogenes Cas9. This resulted in 6 gRNAs, which 
passed all of the filters and were used for subsequent analysis. The sequences of the 
identified gRNAs and their location relative to Foxn1 promoter are shown in Table 
8.2 and Figure 8.2A, respectively. Among these 6 gRNAs, gR1, gR2, and gR5 were 
located upstream (on the positive strand) of the two perfectly matched SMAD4 
binding sites and gR3, gR4, and gR6 were located downstream. Thus, the SMAD4 
binding sites could be deleted using different combinations of upstream and 
downstream gRNAs, resulting in deletion of genomic regions of varying lengths. 
This approach was therefore chosen over the alternate approach of mutating the 
SMAD4 binding sites through homologous recombination for the following reasons. 
First, the identified promoter region is a part of the 27-kb genomic region shown to 
be able to recapitulate Foxn1 expression pattern in the developing thymus, as 
described in Chapter 1. Thus, deletion of regions within the promoter would allow 
determination of the relative contributions of these regions in regulating Foxn1 
expression. Secondly, while this approach does not allow determination of the 
specific role of SMAD4 in regulation of Foxn1 expression, because the deleted 
regions will contain binding sites for many other transcription factors, the presence 
of binding sites for other factors increases the possibility of observing an effect on 
Foxn1 expression. The relative contributions of the different transcription factors 
with binding sites within this region could then be determined by mutating these sites 
using homologous recombination. This could potentially allow identification of other 
transcription factors besides Smad4 that play an important role in regulation Foxn1 
transcription in TEPCs.  
 
Table 8.1: SMAD4 binding sites within Foxn1 promoter.
Shown are all the SMAD4 binding sites identified within the Foxn1 promoter identified in Chapter 4. The 
genomic location of the binding sites, core and matrix similarities, and the matched genomic sequences 
are also shown. Highlighted in red are sites with 100% core and matrix similarity with SMAD4 matrix.
Table 8.2: guideRNA sequences and genomic locations.
Shown are the guideRNAs identified using E-crisp software. The sequences, genomic coordinates, and 
position relative to the two perfectly matched SMAD4 binding sites are also shown. 
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The gRNAs were cloned into pKLV-U6gRNA_BbsI_PGKPuro2ABFP_gRNA 
vector obtained from Dr Keisuke Kaji’s lab (unpublished) (SCRM, University of 
Edinburgh), which results in gRNA being transcribed using U6 promoter and allows 
selection of the transfected cells through the expression of puromycin resistance and 
blue fluorescent protein genes. Plasmids were delivered using lentiviral vectors into a 
transgenic ES line, also obtained from Dr Keisuke Kaji’s lab, which expresses the 
Cas9 gene under a constitutive promoter (unpublished). The gR1 and gR6, or gR5 
and gR6 gRNAs were introduced into ES cells, in order to create deletions of varying 
lengths within Foxn1 promoter. The genomic regions deleted using these 
combinations of gRNAs are shown in Figure 8.2B. The combined transfection with 
gR1 and gR6 leads to deletion of 1768bp, containing seven putative SMAD4 binding 
sites. On the other hand, gR5 and gR6 together lead to a deletion of 592bp, 
containing three putative SMAD4 binding sites.  
 
ES cells transfected with the above combinations of gRNAs were purified by flow 
cytometry, using the blue fluorescent protein present in the plasmid, 48-hours after 
infection and were then cultured at clonal density to allow identification of clones 
containing the desired deletion on both alleles of Foxn1. Individual clones were 
picked and cultured to obtain sufficient cells for subsequent analysis of deleted 
regions and use in future experiments. As shown in Figure 8.3, of the colonies 
obtained from ES cells transfected with gR1 and gR6, clone 11 showed deletion of 
the desired region in both alleles, and clone-13 showed deletion on one allele only. 
Similarly, of the colonies obtained from ES cells transfected with gR5 and gR6, 
clone-21 showed deletion on both alleles. Clones carrying homozygous deletions 
were expanded and frozen in liquid nitrogen for further experiments.  
 
8.1.1 Discussion 
SMAD proteins are the primary downstream effector molecules of the TGFβ and the 
BMP signalling pathways. Thus, it is reasonable to assume that at least some of the 
observed effects of these pathways in TEPCs and TECs are mediated through SMAD 
proteins. Given that SMAD4 is the common SMAD protein important in both of  
A: genotyping ES clones transfected with gR1 and gR6
B: genotyping ES clones transfected with gR5 and gR6
Figure 8.3: Screening of ES cell clones for CRISPR-Cas9 mediated deletion.
Agarose gel electrophoresis images showing deletions within ES cell clones transfected with either (A) 
gR1 and gR6 or (B) gR5 and gR6 guide RNAs. The first lane show 1kb plus marker used to determine the 
sizes of observed DNA bands. A PCR product for undeleted region (last lane) was used as positive control 
for the PCR reaction. Clone 11 in (A) and clones 21 in (B) showed the desired deletions.
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these signalling pathways, I focused on analysing the involvement of SMAD4 in 
regulation of Foxn1 transcription. The two different cell lines described above will 
provide useful tools for testing the importance of some of the identified SMAD4 
binding sites and also testing the role of deleted genomic region in regulation of 
Foxn1 expression in vivo. Chimeric embryos should be generated using these ES cell 
lines to enable analysis of the importance of the deleted regions in development of 
the thymus and regulation of Foxn1 expression in TEPCs and TECs. The thymi from 
such chimeric embryos would be expected to present defects in initiation of Foxn1 
expression, owing to the importance of BMP signalling for this process; and would 
also be expected to demonstrate an absence of effect of TGFβ signalling on Foxn1 
expression in vitro and in vivo. Such transgenic mice could also be aged to determine 
whether this region is important for the age-related decrease in Foxn1 expression and 
for TGFβ and/or BMP mediated effects on thymic involution. These transgenic ES 
cell lines could also be used for direct differentiation into thymic epithelial cells, to 
test the importance of the deleted regions in vitro. The region(s) whose deletion 
results in changes in Foxn1 expression could be further tested for binding and 
regulation by transcription factors, particularly SMAD4, using a combination of in 
vivo and in vitro assays, including mutation of the sites using CRISPR-Cas9 
mediated homology recombination, and luciferase assays. The binding of SMAD4 to 
the identified binding sites in the Foxn1 promoter could be tested by performing 
ChIP-qPCR using thymic epithelial cell lines, which might overcome the issue of 
sample availability, can further help distinguish between direct and in-direct effect of 
TGFβ and BMP signalling pathways. However, the TEC cell lines do not faithfully 
represent their in vivo counterparts due to absence of the 3D structure, other stromal 
cells, and thymocytes and also differ in the expression of key genes, including 
Foxn1. Thus, these cell lines do not present a suitable model for studying TEC 
biology and may not be well suited for the above purpose. Note that the TGFβ and 
BMP signalling pathways can also modulate transcription through SMAD 
independent mechanisms. The approach described above would not be useful in 
studying the role of SMAD independent mechanisms in thymus development and 
function and in regulating Foxn1 expression. One way to test for this would be 
through chemical inhibition of SMAD independent pathways in TECs. 
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8.2 Transcription factor binding sites in Dll4, Ccl25, p63, Kitl, and 
Gata3 promoters identified using MATCH and TRANSFAC 
Dll4 promoter: 
AIRE, AML3, AP-1, AP-2alphaA, Arid5a, BBX secondary motif, BEN, Blimp-1, 
BRCA1:USF2, Cdc5, CDP CR1, Cdx-2, C/EBPalpha, Churchill, CIZ, COE1, CP2, CPBP, 
CREB1, ATF-2, CRX, CTCF, DEAF1, deltaEF1, dlx-3, LXR, PXR, CAR, COUP, RAR, 
DRI1, E2A, E2F, Ebox, Egr-1, ER-alpha, Ets, FAC1, ZNF263, Freac-3, GATA, GCMb, 
GEN_INI, Gfi1, GKLF, GLI, Hbp1, HES-1, Hic1, HIF-1alpha, HMGIY, HNF-1alpha, HNF-
3beta, HSF1, Ikaros, ING4, INSM1, ipf1, IRF-1, islet1, Kaiso, LEF-1, LRH-1, LUN-1, 
MAF, MAFA, MAZ, MAZR, MECP2, MEF-2, MEIS1, MRF2, MTF-1, c-Myb, myogenin, 
MZF-1, NF-1, NF-1A, NF-AT1, NF-Y, Nkx2.5, p53, Pbx, Pit-1, POU2F1, POU6F1, RBP-
Jkappa, RelA-p65, REST, RFX, RFX1, RNF96, RREB-1, RUSH-1alpha, SF-1, Smad4, 
Sox10, Sp1, SP100 seondary motif, SREBP, SRY, STAT1, TATA, Tbx5, TEF-1, TTF-1, 
XBP-1, Xvent-1, YY1, ZFP105 secondary motif, ZFP161, Zfx, ZNF333, ZSCAN4 
secondary motif 
Ccl25 promoter: 
AHR, AIRE, AML3, AP-1, AP-2alphaA, Arid5a, BBX secondary motif, Bcl-6, BEN, 
Blimp-1, BRCA1:USF2, Cdc5, CDP CR1, Cdx-2, C/EBPalpha, Churchill, CIZ, COE1, CP2, 
CPBP, ATF-2, CRX, CTCF, deltaEF1, DMRT4, LXR, PXR, CAR, COUP, RAR, DRI1, 
E2A, E2F, Ebox, EKLF, ER-alpha, Ets, FAC1, ZNF263, Freac-3, GATA, GCMb, GEN_INI, 
Gfi1, GKLF, GLI, HES-1, Hic1, HIF-1alpha, HMGIY, HNF-1alpha, HNF-3beta, HNF-4A, 
HNF-6, HSF1, Ikaros, ING4, INSM1, ipf1, IRF-1, islet1, Kaiso, LEF-1, LRH-1, MAF, 
MAFA, MAZ, MECP2, MEF-2, mef-2A, MEIS1, MRF2, MTF-1, c-Myb, myogenin, NF-1, 
NF-1A, NF-AT1, NF-AT5, NF-Y, Nkx2.5, p53, Pbx, Pit-1, POU2F1, POU6F1, RBP-
Jkappa, RelA-p65, REST, RFX, RFX1, RNF96, RORalpha, RREB-1, RUSH-1alpha, SF-1, 
Smad4, Sox10, Sox2, Sp1, SP100 seondary motif, SREBP, SRY, STAT1, TATA, Tbx5, 
TEF-1, TTF-1, Xvent-1, YY1, ZFP105 secondary motif, ZFP161, Zfx, ZNF333, ZSCAN4 
secondary motif 
p63 promoter: 
AIRE, AML3, AP-1, AP-2alphaA, Arid5a, BBX secondary motif, Bcl-6, BEN, Blimp-1, 
BRCA1:USF2, Cdc5, CDP CR1, Cdx-2, C/EBPalpha, Churchill, CP2, CPBP, CREB1, ATF-
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2, CRX, CTCF, deltaEF1, DMRT4, LXR, PXR, CAR, COUP, RAR, DRI1, E2A, E2F, 
Ebox, Egr-1, ER-alpha, Ets, FAC1, ZNF263, Freac-3, GATA, GCMb, GEN_INI, Gfi1, 
GKLF, GLI, Hbp1, HES-1, Hic1, HIF-1alpha, HMGIY, HNF-1alpha, HNF-3beta, HNF-6, 
HSF1, Ikaros, ING4, INSM1, ipf1, IRF-1, islet1, Kaiso, LEF-1, LRH-1, LUN-1, MAF, 
MAFA, MAZ, MAZR, MEF-2, mef-2A, MEIS1, MRF2, c-Myb, myogenin, NF-1, NF-1A, 
NF-AT1, NF-Y, Nkx2.5, p53, Pbx, Pit-1, POU2F1, POU6F1, RBP-Jkappa, RelA-p65, 
RFX1, RREB-1, RUSH-1alpha, SF-1, Smad4, Sox10, Sox2, Sp1, SP100 seondary motif, 
SREBP, SRY, STAT1, TATA, Tbx5, TEF-1, TTF-1, Xvent-1, YY1, ZFP105 secondary 
motif, ZFP161, ZNF333, ZSCAN4 secondary motif 
Kitl promoter: 
AHR, AIRE, AP-1, AP-2alphaA, Bbx, BBX secondary motif, BEN, BRCA1:USF2, CDP 
CR1, Cdx-2, C/EBPalpha, Churchill, CPBP, CREB1, ATF-2, CRX, CTCF, deltaEF1, DRI1, 
E2A, E2F, Ebox, Egr-1, ER-alpha, Ets, FAC1, ZNF263, Freac-3, GATA, GEN_INI, Gfi1, 
GKLF, GLI, HES-1, Hic1, HIF-1alpha, HMGIY, HNF-1alpha, HNF-3beta, HSF1, Ikaros, 
ING4, ipf1, islet1, Kaiso, LEF-1, LRH-1, MAF, MAFA, MAZ, MECP2, MEF-2, mef-2A, 
MEIS1, MTF-1, c-Myb, myogenin, NF-1, NF-1A, NF-AT1, Nkx2.5, p53, Pbx, Pit-1, 
POU2F1, POU6F1, RBP-Jkappa, RelA-p65, RFX, RFX1, RNF96, RREB-1, RUSH-1alpha, 
SF-1, Smad4, Sox10, Sox2, Sp1, SP100 seondary motif, SRY, TATA, Tbx5, TEF-1, TTF-1, 
Xvent-1, YY1, ZFP105 secondary motif, ZFP161, ZNF333, ZSCAN4 secondary motif 
Gata3 promoter: 
AHR, AIRE, AML3, AP-1, AP-2alphaA, Bbx, BBX secondary motif, BEN, Blimp-1, 
BRCA1:USF2, CDP CR1, Cdx-2, C/EBPalpha, Churchill, CIZ, COE1, CP2, CPBP, CREB1, 
ATF-2, CRX, CTCF, deltaEF1, DMRT4, LXR, PXR, CAR, COUP, RAR, DRI1, E2A, E2F, 
Ebox, Egr-1, ER-alpha, Ets, FAC1, ZNF263, Freac-3, GATA, GCMb, GEN_INI, Gfi1, 
GKLF, GLI, Hbp1, HES-1, Hic1, HIF-1alpha, HMGIY, HNF-1alpha, HNF-3beta, HNF-4A, 
HNF-6, Ikaros, ING4, ipf1, IRF-1, islet1, Kaiso, LEF-1, LRH-1, MAF, MAFA, MAZ, 
MAZR, MEF-2, mef-2A, MRF2, MTF-1, c-Myb, myogenin, MZF-1, NF-1, NF-1A, NF-
AT1, NF-AT5, NF-Y, Nkx2.5, p53, Pbx, Pit-1, POU2F1, POU6F1, RBP-Jkappa, RelA-p65, 
REST, RFX, RFX1, RNF96, RREB-1, RUSH-1alpha, SF-1, Smad4, Sox10, Sox2, Sp1, 
SP100 seondary motif, SREBP, SRY, STAT1, TATA, Tbx5, TEF-1, TTF-1, Xvent-1, YY1, 
ZFP105 secondary motif, ZFP161, Zfx, ZNF333, ZSCAN4 secondary motif 
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